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ABSTRACT
The investigations described in this thesis have examined 
the effects of drugs and neurotransmitters on different classes 
of intraspinal terminal in the lumbosacral spinal cord of 
pentobarbitone anaesthetised cats. The terminals of group I 
primary afferent fibres from extensor muscles were depolarized 
by GABA, whereas the axon terminals of rubrospinal and 
vestibulospinal neurones were neither depolarized nor 
hyperpolarized by GABA in a bicuculline-sensitive manner. It 
is therefore likely that the terminals of rubrospinal and 
vestibulospinal neurones do not possess bicuculline-sensitive 
GABA receptors. In contrast primary afferent terminals, which 
differ from descending terminals by receiving axo-axonic 
synapses and originating in the periphery, do possess 
bicuculline-sensitive GABA receptors. The absence of 
bicuculline-senstitive GABA receptors on rubrospinal and 
vestibulospinal fibres and terminals argues against the 
proposal that such receptors are ubiquitous components of 
mammalian neuronal membranes. Furthermore, it seems that axon 
terminals do not necessarily possess receptors that are present 
on the cell bodies that give rise to them.
The water soluble benzodiazepine midazolam selectively 
augmented the (hyperpolarizing) postsynaptic inhibition of 
interneurones by microelectrophoretic GABA and the 
depolarization of extensor muscle group la primary afferent 
terminals by this amino acid (and piperidine-4-sulphonic acid).
VThis action of midazolam was antagonised by Rol5-1788, which 
alone had no effect on the action of GABA. These findings 
suggest that in the spinal cord benzodiazepines influence the 
action of GABA on bicuculline-sensitive receptors located 
presynaptically on primary afferent terminals and post- 
synaptically on spinal neurones. Thus benzodiazepine receptors 
appear to be present together with bicuculline-sensitive GABA 
receptors on primary afferent terminals and spinal neurones.
The failure of Rol5-1788 to influence the action of 
endogenously released or exogenously administered GABA suggests 
that benzodiazepine receptors are of pharmacological rather 
than physiological importance.
5The synthetic enkephalin analogue methionine - 
enkephalinamide (MENKA) failed to effect the excitability or 
conductance of extensor muscle group la afferent terminals in a 
naloxone-sensitive manner when administered electro- 
phoretically. When administered in this fashion MENKA also had 
no detectable inhibitory effect on transmitter release from 
group I afferent excitatory terminals in the intermediate 
nucleus. Thus the terminals of group I afferent fibres 
apparently do not possess naloxone-sensitive receptors for 
opioids. In contrast, GABA-releasing terminals at axo-axonic 
synapses on la terminals appear to possess enkephalin receptors 
and their activation presumably accounts for the
naloxone-reversible reduction by opioids of synaptically evoked 
primary afferent depolarization. Doses of intravenous naloxone 
which enhanced spinal monosynaptic reflexes failed to effect
vi
the excitability or conductance of la terminals, or their 
sensitivity to GABA. Thus the facilitory effect of naloxone on 
spinal reflexes cannot be explained by a direct opioid effect 
on primary afferent terminals, or an indirect effect of opioids 
mediated through the increased activity of the GABA-releasing 
interneurones which mediate "presynaptic" inhibition.
Systemic doses of baclofen which substantially reduced the 
monosynaptic excitation of intermediate nucleus interneurones 
by impulses in extensor muscle group I afferent fibres had 
little or no effect on excitation of these neurones by impulses 
in descending fibres of the rubrospinal tract or the 
ipsilateral dorsolateral funiculus. Relatively low 
concentrations of baclofen thus appear not to influence the 
release of excitatory transmitters from the terminals of 
rubrospinal, corticospinal and propriospinal fibres, in 
contrast to the reduction of the release of primary afferent 
transmitters. Thus baclofen receptors appear to be present on 
primary afferent terminals, but not on the spinal terminals of 
rubrospinal, corticospinal and propriospinal neurones. It 
seems likely that the existence of receptors for GABA and 
baclofen on primary afferent terminals is related to the 
presence on them of GABA-releasing axo-axonic synapses. The 
failure to detect either type of receptor on the spinal 
terminals of rubrospinal neurones is in accordance with this 
proposal, as there is no suggestion that such terminals receive 
GABA-releasing axo-axonic synapses. The failure of systemic
vii
baclofen to influence the excitation of intermediate nucleus 
neurones by descending volleys suggests that low concentrations 
of baclofen have no direct postsynaptic inhibitory action on 
spinal neurones.
GENERAL INTRODUCTIONI .
Synaptic transmission involves the release of a transmitter 
from the axon terminals of a neurone, and the subsequent effect 
of the transmitter substance on a postsynaptic cell. The 
transmission of information within the nervous system can be 
affected by substances which interfere with the postsynaptic 
action of the transmitter. For example, the inhibition of 
spinal motoneurones which follows activation of Renshaw cells 
can be reduced by strychnine, which competitively antagonises 
the postsynaptic action of the inhibitory transmitter glycine 
released from Renshaw cell terminals (Curtis et al., 1968).
Synaptic transmission can also be affected by substances 
and manipulations which affect the release of neurotransmitter 
from presynaptic terminals. Release of transmitter from 
terminals can be increased or decreased in a relatively 
non-selective manner by variation of such factors as 
temperature and the extracellular free calcium ion 
concentration (Hubbard et al., 1969). More selective effects 
on neurotransmitter release can be achieved if the presynaptic 
terminal possesses receptors for particular drugs, toxins, or 
neurotransmitters. For example, tetanus toxin reduces the 
inhibition of motoneurones which follows Renshaw cell firing by 
blocking the release of glycine from Renshaw cell terminals 
(Brooks et al., 1957; Curtis & DeGroat, 1968). Tetanus toxin , 
however, has no effect on the monosynaptic excitation of 
motoneurones produced by impulses in group la afferents (Brooks 
et al., 1957), presumably because primary afferent terminals 
have fewer or no acceptor sites which bind the toxin. An
2understanding of which receptors are present on different 
presynaptic terminals, and how the activation of presynaptic 
receptors alters transmitter release is important for an 
understanding of the physiology and pharmacology of the nervous 
system.
Probably the best characterised presynaptic receptors in 
the mammalian central nervous system are those located at 
axo-axonic synapses on terminals of group la muscle afferent 
fibres. There is substantial evidence that GABA is released at 
these axo-axonic synapses, where it depolarizes primary 
afferent terminals in a bicuculline and picrotoxinin sensitive 
fashion, probably by increasing the chloride ion conductance 
(Schmidt, 1971; Nicoll & Alger, 1979; Curtis & Lodge, 1982).
The terminal depolarization is accompanied by a reduction in 
the amount of neurotransmitter released by primary afferent 
impulses (Eccles, 1964). Thus the synaptic activation of GABA 
receptors on primary afferent terminals is considered to be 
responsible for the presynaptic component of prolonged spinal 
inhibition.
Primary afferent terminals in the dorsal horn of the spinal 
cord receive axo-axonic contacts from the terminals of both 
GABA-synthesising and enkephalin-containing interneurones 
(Barber, et al., 1978; LaMotte & de Lanerolle, 1983) and it is 
therefore likely that some primary afferent terminals possess 
functionally significant receptors for enkephalins in addition 
to receptors for GABA. Presynaptic receptors on primary 
terminals associated with axo-axonic synapses have an obvious 
functional role in the mediation of presynaptic inhibition.
The physiological role of receptors which are present on the
3terminals of some central neurones is less clear, as they have 
no obvious innervation. For example, the terminals of lateral 
olfactory tract fibres possess bicuculline-sensitive GABA 
receptors (Pickles and Simmonds, 1976), yet these terminals are 
not innervated by GABA-releasing axo-axonic synapses (Westrum, 
1969) and it is unclear whether GABA ever reaches these 
receptors under physiological conditions.
Some presynaptic receptors may be of pharmacological rather 
than physiological importance. For example, benzodiazepine 
receptors appear to be present on primary afferent terminals 
(Fry & Magee, 1982) and their occupation by exogenously 
administered benzodiazepines would be expected to enhance the 
depolarizing action of GABA on primary afferent terminals 
(Haefely et al., 1981). Other presynaptic receptors may be of 
toxicological importance, for example the presynaptic receptors 
on the terminals of central and peripheral neurones which bind 
clostridial neurotoxins.
The various sections of this thesis all relate to the way 
in which various drugs and neurotransmitters affect different 
types of intraspinal terminals. Comparisons are made between 
group la extensor muscle primary afferent terminals in the 
intermediate and motoneuclei, the spinal terminals of 
rubrospinal, vestibulospinal and propriospinal neurones and the 
terminals of the GABA-releasing interneurones which contact 
extensor muscle primary afferent terminals at axo-axonic 
synapses. The presence of a receptor for a particular 
substance is inferred from its effect on transmitter release 
and/or terminal excitability and conductance.
II. METHODS
The experiments described in this thesis involved the use 
of anaesthetised cats.
(I) General Methods
(i) Animal Preparation
a ) Spinal cord preparation
Cats (male or female) were anaesthetised with 
pentobarbitone sodium (40 mg kg  ^ intraperitoneally 
initially; supplemented intravenously when necessary).
Following the induction of anaesthesia the left cephalic vein, 
the right common carotid artery (spinal cord preparations) or 
right femoral artery (supraspinal preparations) and the trachea 
were cannulated. Following a dorsal midline skin incision and 
dissection and retraction of the epaxial muscles, the laminae 
of all lumbar vertebrae were removed in a caudal to rostral 
sequence using rongeurs and bone cutting forceps. In the 
experiments described in Chapters IV and V and in most of the 
experiments in Chapter VI, the spinal cord was transected at 
the thoracolumbar junction after localised infiltration with 1% 
procaine hydrochloride solution. The dural sac was opened 
dorsally over the lumbar and sacral cord, and the seventh 
lumbar and first sacral ventral roots were transected central 
to the dorsal root ganglia and mounted on bipolar platinum 
electrodes which served for either stimulation or recording.
The distal ends of these ventral roots were crushed so that 
reflexes could be recorded monophasically. The second and
5third sacral ventral roots were usually crushed or severed. In 
some experiments the most caudal rootlet of the sixth lumbar 
dorsal root was cut and mounted on bipolar platinum electrodes 
in order to record dorsal root potentials and reflexes.
Cats were mounted in a frame of extreme rigidity using 
lower thoracic, midlumbar and pelvic clamps. The animals were 
suspended so that the abdomen and thorax were held clear of the 
base of the frame to reduce respiratory movement of the spinal 
cord. A coil of silver chloride coated silver wire, covered 
with gauze saturated with 165 mM NaCl, was sutured to exposed 
vertebral muscle near the recording site as the indifferent 
electrode (earth). A pool was formed by raising and anchoring 
skin flaps, and the exposed spinal cord and vertebral muscles 
were covered with warmed liquid paraffin which was maintained 
at 36-38°C by heating coils.
The temperature of the cats was maintained between 36 and 
38° by means of heating pads placed under the abdomen and the 
chest. A thermometer and temperature sensitive probe were 
placed between the left scapula and the thoracic wall, the 
current flowing through one of the heating pads being 
controlled by a solid state current regulating unit. The blood 
pressure and pulse rate were continuously monitored in all 
experiments using a Strathom pressure transducer, and the 
expired CC>2 level was recorded during experiments concerned 
with terminal excitability. A mixture of low molecular weight 
and high molecular weight dextran (Macrodex 5% and 
Rheomacrodex; Pharmacia) in "normal saline" was routinely 
administered intravenously in an attempt to maintain a normal
6circulating blood volume. A single intramuscular dose of 
dexamethasone sodium phosphate (0.5 mg kg ^) was usually- 
administered just before commencing the laminectomy as a 
prophylactic measure towards the control of spinal cord oedema.
b ) Peripheral nerve preparation
In most experiments nerves in the left hind limb were 
prepared for electrical stimulation and/or monophasic 
recording. An incision extending from the ischiatic tuberosity 
to the calcaneal tendon was made on the caudal surface of the 
hind leg, and after carefully dissecting out the fat pad in the 
popliteal fossa some or all of the following nerves were 
transected as far peripherally as possible and freed from 
adherent connective tissue: posterior biceps-semitendinosus
(PBST), sural (S; sometimes divided into two or three bundles), 
common peroneal (CP), medial gastrocnemius (MG), lateral 
gastrocnemius-soleus (LG), plantaris (PI), flexor digitorum 
longus (FDL; usually divided into two bundles), tibial (TIB).
A cotton thread was tied on the distal extremity of the 
transected nerve to form a small loop. This loop was later 
used to anchor the nerve to the bipolar platinum wire "hook" 
electrode. When extensor muscle nerves were used for 
monophasic recording the portion of the nerve adjacent to the 
cotton loop was crushed. An oil pool was formed by raising and 
anchoring skin flaps and filled with warmed liquid paraffin 
which was maintained at 37°C by heating coils. The quadriceps 
nerve (Q) was required for some experiments on spinal 
reflexes. It was dissected out and transected following 
exposure in the medial thigh and mounted in a buried perspex 
electrode for electrical stimulation.
7c) Surgical preparation prior to locating the lateral
vestibular nucleus
The cat's head was fixed in a Horsley Clark type head frame 
which allowed rotation about an axis parallel to the interaural 
line. A dorsal midline skin incision was made and the muscles 
overlying the left occipital bone were retracted laterally.
Part of the left occipital bone was removed with rongeurs to 
expose the cerebellar cortex. After removing the exposed dura 
and cauterising large superficial vessels, the vermis and left 
cerebellar hemisphere were partially removed by suction until a 
clear view of the middle cerebellar peduncle was achieved. The 
head frame was fixed to the rigid cat frame and adjusted so 
that the cat's head was ventroflexed by approximately 38°C.
The exposed brainstem was continually flushed with a warmed 
(38°C) mammalian Ringer solution which was equilibrated with 5% 
C02, 95% 02.
d) Surgical preparation prior to locating the red nucleus
After the cat's head was fixed in a stereotaxic headframe 
(as above) a dorsal midline skin incision was made over the 
cranial vault. The right temporalis muscle was dissected from 
the underlying bone and retracted laterally. An oval piece of 
parietal bone was separated from the remaining calvarium using 
a dental burr and prised away with rongeurs. Bleeding from 
bone edges was controlled with bone wax. After incising and 
removing the dura and cauterising superficial and deep vessels 
the right occipital pole of the cerebrum was partially removed 
to expose the right superior colliculus. The head frame was 
fixed to the rigid cat frame and adjusted so that the Horsley
8Clark horizontal plane was level. The exposed midbrain was 
continually flushed with a warmed mammalian Ringer solution as 
above.
(ii) Electrical stimulation and recording
a) Peripheral nerve stimulation
Peripheral nerves were mounted on bipolar platinum hook 
electrodes (6-12 mm separation) and stimulated with thyratron 
discharge pulses (approximately 50 ps duration) delivered by 
stimulus isolation units. The stimulus intensity was measured 
in multiples of the threshold (T) of the most excitable, 
fastest conducting fibres of a particular nerve. The afferent 
volley was recorded with a platinum ball electrode placed on 
the dorsal columns close to the appropriate dorsal root entry.
b ) Spinal reflex recording
Monosynaptic reflexes were recorded monophasically from the 
seventh lumbar or first sacral ventral root in response to 
electrical stimulation (1Hz, 1.5-2T) of the following hind limb 
nerves: quadriceps (Q), medial and lateral gastrocnemius and
soleus (G) and posterior biceps-semitendinosus (PBST).
Reflexes were usually facilitated and thus stabilised by 
preceding submaximal stimulation of the same nerve, this 
stimulus being subliminal for a reflex response. Reflexes 
initiated by stimulation of one muscle nerve were inhibited by 
prior volleys in other muscle nerves. Two types of inhibition 
were examined, the short latency "direct" inhibition of PBST 
monosynaptic reflexes by impulses in low threshold Q afferents
9(Bradley et al., 1953) and the prolonged "presynaptic" 
inhibition of G reflexes by tetanic stimulation of low 
threshold PBST afferents (Eccles et al., 1963).
Reflexes recorded from ventral roots were amplified and 
displayed on an oscilloscope. The area beneath the 
monosynaptic reflex was measured using a voltage-to-frequency 
converter (Vidar 260) and displayed by means of a gated counter 
with analogue output (Hewlett Packard Counter 5214L and Digital 
recorder H23-562A). The recorder output was used to construct 
inhibitory curves, which were plotted directly on an X-Y 
recorder (Varian F-80; converted to a point plotter): the X
voltage was proportional to the interval between the inhibitory 
and testing volleys, the Y voltage was proportional to the area 
beneath the monosynaptic reflex.
c) Dorsal root potential recording
Dorsal root potentials (DRPs) and dorsal root reflexes were 
evoked by tetanic stimulation of PBST afferents (2T, 4 volleys 
at 320Hz) and recorded from the most caudal rootlet of the 
sixth lumbar dorsal root using an amplifier having a time 
constant of 1 second. DRPs were averaged (Nicolet Model 527 
Signal Averager 8 sweeps, 1Hz) and plotted on a paper recorder 
(Gould/Brush Model 280).
d) Extracellular recording techniques
Extracellular recordings of field and action potentials 
were made using glass micropipettes filled with 3.6M NaCl - 
either single glass micropipettes or the centre barrel of seven 
barrel glass micropipettes. Single glass micropipettes were 
drawn from 3mm (outside diameter) pyrex glass tubing in a
10
vertical microelectrode puller and filled with the aid of fine 
glass fibres which were inserted prior to pulling. Electrode 
tips were broken back under microscopic observation to the 
appropriate size (usually l-2pm) with a fine glass rod mounted 
on a pneumatic "joystick" micromanipulator (DeFonbrune). The 
preparation of seven barrel micropipettes is discussed in a 
later section. Glass microelectrodes were inserted into the 
brain and cord through small "patches" where the pia had been 
removed with fine forceps.
The electrolyte within the micropipette was connected to a 
high-impedance unity-gain input stage with capacitance 
compensation (WPI M701 Microprobe) by a silver/silver chloride 
junction. Recordings of extracellular potentials were made 
relative to the indifferent electrode (stitched to vertebral 
muscles) using the WPI Microprobe and displayed on a double 
beam oscilloscope after suitable amplification (high gain, 
short time constant). Extracellularly recorded action 
potentials were also fed, after suitable amplification, to a 
window discriminator. The action potentials, the window levels 
and the output pulses of the discriminator were observed on a 
multiple beam oscilloscope so that the output represented the 
activity of a single neurone, selected on the amplitude and 
shape of its action potential. The output pulses of the window 
discriminator were counted by means of a ratemeter, and the 
output of the ratemeter (time constant usually 0.2 sec),was 
displayed on a rectilinear pen recorder (Recti-Riter, Texas 
Instruments) upon which side marker pens indicated periods of 
electrophoretic ejection of compounds. The output pulses of
11
the discriminator were also delivered to a Nicolet Model 527 
multiscaler, appropriately triggered, to construct peristimulus 
histograms which were subsequently plotted on a Gould/Brush 
Model 280 paper recorder.
In some experiments (Chapter III) extracellular recordings 
were obtained from two independent microelectrodes. The second 
recording electrode (inserted into either the lateral 
vestibular nucleus or the red nucleus) was connected to a 
negative capacitance cathode follower, the signals amplified 
and displayed on an oscilloscope.
e) Excitability testing of single intraspinal fibres and
terminals
Single intraspinal fibres and terminals were stimulated 
extracellularly with 0.3ms, cathodal pulses of less than 2pA 
passed at 10Hz through the central 3.6M NaCl containing barrel 
of seven barrel micropipettes (Curtis & Lodge, 1982).
Antidromically conducted action potentials were recorded either 
monophasically from the central ends of extensor muscle nerves 
(single primary afferent fibres) or extracellularly within the 
ipsilateral lateral vestibular nucleus or the contralateral red 
nucleus (single neurones). A series of high gain, short time 
constant (0.02 or 0.2 sec) differential amplifiers and 
multibeam oscilloscopes were used to monitor activity in as 
many as five peripheral nerves and the lateral vestibular or 
red nucleus. Once an antidromically conducted action potential 
was detected, and could be readily distinguished by its 
latency, shape and amplitude from other spontaneous and evoked
12
action potentials, a time gated window discriminator was used 
to convert the selected action potentials into standard pulses 
for counting.
The amplitude of the threshold pulse was continuously 
adjusted by a feedback device to maintain a firing index of 50% 
for the single unit under study (i.e. individual fibres or 
terminals responded to 50% of stimuli delivered at 10Hz) (see 
Curtis, 1979). Percent changes in the amplitude of this 
stimulating pulse, indicated by a continuous plot on a paper 
recorder (Gould 2600S) of the multiplying factor within the 
feedback system, were used as a measure of the changes in 
threshold (AT) of intraspinal fibres and terminals. The 
multiplying factor within the feedback system was plotted 
continuously on two channels of the paper recorder, one with a 
time constant of response of about 80ms, the other of 700ms and 
twice the gain.
Structures stimulated were considered to be unmyelinated 
and hence either terminal boutons, pre- or interbouton fibres 
("terminations") when the anodal blocking factor was less than 
four. The anodal blocking factor is the ratio between the 
amplitude of the just threshold stimulating pulse and the 
larger pulse which just suppresses propagation of the impulse 
as a consequence of the hyperpolarization of membrane adjacent 
to the site of impulse initiation: lower values are found for
unmyelinated than for myelinated fibres (Katz & Miledi, 1965; 
Curtis & Lodge, 1982).
Stimulating pulses were fed to the centre barrel of seven 
barrel micropipettes by an isolating pulse transformer
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(Argonaut LIT 069) which received the amplified output of the 
feedback device. Stimulating currents were measured by 
determining the voltage across 100 ohm between the preparation 
and earth, using a variable capacitor (10-400pF), in parallel 
with a 2 Mohm limiting resistance in series with the 
stimulating electrode, to "square up" the pulse.
f) Excitability testing of intraspinal fibres and terminals 
Alterations in the excitability of a population of fibres 
and terminals can be determined from increases or decreases in 
the number activated by a constant large stimulus. To 
determine the excitability of a population of extensor muscle 
la afferent fibres and terminals, the tip of a single 3.6M NaCl 
containing micropipette was placed in the vicinity of 
gastrocnemius motoneurones, using the magnitude of orthodromic 
and antidromic field potentials as a guide. Cathodal pulses 
(0.3ms duration, 12pA, 1Hz) supplied by a Grass stimulator and 
isolation unit were passed through the single micropipette to 
activate many la afferent fibres and terminals near 
gastrocnemius motoneurones. Antidromic action potentials were 
recorded monophasically from the gastrocnemius-soleus and 
plantaris nerves. The area of the antidromic response was 
measured using a voltage to frequency converter and a gated 
counter with analogue output as for reflexes (see earlier). 
Five antidromic responses were summed and plotted on a pen 
recorder.
g) Microelectrophoresis
The technique of microelectrophoresis was used to eject 
substances in the vicinity of spinal neurones and intraspinal 
fibres and terminals. Ionized compounds were electrically
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ejected into the extraneuronal space from aqueous solutions in 
the outer barrels of seven barrel micropipettes. The methods 
used were those described by Curtis (1964). Seven barrel 
micropipette "blanks" were drawn out to a fine tip in a 
vertical electrode puller. The micropipette tips were viewed 
microscopically/ and# by means of a fine glass rod attached to 
a pneumatic "joystick" micromanipulator/ the tips were broken 
back to a diameter of 4-8pm. The solutions to be used were 
centrifuged, transferred to the barrels of the micropipettes, 
and then driven to the tips by centrifugation. The centre 
barrel of each micropipette was filled with 3.6M NaCl, while 
the outer barrels were filled with aqueous solutions of the 
substances being examined, in the particular combination 
required for each experiment. Details of the standard 
solutions used are contained in Table 1. Details of the other 
solutions used are given later in the appropriate methods 
section. After filling, the micropipettes were examined 
microscopically using a water immersion lens and the electrical 
resistance of each barrel was measured. Usually the 
micropipettes were then bevelled at an angle of 45°. 
Micropipettes were also examined microscopically after use.
The micropipettes were held in either a manually operated 
"Canberra-type" micromanipulator or a remotely controlled 
stepping-motor micromanipulator. The micromanipulators allowed 
movement in three axes and were securely attached to the cat 
frame. Electrical contact was made with the 3.6M NaCl 
containing centre barrel by means of a small silver/silver 
chloride junction and with the outer barrels by means of 
individual silver wires. When the micropipette was placed in 
the spinal cord, the resistance of each barrel was again
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Table 1
COMPOUND MOLARITY pH
KC1 200mM
NaCl 1.8M
GABA (HC1) 200mM 3
L-Histidine (HC1) lOOmM 3.2
DLH (NaOH) 200mM 7.5
Glycine (HC1) 500mM 3
Noradrenaline bitartrate lOOmM 3
NMDA (NaOH) 50mM* 7.5
P4S (HC1) 20 or 50mM* 3
BMC lOmM* 3
*in 150mM NaCl
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measured in situ by determining the current required to
establish a 0.5V potential difference across the barrel
orifice. Retaining voltages of the order of 0.5V were applied
to each drug-containing barrel in order to control the
diffusional efflux of active ions, and this retaining current
was maintained throughout the experiment. The magnitude of
ejecting and retaining currents are quoted in nanoamperes 
-  9(nA, 10 A). Currents ejecting cations have been termed
cationic, whilst those ejecting anions have been termed 
anionic. A current of OnA indicates removal of the retaining 
current from a barrel, thus allowing the diffusional efflux of 
a compound; with some compounds this was sometimes sufficient 
to produce measurable effects. In most experiments 
electrophoretic ejecting currents were balanced by passing an 
equal current in the opposite direction through a barrel 
containing NaCl (1.8M) to minimise effects due to current flow 
per se.
In many of the figures of this thesis, horizontal bars, 
appropriately labelled and generally with a figure indicating 
current (nA), signal periods of microelectrophoretic ejection.
h ) Physiological and pharmacological identification of la
afferent fibres and terminations
Both group la and group II muscle primary afferents 
terminate on motoneurones in the ventral horn of the spinal 
cord (Brown & Fyffe, 1978; Fyffe, 1979). Afferents activated 
near motoneurones were considered to be la if the antidromic 
latency of the evoked impulse was within 0.7ms of the group I
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orthodromic latency; group II afferents failed to meet this 
criterion because of their slower conduction velocity (Curtis & 
Lodge, 1982).
Both group la and group lb primary afferents terminate in 
the intermediate nucleus (Brown & Fyffe, 1978; Brown & Fyffe, 
1979). It is impossible to reliably distinguish antidromically 
activated la afferents from lb afferents in the intermediate 
nucleus on the basis of their peripheral electrical threshold 
or conduction velocity (Willis et al., 1976). However tetanic 
stimulation of low threshold sural afferents depolarized lb 
afferents but not la afferents, whereas tetanic stimulation of 
low threshold PBST afferents usually depolarized la afferents 
but not lb afferents (Willis et al., 1976). This differing 
response allowed single afferents in the intermediate nucleus 
to be classified as la or lb.
Terminations were distinguished from afferent fibres on the 
basis of their location (near motoneurones and intermediate 
nucleus interneurones), anodal blocking factors less than four, 
depolarization by microelectrophoretic GABA or
piperidine-4-sulphonic acid (P4S) with a concomitant reduction 
in PAD, and the reduction of PAD by bicuculline methochloride 
(BMC) ejected with currents of 20-40nA (see Curtis and Lodge, 
1982).
Structures were often stimulated which had blocking factors 
less than 4, and hence were probably terminations, but which 
were insensitive to GABA (40-80nA), P4S (20-40nA) and BMC
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(40-60nA). Further investigation of these terminals was not 
carried out, the tip of the micropipette presumably being 
capped with tissue debris (see Anderson & Curtis, 1964) which 
prevented substances ejected from the micropipette from 
reaching the terminal. Such material was present on the tips 
of many micropipettes after removal from the cord. The 
thresholds of some terminations encountered could be reduced by 
electrophoretic GABA or P4S, and by synaptically evoked PAD; 
the PAD, however, was completely insensitive to BMC (40-60nA) 
suggesting that it was generated at distant axo-axonic 
synapses, inaccessible to electrophoretically administered 
substances. Such terminations were unsuitable for analysing 
the effects of electrophoretic substances on GABAergic 
axo-axonic transmission.
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(II) Methods used in the individual chapters
(i) The effect of GABA on lumbar terminations of
vestibulospinal and rubrospinal neurones in the cat 
spinal cord
(a ) The effect of GABA on lumbar terminations of 
vestibulospinal neurones in the ventral horn 
After fixation of the animals head in a stereotaxic head 
frame, and partial removal of the cerebellar vermis [see 
Section I (i) c) earlier], 3.6M NaCl containing microelectrodes 
(2-4 Mohm) were inserted by means of a stepping-motor 
micromanipulator into the ipsilateral lateral vestibular 
nucleus at an angle of approximately 42° above the 
Horsley-Clarke horizontal plane at the caudal edge of the 
middle cerebellar peduncle, 3.5-4.5mm from the midline. The 
nucleus was located by recording antidromic action and field 
potentials (latencies 3.2-7.5ms) generated by electrical 
stimulation of vestibulospinal axons in the ipsilateral 
ventromedial funiculus (Ito et al., 1964). The ventromedial 
funiculus was stimulated at the L^-L^ level using either 
bipolar platinum electrodes placed on the ventral surface of 
the cord or intraspinal electrodes (monopolar: 3.6M NaCl glass 
microelectrodes, 1-2 Mohm; bipolar: steel coaxial electrode,
300^aM diameter) inserted from the dorsal surface and orientated 
ventrally 1mm from the midline.
Single 3.6M NaCl containing micropipettes (2-4 Mohm) 
attached to a second stepping-motor micromanipulator were used
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initially to locate gastrocnemius motoneurones in the ventral 
horn of L^-S^ segments, using the magnitude of 
extracellular field and action potentials generated by 
orthodromic and antidromic impulses as a guide. These 
electrodes were replaced with seven barrel micropipettes, the 
tips of which were placed in the vicinity of gastrocnemius 
motoneurones; again the recording of orthodromically and 
antidromically evoked field and action potentials by the centre 
3.6M NaCl containing barrel (3-8 Mohm) established the location 
of the gastrocnemius motonucleus. The centre barrel was then 
used as an extracellular stimulating microelectrode to locate 
sites of minimal threshold for individual intraspinal fibres 
and terminations. Antidromically conducted action potentials 
were recorded either monophasically from the central end of the 
transected medial gastrocnemius and lateral gastrocnemius- 
soleus nerves (single la fibres) or extracellularly within the 
ipsilateral lateral vestibular nucleus (single vestibulospinal 
neurones). The seven barrel micropipette was tracked 
systematically through the ventral horn while recording from 
the gastrocnemius nerves and the lateral vestibular nucleus. 
Sometimes the seven barrel micropipette was kept stationary in 
the cord, while the single microelectrode in the lateral 
vestibular nucleus was moved to locate antidromically activated 
cells (see Fig. 1).
Vestibulospinal terminations were located near primary 
afferent terminals synapsing on gastrocnemius motoneurones, and 
also more medially in laminae VII and VIII where the 
vestibulospinal tract also terminates (Erulkar et al., 1966;
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Fig. 1. Diagram of the experimental set up in Chapter
III(i). Cathodal pulses (0.3ms, <2juA, 10Hz) were passed 
through the centre barrel of a seven barrel micropipette to 
activate gastrocnemius la afferent fibres and terminals, and 
descending vestibulospinal fibres and terminals in the vicinity 
of the gastrocnemius motor nucleus. Antidromically conducted 
action potentials were recorded from the cut end of the medial 
and lateral gastrocnemius nerves (using platinum wire 
electrodes) and the ipsilateral lateral vestibular nucleus 
(using a single glass microelectrode). The lateral vestibular 
nucleus was located by recording antidromic action and field 
potentials in response to stimulation of the ventromedial 
funiculus (L^-L^). The film record inserts show action 
potentials (*) of a single lateral vestibular nucleus cell 
which is fired in response to stimulation of its axon (B) in 
the ventromedial funiculus (L^ ) and in response to 
stimulation of one of its axon terminals (A) in the 
gastrocnemius motor nucleus (L^). Note that and 
ventral roots are cut.
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Skinner & Remmel, 1978). Structures stimulated were considered 
to be terminations when the anodal blocking factor was less 
than 4; myelinated fibres would be expected to have higher 
blocking factors. When a vestibulospinal or primary afferent 
termination was located, the amplitude of the stimulating pulse 
passed through the centre barrel of the micropipette was 
adjusted continuously using a feedback device to maintain a 
firing index of 50% for the single unit under study. Primary 
afferent depolarization (PAD) of gastrocnemius la terminations 
was generated by tetanic stimulation (2T, 4 volleys, 320Hz) of 
PBST low threshold afferents 30ms before each testing pulse for 
periods of 6-8 seconds, and was measured as the percentage 
reduction in the threshold of the terminal.
The outer barrels of the micropipettes contained the 
following aqueous solutions: NaCl, KC1, GABA, L-histidine, P4S 
(20mM in 150mM NaCl) and BMC (see Table 1).
(b) The effect of GABA on lumbar terminations of rubrospinal
neurones in the intermediate nucleus
After fixation of the animals head in a stereotaxic 
headframe, and partial removal of the right occipital pole of 
the cerebrum [see Section I(i) d) earlier], 3.6M NaCl 
containing microelectrodes (2-4 Mohm) were inserted by means of 
a stepping-motor micromanipulator into the right red nucleus 
through the exposed superior colliculus at an angle of 20° 
caudal to the vertical (AP) Horsley-Clarke plane, parallel to 
and 2mm from, the midline. The nucleus was located at a depth 
of 8.5-10.5mm by recording field and action potentials
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(latencies 3.5-10.Oms) generated by electrical stimulation of 
rubrospinal fibres in the left dorsolateral funiculus (Hongo et 
al., 1969) with two steel needles (2.5mm separation) placed on 
the surface of the cord just ventral to the third, fourth or 
fifth lumbar dorsal root entry.
Single 3.6M NaCl containing micropipettes (2-4 Mohm) 
attached to a second stepping-motor micromanipulator were used 
initially to locate intermediate nucleus interneurones in the 
seventh lumbar segment fired monosynaptically by impulses in 
group I muscle afferent fibres. These electrodes were replaced 
by seven barrel micropipettes, the tips of which were placed in 
the vicinity of intermediate interneurones. The centre barrel 
was then used as a stimulating electrode to locate sites of 
minimal threshold for individual intraspinal fibres and 
terminals. Antidromically conducted action potentials were 
recorded either monophasically from the central end of 
transected extensor muscle (MG, LG, PI, FDL divided into 2 
bundles) nerves (single la fibres) or extracellularly within 
the contralateral red nucleus (single rubrospinal neurones).
The seven barrel micropipette was tracked systematically 
through the intermediate region while recording from extensor 
nerves and the red nucleus. Sometimes the stimulating seven 
barrel micropipette was kept stationary in the cord while the 
single microelectrode in the red nucleus was moved to locate 
antidromically activated units (see Fig. 2). Structures 
stimulated were considered to be terminations when the anodal 
blocking factor was less than four. Primary afferent 
depolarization (PAD) of extensor muscle group la afferent
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Fig. 2. Diagram of the experimental set up in Chapter
III(ii). Cathodal pulses (0.3ms, <2pA, 10Hz) were passed 
through the centre barrel of a seven barrel micropipette to 
activate extensor muscle group I afferent fibres and terminals, 
and descending rubrospinal fibres and terminals in the vicinity 
of the spinal intermediate nucleus. Antidromically conducted 
action potentials were recorded from the cut end of extensor 
muscle nerves (using platinum wire electrodes) and the 
contralateral red nucleus (using a single glass 
microelectrode). The red nucleus was located by recording 
antidromic action and field potentials in response to 
stimulation of the dorsolateral funiculus (L^-Lc). TheJ D
film record inserts show action potentials (*) of a single 
rubrospinal cell which is fired in response to stimulation of 
its axon (B) in the dorsolateral funiculus (L._) and in
D
response to stimulation of one of its axon terminals (A) in the 
intermediate nucleus (L^).
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terminations, and presynaptic depolarization (PD) of 
rubrospinal terminations were generated by tetanic stimulation 
(4 volleys, 320Hz, 2T or 4T) of PBST, CP, TIB or S afferents 
30ms before each testing pulse.
The outer barrels of the micropipettes contained the 
following aqueous solutions: NaCl, KC1, GABA, L-histidine, P4S 
(20mM in 150mM NaCl) and BMC (see Table 1).
(ii) Actions of midazolam and Rol5-1788 in the cat spinal
cord
Midazolam and Rol5-1788 were administered, either micro- 
electrophoretically near spinal neurones or intravenously, to 
examine their effect on the postsynaptic inhibitory action of 
electrophoretic GABA, glycine and noradrenaline. The action 
potentials of single dorsal horn neurones were recorded by the 
centre 3.6M NaCl containing barrel of seven barrel 
micropipettes. The background firing rate of neurones was 
maintained between 30 and 60Hz by the continuous 
microelectrophoretic ejection of DL-homocysteic acid (DLH). 
GABA, glycine and noradrenaline were ejected cyclically (fixed 
currents for fixed times at regular intervals) with currents 
that produced submaximal inhibition of firing. After 2-3 
consistent control responses had been obtained, the effects of 
midazolam and Rol5-1788, ejected as cations, were studied by 
determining the percentage change induced in the effects of the 
inhibitory amine and amino acids.
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Midazolam and Rol5-1788 were administered either 
intravenously, or microelectrophoretically near single group la 
extensor muscle afferent terminations located near extensor 
motoneurones, to examine their effect on the depolarizing 
action of electrophoretic GABA and piperidine-4-sulphonic acid 
(P4S) and on the synaptically evoked depolarization produced by 
tetanic PBST stimulation (PAD). Synaptically evoked PAD was 
generated by tetanic stimulation (2-3T, 4 volleys at 320Hz) of 
the ipsilateral PBST nerve 30-70ms prior to the stimulating 
pulse for periods of 6-8 seconds. An interval of 70ms was 
generally used so that PAD was submaximal. Small GABA and P4S 
ejecting currents were chosen, after first establishing that 
larger currents could produce greater terminal depolarizations.
The outer barrels of the micropipettes contained DLH, 
glycine, GABA, noradrenaline, BMC, midazolam maleate (2mM in 
lOOmM NaCl, 5 or 20mM in 150mM NaCl, pH 3), Rol5-1788 
(saturated solution approx. ImM, pH3) and P4S (50mM in 150mM 
NaCl). When given intravenously midazolam maleate was 
dissolved in 165mM NaCl to give a solution containing lmg/ml. 
For intravenous administration Rol5-1788 was dissolved in 0.2ml 
ethanol per mg and diluted to lmg/ml with 165mM NaCl.
Midazolam maleate was administered intravenously in 
increasing doses from 0.1 mg kg 1 to a maximum of 10 mg 
kg-1 to examine its effects on dorsal root potentials (DRPs), 
flexor and extensor monosynaptic reflexes, short latency 
"direct" inhibition and prolonged "presynaptic" inhibition.
The effect of intravenous midazolam on conscious cats was also
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examined: midazolam maleate (1,5 and 20mg kg  ^diluted in 5ml 
of 165mM NaCl) was injected into the right cephalic vein of 
gently restrained adult cats (4.5-5.0 kg) over a period of 5 
seconds. Cats were restrained for the first minute after 
injection and their behaviour then observed.
(iii) The effects of naloxone, morphine and methionine-
enkephalinamide on la afferent terminations in the cat 
spinal cord
5Methionine -enkephalinamide (MENKA), morphine, naloxone 
and procaine were ejected microelectrophoretically near single 
group la extensor muscle afferent terminals to examine their 
effects on terminal excitability, the depolarizing action of 
electrophoretic GABA and P4S, and on the synaptically evoked 
depolarization produced by tetanic PBST stimulation (2.0-2.5T,
4 volleys at 320Hz) 30ms prior to the stimulating pulse (PAD). 
The la terminations studied were located in the ventral horn, 
near extensor muscle motoneurones, and in the intermediate 
region, near interneurones fired monosynaptically by impulses 
in group I muscle afferents.
Frequently the microelectrophoretic administration of 
MENKA, morphine, naloxone and procaine altered the threshold of 
the termination under study to a constant plateau level. When 
this occurred, the amplitude of the input pulse of the feedback 
device was usually adjusted to restore the multiplying factor 
to 1.00. This enabled transient changes in threshold, such as 
PAD or those produced by gabamimetics, to be indicated directly 
as percentage changes of existing threshold.
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In four experiments naloxone hydrochloride was administered 
intravenously (50-100pg kg 0.5 mg/ml 165mM NaCl) while 
measuring the excitability of single la fibres or 
terminations. In one experiment intravenous naloxone (0.33 mg 
kg ^) was administered while measuring the excitability of a 
population of la afferent fibers and terminals.
The effect of microelectrophoretic MENKA on the 
monosynaptic excitation of interneurones in the intermediate 
nucleus was also examined. Action potentials of single 
neurones were recorded by means of the centre 3.6M 
NaCl-containing barrel of seven barrel micropipettes.
Wave-forms of appropriate size, shape, polarity and timing were 
used to compensate for field potentials generated by afferent 
volleys so permitting the superimposed action potentials of 
single neurones to be detected by the window discriminator.
The firing of single neurones was maintained at a constant 
level (30-60Hz) by the continuous ejection of varying currents 
of DLH. Group I afferent fibres from extensor muscles were 
excited peripherally with stimuli of twice threshold, and 
peristimulus histograms were constructed using a multiscaler 
(Nicolet Model 527, 0.1ms bins, 32 sweeps, 4Hz) triggered by 
the stimulus. An electronic counter (Hewlett Packard 52142) 
gated for appropriate times, was also used to count and 
totalise action potentials considered to be monosynaptic in the 
same number of sweeps, the responses being expressed as a 
percentage of a 100% firing index. Excitations were considered 
to be monosynaptic when cells were fired, generally only once, 
at a constant short central latency (less than 1.3ms) by
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impulses in group I afferents, and followed repetitive afferent 
nerve stimulation exceeding 320Hz. MENKA and (-)-baclofen were 
administered near single intermediate nucleus interneurones to 
assess their respective effects on group I excitatory 
transmission. Both MENKA and (-)-baclofen depressed the 
background firing of intermediate cells (Duggan et al., 1977; 
Curtis et al., 1981) and their effects on monosynaptic firing 
were assessed both during the period of depressed firing and 
after postsynaptic excitability had been restored by the 
ejection of an increased amount of DLH.
The outer barrels of the micropipettes contained the
following aqueous solutions: NaCl, KC1, GABA, glycine, DLH,
BMC, (-)-baclofen hydrochloride (lOmM in 150mM NaCl), procaine
hydrochloride (20mM in 150mM NaCl), naloxone hydrochloride
(20mM in 150mM NaCl), morphine sulphate (50mM in 150mM NaCl),
5methionine -enkephalinamide (MENKA, Sigma, 20mM in lOOmM 
NaCl) and P4S (20mM or 50mM in 150mM NaCl).
(iv) The differential effects of baclofen on segmental and
descending excitation of spinal neurones
Seven cats were used in the first part of this 
investigation. In four cats the cord was cut at the 
thoracolumbar junction; caudal to this section, after removal 
of both dorsal columns for 12-15mm, the dorsal third of the 
ipsilateral lateral column was dissected free for a similar 
length for mounting on bipolar platinum electrodes as the 
"dorsolateral funiculus" (DLF). In three cats the cord was
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intact/ and bipolar sharpened steel needles (1.5mm separation, 
insulated except for 500pm at the tips) were inserted in a 
sagittal plane 0.5mm into the dorsolateral column just 
ventrolateral to the dorsal root entry (L-^ -L^  level) in 
order to stimulate DLF fibres. Descending volleys were 
recorded at the L^-S^ level by a platinum ball electrode on 
the dorsolateral surface of the cord. In two of these 
experiments, these stimulating electrodes were used to locate 
the contralateral red nucleus [see section II(i) b)]. The red 
nucleus was located 8.0-10.5mm beneath the surface of the 
exposed superior colliculus using a single glass microelectrode 
(2-4 Mohm) to record antidromic field and action potentials 
evoked by stimulation of rubrospinal fibres in the DLF. The 
glass recording electrode was then replaced by a pair of 
tapered tungsten wire electrodes, 1.5mm apart, and insulated 
except for 350pm at the tips which straddled the red nucleus 
(RN). Electrical stimulation (4 Hz, 0.25 ms pulses, maximum 
amplitude 2mA) yielded volleys recorded at the L7~S1 level 
with a maximum velocity of 97 and 110 m s 1 in these two 
animals. Volleys evoked from direct DLF stimulation had 
maximum velocities ranging between 100 and 118 m s 1.
A second micromanipulator was used to insert 3.6M NaCl 
containing microelectrodes (4-6 Mohm) into the intermediate 
nucleus of the left L^-S^ segments in the vicinity of 
interneurones excited monosynaptically by impulses in group I 
extensor muscle afferent fibres. Potentials were also recorded 
in response to DLF or RN stimulation. Since single stimulation 
of either structure rarely fired spinal interneurones, although
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generally facilitating excitation by subthreshold primary 
afferent volleys, field potentials generated by the excitation 
of many neurones were recorded rather than action potentials of 
individual neurones. The use of the latter would have enabled 
a comparison to be made of the effects of micro­
elect rophoretically administered (-)-baclofen on monosynaptic 
excitation by primary afferent and descending volleys.
In general, field potentials generated by group I afferent 
volleys reached a maximum amplitude more dorsally than those 
evoked by either DLF or RN stimulation (see Hongo et al.,
1972), and sites of recording were selected (1.9-2.6mm from the 
dorsal surface) at which the latter fields were of maximum 
amplitude and of similar size to those evoked by stimulation of 
muscle afferent fibres. Field potentials were averaged 
(Nicolet Model 527 Signal Averager, 16-32 sweeps, 4Hz) and 
plotted on a paper recorder (Gould/Brush Model 280). In all 
experiments except one, these potentials were not dominated by 
the action potentials of individual neurones.
Baclofen was administered intravenously using solutions 
containing either (t)-baclofen (2mg/ml and mannitol 50 mg/ml; 
"Lioresal"), (+)-baclofen hydrochloride (2 mg/ml) or 
(-)-baclofen hydrochloride (2 mg/ml). Baclofen was generally 
administered in sequential doses of lmg kg \  at intervals of 
5-10 minutes.
In 3 cats, standard microelectrophoretic procedures were 
used to examine the effect of bicuculline methochloride (BMC)
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on the depression by (-)-baclofen of group I excitation of 
single intermediate nucleus interneurones (Curtis et al. ,
1981). Action potentials were recorded by means of the 3.6M 
NaCl-containing centre barrel of seven barrel micropipettes 
(4-6.6pm) and cell firing rates were maintained at constant 
levels (30-70 Hz) by the continuous ejection of N-methyl-D- 
aspartic acid (NMDA). Group I afferent fibres were excited 
peripherally with stimuli of 1.3-2T, and peristimulus 
histograms were constructed using a multiscaler (Nicolet Model 
521, 0.2 ms bins, 32 or 64 sweeps, 4 Hz) triggered by the 
stimulus. An electronic counter, (Hewlett Packard 5214L), 
gated for appropriate times, was also used to count and 
totalize action potentials considered to be monosynaptic in the 
same number of sweeps, the responses being expressed as a 
percentage of a 100% firing index. The firing of group I 
interneurones was also inhibited by prior (30ms) tetanic 
stimulation (4 volleys, 320Hz) of low threshold PBST afferents.
In 8 cats GABA, P4S, muscimol and (-)-baclofen were 
administered microelectrophoretically near single intermediate 
nucleus interneurones to assess their respective effects on 
group I excitatory transmission. All these GABA analogues 
depressed the NMDA-maintained firing of lamina VI neurones, and 
their effects on monosynaptic firing were assessed both during 
the period of depressed firing and after postsynaptic 
excitability had been restored by the ejection of an increased
amount of NMDA.
31
The outer barrels of the seven barrel micropipettes 
contained the following aqueous solutions: NaCl, NMDA, BMC,
GABA, P4S (20mM in 150mM NaCl), muscimol (20mM in 150mM NaCl) 
and (-)-baclofen hydrochloride (5mM in 150mM NaCl).
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III. THE EFFECT OF GABA ON LUMBAR TERMINATIONS OF
VESTIBULOSPINAL AND RUBROSPINAL NEURONES IN THE CAT 
SPINAL CORD
INTRODUCTION
GABA is an important postsynaptic inhibitory 
neurotransmitter in all parts of the mammalian central nervous 
system (Curtis, 1978). The inhibitory action of GABA is 
attributable to an increased membrane chloride conductance and 
neuronal hyperpolarization (Curtis & Johnston, 1974). Central 
neurones have an outwardly directed chloride pump which keeps 
the intracellular chloride concentration low (Lux et al., 1970;
Sypert & Bidgood, 1977). Thus a GABA-activated increase in 
chloride conductance results in an influx of chloride ions and 
neuronal hyperpolarization. Bicuculline and picrotoxinin 
selectively antagonise the inhibitory action of GABA on central 
neurones, and their use in many neuropharmacological studies 
has demonstrated that GABAergic postsynaptic inhibition occurs 
in all regions of the mammalian CNS (Curtis & Johnston, 1974). 
Furthermore, virtually all central neurones appear to be 
hyperpolarized by GABA and GABA analogues in a bicuculline- 
sensitive, chloride-dependent fashion. It is therefore likely 
that most central neurones possess bicuculline-sensitive GABA 
receptors on their cell bodies and dendrites.
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Although a neurotransmitter role for GABA in mammals 
appears to be limited to the CNS (Brown, 1979; but see also Ong 
& Kerr, 1984), a variety of peripheral neurones derived from 
the neural crest also bear receptors for GABA. For example, 
sympathetic ganglion cells (Adams & Brown, 1975), dorsal root 
ganglion cells (Gallagher et al., 1978) and myenteric neurones 
(Cherubini & North, 1984) are all depolarized by artificially 
applied GABA and various gabamimetics in a bicuculline- 
sensitive, chloride-dependent fashion. It is clear, therefore, 
that some peripheral neurones possess GABA receptors on their 
cell bodies. These receptors are not innervated and have no 
known functional significance - they have therefore been termed 
non-synaptic or extrasynaptic (Brown, 1979). As in the CNS, 
the depolarization of peripheral neurones by GABA results from 
an increase in chloride ion conductance. Neurones of neural 
crest origin apparently have an inwardly directed active 
chloride pump which maintains a high intracellular chloride ion 
concentration; thus a GABA activated increase in chloride 
conductance results in an efflux of chloride ions and 
depolarization (Adams & Brown, 1975; Gallagher et al., 1978; 
Gallagher et al., 1983).
GABA receptors are not confined to the body and dendrites 
of neurones. The central terminals of dorsal root ganglion 
cells (primary afferent terminals) are depolarized by GABA in a 
bicuculline-sensitive fashion (Curtis & Lodge, 1982). The GABA 
receptors on primary afferent terminals are postsynaptic at 
GABA-releasing axo-axonic synapses and their activation is 
associated with the presynaptic inhibition of primary afferent
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excitatory transmission (Levy, 1977; Nicoll & Alger, 1979).
The terminals of sympathetic preganglionic neurones (Brown et 
al., 1981) and olfactory bulb mitral cells (Pickles & Simmonds, 
1976; Pickles, 1979; Cain & Simmonds, 1982) also possess GABA 
receptors whose activation results in bicuculline-sensitive 
chloride-dependent depolarization. However, axo-axonic 
synapses are not present on lateral olfactory tract or 
intraganglionic terminals (Westrum, 1969) and so these GABA 
receptors appear to be non-synaptic and so far have no known 
functional significance.
GABA receptors are also present on the axons of some 
central and peripheral neurones. Lateral olfactory tract 
fibres in the olfactory cortex and optic nerve fibres are 
depolarized by GABA in a chloride-dependent, picrotoxin­
sensitive fashion (Pickles & Simmonds, 1976; Cain 8c Simmonds, 
1982; Simmonds, 1983), suggesting that they possess 
non-synaptic GABA receptors. The axons of hypothalamic 
neurones that project to the posterior pituitary appear to bear 
bicuculline-sensitive GABA receptors (Zingg et al., 1979; 
Mathison & Dreifus, 1981). Preganglionic fibres in the 
cervical sympathetic trunk and C fibres in the vagus nerve are 
also depolarized by GABA and gabamimetics in a
chloride-dependent bicuculline-sensitive manner (Brown & Marsh, 
1978), and even myelinated afferent A fibres in peripheral 
nerves are depolarized by GABA in a bicuculline-sensitive 
fashion (Morris et al., 1983).
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The widespread occurrence of GABA receptors on the bodies, 
axons and terminals of many central and peripheral neurones has 
led to speculation that GABA receptors might be "ubiquitous 
components of mammalian nerve cell membranes" (Brown & Marsh, 
1978).
A recent comparison of the action of microelectrophoretic 
GABA on the intraspinal terminal portions of extensor muscle la 
afferents and vestibulospinal axons within lumbar segments of 
the cat spinal cord has demonstrated that whereas GABA lowered 
the electrical threshold of (and presumably depolarized) 
primary afferents, the threshold of vestibulospinal fibres was 
increased (Rudomin et al., 1981). Tetanic stimulation of 
segmental low threshold flexor afferents depolarized la 
terminals near motoneurones but had no effect on the 
excitability of neighbouring vestibulospinal fibres. It was 
proposed that vestibulospinal terminals were hyperpolarized by 
GABA in a manner akin to the hyperpolarization of lateral 
vestibular nucleus neurones by this amino acid (Obata et al., 
1967). This would be expected if GABA receptors were present 
on vestibulospinal terminals (as might be expected from the 
hypothesis of Brown & Marsh), and if the intracellular chloride 
concentration within vestibulospinal terminals was similar to 
that of the neurones that give rise to them.
Rudomin et al. (1981) also demonstrated that whereas GABA 
lowered the electrical threshold of (and presumably 
depolarized) primary afferents in the intermediate nucleus, the 
threshold of rubrospinal fibres was increased. Rudomin and
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co-workers proposed that rubrospinal terminals were hyper- 
polarized by GABA in a manner akin to the hyperpolarization of 
rubrospinal neurones by this amino acid (Altman et al., 1976). 
In a related study Rudomin & Jankowska (1981) demonstrated that 
tetanic stimulation of segmental low threshold flexor afferents 
depolarized extensor muscle la fibres and terminals but had 
little effect on the excitability of neighbouring rubrospinal 
fibres and terminals in the intermediate nucleus of the spinal 
cord. In contrast, stimulation of afferent fibres in the 
superficial peroneal nerve depolarized rubrospinal fibres and 
terminals, but had no effect on the excitability of la 
terminals.
In an investigation of the effects of microelectrophoretic 
GABA and bicuculline methochloride (BMC) on the myelinated 
fibres and the unmyelinated "terminations" of extensor muscle 
la afferents in the ventral horn, Curtis & Lodge (1982) have 
demonstrated that la terminations are depolarized by 
electrophoretic GABA and gabamimetics in a bicuculline- 
sensitive fashion, and indirect evidence suggested that the 
terminal depolarization was associated with an increase in the 
conductance of the terminal membrane. A depolarizing action of 
GABA on myelinated la fibres within the cord could not be 
detected using the same methods. The depolarization of primary 
afferent terminals produced by tetanic stimulation of low 
threshold flexor afferents (PBST, 2T, 4 volleys at 320Hz) was 
reduced by BMC, suggesting that this synaptically evoked PAD 
resulted from the activation of GABA receptors on primary 
afferent terminals. Thus la terminals, which are postsynaptic
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to GABA-releasing terminals at axo-axonic synapses, possess 
bicuculline-sensitive GABA receptors while the intraspinal 
fibres that give rise to them appear not to have detectable 
GABA receptors.
The effects of GABA and other amino acids on the electrical 
excitability of intraspinal fibres and terminations are, 
however, complicated by indirect effects that may result from 
the administration of abnormally large quantities of amino 
acids into the extracellular space. Studies using a range of 
amino acids have demonstrated that microelectrophoretically 
administered GABA and gabamimetic amino acids may have at least 
two effects on the electrical excitability of la terminations 
(Curtis et al., 1982). A bicuculline-sensitive depolarization 
of terminations was distinguished from a bicuculline- 
insensitive increase in the threshold of afferent terminations 
and fibres. The increase in termination threshold was not 
associated with any alteration in terminal membrane conductance 
(there being no concomitant reduction in synaptically evoked 
PAD), and could be mimicked by nontransmitter amino acids with 
no structural similarity to GABA, such as L-histidine.
Evidence was presented that the observed threshold increases 
could be attributed to changes in the composition of the 
extracellular medium and the size of the extracellular space 
associated with the microelectrophoretic administration and 
subsequent cellular uptake of non-physiological quantities of 
amino acids.
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Since such an effect could account for the reported action 
of GABA on vestibulospinal and rubrospinal fibres, it was 
necessary to reevaluate the proposal that vestibulospinal and 
rubrospinal terminals possess GABA receptors by comparing the 
effects of GABA, L-histidine and the potent gabamimetic 
piperidine-4-sulphonic acid (P4S) on these terminals, and to 
attempt to demonstrate antagonism by bicuculline. The effect 
of P4S on vestibulospinal and rubrospinal terminations was 
expected to be particularly informative, as this amino acid is 
much more potent than GABA at inhibiting neurones and 
depolarizing la terminations, yet less likely to artifactually 
increase fibre and terminal threshold since, unlike GABA and 
L-histidine, it is poorly taken up by spinal tissue 
(Krogsgaard-Larsen et al., 1980; Curtis et al., 1982).
The presynaptic depolarization (PD) of rubrospinal fibres 
and terminals described by Rudomin & Jankowska was further 
characterised and compared with the synaptically evoked 
depolarization of extensor muscle la afferent terminals (PAD).
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RESULTS
(i) The effect of GABA on lumbar terminations of 
vestibulospinal neurones in the ventral horn
On the basis of anodal blocking factors less than four, 
five vestibulospinal terminations (blocking factors 2-4; 
threshold 0.5-1.0pA) and two probable fibres (blocking factors 
5 and 4.7; threshold 1.0 and 1.5pA) were studied in five cats. 
The latencies of antidromically evoked action potentials 
recorded in the lateral vestibular nucleus were 3.0-7.5ms from 
L^-S^ segments. Collision between ascending and descending 
impulses could generally be demonstrated by prior stimulation 
of the ventromedial funiculus more cranially.
Fig. 3 illustrates results from one experiment in which a 
gastrocnemius la termination (Fig. 3A) was excited 
approximately 16 pm from a vestibulospinal termination (Fig. 
3B). As reported previously (Curtis & Lodge, 1982; Curtis et 
al., 1982), the threshold of the la termination (threshold 0.7 
pA, blocking factor 3) was reduced by tetanic stimulation of 
low threshold PBST afferents 30ms beforehand (PAD), and by the 
microelectrophoretic ejection of potassium ions (K, 60nA) and 
P4S (60nA; Fig. 3Aa). GABA (140nA) had a biphasic action on 
this particular termination, an initial depolarization being 
followed by an increase in threshold (see Curtis et al., 1982), 
whereas the non-gabamimetic amino acid, L-histidine, increased
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Fig. 3. Percentage changes in the electrical threshold
(Ordinates: AT%) of a gastrocnemius la termination (A) of
threshold 0.7pA, blocking factor 3, and a vestibulospinal 
termination (B) of threshold 0.75pA, blocking factor 2 , excited 
in the ventral horn (see text). Primary afferent 
depolarization (PAD) was produced by tetanic stimulation of the 
PBST nerve (four volleys, 2T, 320Hz) 30 ms prior to the testing 
pulse, the same afferent volley being used for the 
vestibulospinal termination ("PAD"). The horizontal bars 
indicate the microelectrophoretic ejection (current, nA) of 
potassium (K), piperidine-4-sulphonic acid (P4S), L-histidine 
(LH), GABA (GA) and bicuculline methochloride (BMC).
(Abscissae: time, min).
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the threshold (Fig. 3Ab). During the microelectrophoretic 
ejection of BMC (40nA)/ the depolarizing action of P4S was 
abolished as was the initial depolarization by GABA, and PAD 
was reduced (Fig. 3Ac).
In contrast (Fig. 3Ba), tetanic stimulation of PBST 
afferents ("PAD") had no effect on the threshold of this 
vestibulospinal termination (threshold, 0.75 pA; blocking 
factor, 2; antidromic latency from S^ , 5ms) which was, 
however, depolarized by potassium ions (K, 60nA; Fig. 3Bb).
This termination was insensitive to P4S (60nA), and both GABA 
(80nA) and L-histidine (60nA) increased its threshold. 
Furthermore, the increase of threshold induced by GABA was not 
diminished by BMC (Fig. 3Bd), ejected in amounts which 
invariably reduce the depolarizing action of gabamimetics on la 
terminations and the inhibitory effects of these agents on 
neurones. The apparent reduction in threshold in Fig. 3Bd was 
not directly related to the ejection of BMC and merely reflects 
the difficulty of maintaining stable stimulating conditions in 
this type of investigation.
Results consistent with those illustrated were obtained 
from 4 other vestibulospinal unmyelinated terminations 
(thresholds, 0.5-1 pA; blocking factors, 2.4-4; latencies,
3.2-7.5ms) and two probable fibres (threshold 1 and 1.5 pA; 
blocking factors 5 and 4.7; latencies 3.8 and 3.0 ms) in 4 
other cats. All except the higher threshold fibre were 
depolarized by potassium (60-100nA). Thresholds were 
unaffected or increased by GABA (60-150nA), and P4S (40-80nA) 
either increased the threshold slightly (less than GABA) or had
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no effect. BMC (40-120nA) had no effect on elevations of 
threshold by either GABA or P4S. L-Histidine (40-200nA) raised 
the thresholds of two terminals and the lower threshold fibre.
(ii) The effect of GABA on lumbar terminations of
rubrospinal neurones in the intermediate nucleus
On the basis of anodal blocking factors less than four, 6 
rubrospinal terminations (blocking factors 1.5-3.5) and 8 
fibres (blocking factors 4 - greater than 10) were studied 
close to intermediate nucleus interneurones excited 
monosynaptically by impulses in group I muscle afferent 
fibres. The blocking factor of one other presumed fibre was 
not determined. Electrical thresholds ranged between 0.7 and 
2.4 pA, and the latencies of action potentials antidromically 
recorded in the red nucleus were 3.7-9.0ms from the L^-S^ 
segments. Collision could generally be demonstrated by prior 
stimulation of the dorsolateral funiculus more cranially.
Fig. 4 illustrates results from one experiment in which a 
gastrocnemius la termination (Fig. 4A) was excited 100 pm from 
a rubrospinal termination (Fig. 4B). The threshold of the la 
termination (threshold 0.95 pA; blocking factor 2.5) was 
reduced by tetanic stimulation of low threshold PBST afferents 
(Fig. 4A i7 PAD) and by microelectrophoretic ejection of P4S 
(Fig. 4A ii, 40nA), GABA (Fig. 4A iii; GA, 60nA) and DLH (Fig. 
4A iv, 70nA). Reductions in threshold during PAD, P4S and 
GABA, but not that by DLH, were diminished by bicuculline 
methochloride (Curtis & Lodge, 1982; Curtis et al., 1982;
Fig. 4. Percentage changes in the electrical threshold
(Ordinates: AT%) of a gastrocnemius la termination (A) of
threshold 0.95pA, blocking factor 2.5 and a rubrospinal 
termination (B) of threshold 1.2pA, i-iii; 1.5pA, iv-viii; 
blocking factor 3.5, antidromic latency to red nucleus 7.0 ms, 
excited in the intermediate nucleus at sites separated by 
100pm. Primary afferent depolarization (A, PAD) was produced 
by tetanic stimulation of the PBST nerve (four volleys, 2T, 
320Hz) 30 ms prior to the testing pulse (Ai, Bi), and 
presynaptic depolarization of the rubrospinal termination by 
similar stimulation, but at 4T, of the common peroneal (CP) 
nerve (B vi-viii). The horizontal bars indicate the micro- 
electrophoretic ejection (current, nA) of piperidine- 
4-sulphonic acid (P4S), GABA (GA), DL-homocysteic acid (DLH) 
and bicuculline methochloride (BMC). In B v, BMC had been 
ejected for 4 min without altering threshold, the ejection 
ceasing at the vertical broken line. B vi was recorded 17 min 
later, B vii when BMC had been ejected for 4 min, the threshold 
increasing by approximately 10%, B viii 2 min after B vii. 
(Abscissae: time, min).
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Curtis et al., 1984). The depolarizing effect of the excitant 
amino acid DLH on myelinated fibres and unmyelinated terminals 
presumably occurs as a consequence of changes in the 
extracellular medium associated with the depolarization and 
firing of neurones (Curtis et al., 1984).
In contrast, (Fig. 4B i), tetanic PBST stimulation did not 
alter the threshold of a rubrospinal termination (threshold 1.2 
pA, blocking factor 3.5; antidromic latency from L-,, 7.0ms), 
although the threshold was reduced by DLH (Fig. 4B ii). The 
threshold of this particular termination was transiently 
reduced (Fig. 4B iii) by P4S (80nA), an effect not observed 
with any other rubrospinal termination or fibre (see Fig. 5B & 
C). The subsequent increase in threshold was not associated 
with the ejection of this amino acid, but with movement between 
the stimulating electrode and the termination, the control 
threshold increasing from 1.2 (Fig. 4B i-iii) to 1.5 pA (Fig.
4B iv-vii). GABA (80nA) increased the threshold of this 
rubrospinal termination by approximately 13%, an effect not 
modified by BMC (Fig. 4B v).
Similar results were obtained with the other rubrospinal 
terminations and fibres. Potassium ions (60-80nA) reduced the 
threshold of 7 (not illustrated), having no effect on 4; GABA 
(40-80nA) increased the threshold of all 13 examined, an effect 
not modified by BMC (40-60nA) on all 7 tested. P4S (40-80nA) 
had no effect on the threshold of two rubrospinal terminations 
and three rubrospinal fibres, increasing the threshold of two 
terminations and five fibres by 2-5%. Such a relatively small 
increase in termination threshold by P4S, which was insensitive
to BMC, has been reported for vestibulospinal terminals and la
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terminations in the presence of BMC, and is presumably 
associated with the uptake of P4S by spinal tissue (Curtis et 
al., 1982). DLH decreased the threshold of two terminations 
and one fibre, whereas L-histidine increased the threshold of 
two fibres.
Although tetanic stimulation of PBST afferent fibres 
readily depolarized la terminations in the intermediate nucleus 
(and ventral horn, Curtis & Lodge, 1982), there was no change 
in the thresholds of all 14 rubrospinal terminations and fibres 
tested (see also Rudomin & Jankowska, 1981). Reductions in 
threshold, of the order of 5-10% were produced by tetanic 
stimulation (2 and 4T) of the ipsilateral tibial or common 
peroneal nerve, as illustrated in Fig. 4B vi-viii, but not by 
stimulation of the sural nerve (2 and 4T). Such presynaptic 
depolarization (PD) was not reduced by BMC (2 terminations, 1 
fibre) ejected in amounts adequate to diminish the much larger 
(10-20% reduction in threshold) PAD of neighbouring group I 
afferent terminations generated by volleys in these mixed 
nerves.
This is shown in Fig. 5, which illustrates results from two 
experiments in which la and rubrospinal fibres and terminals 
were excited in the intermediate nucleus. The threshold of the 
la termination (threshold 0.64-0.73pA; blocking factor 1.6) was 
reduced (23%) by tetanic stimulation of low threshold (2T) 
tibial afferents (Fig. 5A i, TIB) and by microelectrophoretic 
ejection of P4S (Fig. 5A i, 40nA). Reductions in threshold 
during tibial evoked primary afferent depolarization and P4S 
were diminished by BMC (Fig. 5A ii, 40nA). In contrast, the 
threshold of the rubrospinal fibre (threshold 1.3-1.5uA;
Fig. 5. Percentage changes in the electrical threshold
(Ordinates: AT%) of a flexor digitorum longus (FDL) la
termination (A) of threshold 0.64 - 0.73pA, blocking factor 
1.6, a rubrospinal fibre (B) of threshold 1.3 - 1.5pA, blocking 
factor 5, antidromic latency to red nucleus 6.5 ms and a 
possible rubrospinal terminal (C) of threshold 1.45 - 1.57pA, 
blocking factor 3, antidromic latency to red nucleus 3.7 ms. 
Primary afferent depolarization of the FDL termination and 
presynaptic depolarization of the rubrospinal fibre were 
produced by tetanic stimulation of the tibial (TIB) nerve (four 
volleys, 2T, 320Hz) 30 ms prior to the testing pulse. The 
horizontal bars indicate the microelectrophoretic ejection 
(current, nA) of piperidine-4-sulphonic acid (P4S), GABA (GA) 
and bicuculline methochloride (BMC). A iii was recorded 1 min 
after cessation of BMC ejection (40nA for 2.5 min). B iii was 
recorded 30 sec after cessation of BMC ejection (80nA for 2 
min). C iii was recorded 2 min after cessation of BMC ejection 
(60nA for 2.5 min) (Abscissae: time, min).
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blocking factor 5) was unaffected by electrophoretic P4S (Fig.
5B i, 40nA) and although tetanic stimulation of low threshold 
tibial afferents (Fig. 5B i; TIB) reduced termination threshold 
by 7%, this depolarization was unaffected by electrophoretic 
BMC (Fig. 5B ii, 80nA).
(-)-Baclofen was ejected electrophoretically near 
rubrospinal fibres to determine its effect on the PD produced 
by tetanic stimulation of low threshold afferents, as it had 
previously been shown to reduce the synaptically evoked PAD of 
la terminations, probably by decreasing the release of GABA at 
axo-axonic synapses (Curtis et al., 1981). When administered 
microelectrophoretically near two rubrospinal fibres, 
(-)-baclofen failed to alter the electrical threshold of either 
fibre. Conditioning stimulation of peripheral afferents 
reduced the threshold of only one fibre; the PD of this 
rubrospinal fibre was reversibly reduced by (-)-baclofen.
This is shown in Fig. 6 which illustrates results from a 
rubrospinal fibre (threshold 1.5-2.0jiA, blocking factor 5) 
excited in the intermediate nucleus. The threshold of this 
rubrospinal fibre was reduced by tetanic stimulation of low 
threshold tibial afferents (Fig. 6 i, TIB 2T). Electrophoretic 
(-)-baclofen (lOmM in 150mM NaCl, lOOnA) progressively reduced 
the tibial evoked presynaptic depolarization in the absence of 
any effect on fibre threshold (the change from 1.5 to 1.71 
occurring before the period of baclofen ejection) (Fig. 6 i). 
The action of (-)-baclofen was reversible, partial recovery 
occurring 9 minutes after termination of ejection (Fig. 6 ii).
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Fig. 6. Percentage changes in the electrical threshold
(Ordinate: AT% ) of a rubrospinal fibre of threshold
1.5pA-2.0pA, blocking factor 5, antidromic latency to red 
nucleus 6.5 ms, excited in the intermediate nucleus. 
Presynaptic depolarization of the rubrospinal fibre was 
produced by tetanic stimulation of the tibial (TIB) nerve (four 
volleys, 2T, 320Hz) 30ms prior to the testing pulse. The 
horizontal bar indicates the microelectrophoretic ejection of 
(-)-baclofen lOOnA for 3 minutes. (-)-Baclofen reduces the 
size of presynaptic depolarizations without affecting 
termination threshold. The traces of II were recorded 9 minutes 
after (-)-baclofen ejection. The vertical arrow in I signals 
adjustment of the multiplying factor in the feedback system to 
a value of 1.00 30s before (-)-baclofen ejection commenced. 
(Abscissae: time, min).
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DISCUSSION
Had GABA hyperpolarized vestibulospinal and rubrospinal 
terminals at receptors similar to those on neurones in the 
lateral vestibular and red nuclei/ receptors which appear to be 
similar to those on other central neurones (Altman et al.,
1976; Bruggencate & Engberg, 1969; Obata et al., 1967), P4S 
would be expected to have been more effective than GABA in 
raising termination thresholds, and the effects of both GABA 
and P4S should have been blocked by bicuculline methochloride 
(Curtis et al., 1970; Curtis et al., 1971a; Curtis et al., 
1971b). Yet, P4S had little or no effect on the thresholds of 
vestibulospinal and rubrospinal terminations, although readily 
depolarizing la terminations, an action blocked by BMC. 
Furthermore, the elevation of vestibulospinal and rubrospinal 
termination threshold by GABA was not reduced by BMC, and 
similar elevations of threshold were produced by the 
non-transmitter amino acid L-histidine.
These results suggest that vestibulospinal and rubrospinal 
fibres and terminals, unlike the cell bodies that give rise to 
them, do not possess bicuculline-sensitive GABA receptors. The 
observed increase in termination and fibre threshold by 
L-histidine, GABA (and to a lesser extent P4S) probably 
resulted from uptake of microelectrophoretically administered 
amino acids from the extracellular space and hence presumably 
is an investigational artifact rather than a postsynaptic 
receptor mediated event (see Curtis et al., 1982). Thus 
although GABA is an inhibitory transmitter controlling the
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activity of lateral vestibular nucleus (Obata et al., 1967) and 
red nucleus (Altman et al., 1976) neurones, this amino acid is 
unlikely to be a transmitter acting at bicuculline-sensitive 
receptors upon vestibulospinal or rubrospinal terminals.
The apparent absence of GABA receptors on vestibulospinal 
and rubrospinal fibres and terminations is contrary to the view 
that such receptors are ubiquitous components of mammalian 
nerve cell membranes (Brown & Marsh, 1978). It is significant 
that although motoneurones are hyperpolarized by GABA (Curtis 
et al., 1968) in a bicuculline-sensitive fashion, GABA has no 
effect on the excitability of peripheral motor fibres (Morris 
et al., 1983), and no effect on the release of transmitter at 
the neuromuscular junction (Smart, 1980; but see Bornstein, 
1980). Thus GABA receptors are also absent from the fibres and 
terminals of motoneurones. Clearly the sensitivity of axon 
terminals to transmitters cannot always be predicted from the 
sensitivity of the neurones that give rise to them.
Some central neurones that are inhibited by GABA in a 
bicuculline-sensitive manner do have bicuculline-sensitive GABA 
receptors present on their fibres and terminals. Mitral cells 
in the olfactory bulb are hyperpolarized by GABA in a 
chloride-dependent bicuculline-sensitive manner; furthermore 
the presence of bicuculline-sensitive hyperpolarizing IPSPs in 
mitral cells suggests that the GABA receptors on them are 
synaptic (Jahr & Nicoll, 1982; see also Nicoll, 1972). The 
axons (lateral olfactory tract fibres) and terminals of mitral 
cells are also sensitive to GABA, however they are depolarized
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in a chloride-dependent bicuculline- sensitive fashion at 
receptors which, in the absence of axo-axonic synapses 
(Westrum, 1969), appear to be non-synaptic (Pickles & Simmonds, 
1976). GABA also depolarizes optic nerve fibres in a 
chloride-dependent bicuculline-sensitive manner (Simmonds,
1983), in contrast to its hyperpolarizing action on the retinal 
ganglion cells that give rise to them (Miller et al., 1981). 
GABA inhibits, and presumably hyperpolarizes sympathetic 
preganglionic neurones within the spinal intermediolateral 
nucleus at bicuculline-sensitive receptors (Backman & Henry, 
1983). However, the axons and terminals of these cells within 
peripheral sympathetic ganglia are depolarized by GABA in a 
chloride-dependent bicuculline-sensitive fashion (Brown et al., 
1981). GABA inhibits the firing and presumably hyperpolarizes 
hypothalamic cells that project to the posterior pituitary at 
bicuculline-sensitive synaptic receptors (Blume et al., 1981; 
Mayer, 1981; Arnauld et al., 1983). GABA and gabamimetics also 
influence the axons of these cells in a chloride-dependent 
bicuculline-sensitive fashion, and indirect evidence 
(depression and slowing of the hypothalamohypophyseal tract 
compound action potentials) suggests depolarization (although a 
hyperpolarizing conductance increase remains a possibility in 
the absence of direct measurement of axon membrane potential or 
excitability)(Zingg et al., 1979; Mathison & Dreifuss, 1981; 
Loeffler et al., 1982).
The differing chloride-dependent effects of GABA on the 
membrane potential of certain central neurones, and the axon 
terminals they give rise to suggests that the intracellular
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Chloride concentration within these neurones is unlikely to be 
uniform. Studies on spinal motoneurones and some supraspinal 
neurones have provided evidence that the intracellular chloride 
concentration within the bodies of central neurones is lower 
than would be expected from a passive distribution of this ion 
and implicate the involvement of an outwardly directed chloride 
pump that is sometimes sensitive to ammonium ions and/or cobalt 
ions (Lux et al., 1970; Allen et al., 1977; Sypert & Bidgood, 
1977). The chloride-dependent depolarizing action of GABA on 
the fibres and terminals of certain central neurones suggests 
that the intracellular chloride concentration within these 
axons and terminals may be considerably higher than in the cell 
bodies that give rise to them. The higher intraterminal 
chloride concentration might be associated with an inwardly 
directed chloride pump; the action of such a pump would 
establish a large chloride gradient between the axon and cell 
body, a possibility which seems rather unlikely. Alternatively 
the depolarizing action of GABA on the fibres and terminals of 
these neurones may be an investigational artifact attributable 
to an abnormal distribution of chloride between the 
intracellular and extracellular compartments in vitro, or due 
to the presence of a novel chloride-dependent cation 
conductance. Further investigation of these GABA effects, 
preferably in vivo as well as in vitro, is required as the 
possibility of a non-uniform distribution of chloride (and 
possibly other ions) within neurones could be important in 
determining the physiological behaviour of neurones and their 
terminals. The functional significance, if any, of the 
"non-synaptic" GABA receptors on fibres and terminals of some
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central neurones also requires further clarification: can
presynaptic inhibition occur in response to physiological 
stimuli in the absence of axo-axonic synapses?
To summarise, some central neurones (rubrospinal neurones, 
vestibulospinal neurones and spinal motoneurones) which possess 
synaptic GABA receptors on their somata and dendrites do not 
possess GABA receptors on their axons and terminals, while 
others (mitral cells, retinal ganglion cells, sympathetic 
preganglionic neurones and some hypothalamic neurones) 
apparently do possess GABA receptors on their axons and 
terminals (although they are non-synaptic in the sense that 
they are not innervated by GABA-releasing axo-axonic synapses).
Primary afferent terminals and the dorsal root ganglion 
cells that give rise to them are both depolarized by GABA in a 
bicuculline-sensitive manner (Curtis & Lodge, 1982; Gallagher 
et al., 1978). There is good evidence that an active inwardly 
directed chloride pump maintains a high intracellular chloride 
concentration in dorsal root ganglion cells, and presumably 
their terminals, so that the chloride equilibrium potential is 
depolarized with respect to the resting membrane potential 
(Gallagher et al., 1978; Gallagher et al., 1983). The GABA 
receptors present on primary afferent terminals are 
postsynaptic at axo-axonic synapses, while those on dorsal root 
ganglion cells are not innervated and have no apparent 
functional importance in the mature animal. Studies on the 
relative order of potency of a range of gabamimetic amino acids 
have suggested that the synaptic GABA receptors on primary
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afferent terminals are similar to those located 
postsynaptically on spinal neurones, but differ from the 
non-synaptic GABA receptors on dorsal root ganglion cells, even 
though bicuculline is an antagonist at all these sites (Curtis 
et al., 1982). The membrane sites at which GABA influences the 
properties of dorsal root ganglion cells (and sympathetic 
ganglion cells) may be a redundant legacy of a function of 
evolutionary or developmental importance which is no longer of 
significance to the mature animal. Receptors on the central 
terminals of afferent fibres are presumably modified by their 
involvement in functionally significant synapses, a process 
which occurs, for example, with acetylcholine receptors at 
neuromuscular junctions (Edwards, 1979).
The presynaptic depolarization of rubrospinal terminals 
observed in the present investigation was of a similar 
magnitude to that observed in the earlier study of Rudomin et 
al. (1981), even though tetanic conditioning stimulation was 
used rather than single stimuli. Conditioning stimulation at 
4T consistently produced a greater rubrospinal depolarization 
than at 2T, the only strength used in the earlier investigation.
If the depolarization of rubrospinal terminals was 
attributable to the action of GABA, both GABA and P4S would 
have been expected to decrease the threshold of rubrospinal 
terminals in a bicuculline-sensitive fashion and the 
synaptically evoked depolarization of rubrospinal terminals 
should have been reduced by BMC. The failure to demonstrate 
the presence of bicuculline-sensitive GABA receptors on
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rubrospinal terminals and the failure of electrophoretic BMC to 
reduce rubrospinal PD suggests that GABA is not a transmitter 
mediating the depolarization of rubrospinal terminals.
If an increase in the extracellular potassium ion 
concentration within the intermediate nucleus was responsible 
for the depolarization of rubrospinal terminals (Rudomin et 
al., 1981; see also Kriz et al.# 1974) it would be expected 
that la, lb and rubrospinal fibres terminating in the same 
region would all be affected, at least to some degree, by the 
same conditioning stimuli. Rudomin & Jankowska (1981) have 
demonstrated, however, that stimulation of the superficial 
peroneal nerve depolarizes rubrospinal fibres, without 
affecting the threshold of neighbouring la fibres.
Furthermore, although tetanic stimulation of sural and common 
peroneal nerves produce comparable increases in the 
extracellular level of potassium in the intermediate nucleus 
(Jimenez et al., 1983), common peroneal conditioning stimuli, 
but not sural conditioning stimuli, depolarize rubrospinal 
terminals. Thus an increase in the extracellular potassium 
concentration seems a possible but unlikely explanation for 
rubrospinal PD.
What then is the likely cause of the PD of rubrospinal 
terminals? It is possible that the threshold reductions 
detected are artifactual and somehow result from the type of 
synchronous, non-physiological stimuli used in this type of 
investigation. Alternatively it seems plausible that the 
synaptically evoked depolarization of rubrospinal terminals may
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result from the action of a transmitter other than GABA on 
rubrospinal terminals. This notion is supported by the finding 
that the PD of one rubrospinal fibre was reversibly reduced by 
electrophoretic (-)-baclofen, which has been demonstrated to 
reduce the release of excitatory transmitters from primary 
afferent terminals and also that of GABA at axo-axonic synapses 
upon them (Curtis et al.# 1981). Further investigation of 
rubrospinal PD is required, to elucidate which (if any) 
transmitter is involved, how it reaches the rubrospinal 
terminals and whether the change in terminal excitability is 
associated with alterations in transmitter release. Definitive 
experiments, however, would be demanding, as long intracellular 
recording from intermediate neurones would be required to 
determine whether the depolarization of rubrospinal terminals 
was of any functional significance. It is of interest that a 
synaptically evoked depolarization of corticospinal terminals 
has also been reported (Rudomin et al., 1978). So far, 
however, no synaptically evoked depolarization of 
vestibulospinal terminals in the ventral horn has been observed 
(Rudomin et al. , 1981).
The failure of tetanic PBST conditioning volleys to alter 
the threshold of vestibulospinal terminals is in keeping with 
the observation that vestibulospinal evoked monosynaptic EPSPs 
in motoneurones are unaffected by such volleys, which, however, 
depolarize la terminals and concomitantly depress monosynaptic 
la EPSPs (Rudomin et al., 1975; Rudomin et al., 1981). 
Apparently there is no GABA-mediated presynaptic control of 
descending vestibulospinal excitatory transmission.
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GABA-releasing interneurones in the mammalian spinal cord 
presynaptically control the input of sensory information into 
the CNS at synapses of primary afferents. These interneurones 
are influenced by impulses in pathways of segmental and 
supraspinal origin (see Rudomin et al.# 1983). In contrast, no 
GABA-mediated presynaptic inhibitory process affects the 
terminals of descending vestibulospinal and rubrospinal 
tracts. Perhaps supraspinally programmed plans for motor 
performance must take priority over and be largely unaffected 
by peripheral inputs (see Rudomin, 1980; Wetzel & Stuart, 1976).
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IV. ACTIONS OF MIDAZOLAM AND Rol5-1788 IN THE CAT SPINAL
CORD
INTRODUCTION
Benzodiazepines are widely used in clinical practice to 
produce sedation, sleep, "anxiolysis", muscle relaxation and to 
prevent or terminate convulsions. Early studies on spinal cats 
revealed that diazepam administered intravenously in small 
doses (.05-1.0 mg kg increased and lengthened dorsal root 
potentials and the prolonged, "presynaptic" inhibition of 
extensor monosynaptic reflexes, while having no effect on short 
latency, "direct", postsynaptic inhibition (Schmidt et al., 
1967). As there was evidence that prolonged spinal inhibition 
and the associated depolarization of primary afferents were 
attributable to the action of the neurotransmitter GABA (Eccles 
et al., 1963), it was postulated that benzodiazepines somehow 
enhanced the postsynaptic effectiveness of this amino acid. 
Further in vivo studies established that systemically 
administered benzodiazepines enhanced a variety of GABA- 
mediated inhibitions in the nervous system: inhibition of
cerebellar Purkinje cells by GABA-releasing basket cells 
(Curtis et al., 1976b; Geller et al., 1978), local 
GABA-mediated inhibition in the cerebral cortex (Zakusov et 
al., 1977) and pre- and postsynaptic GABAergic inhibition in 
the cuneate nucleus (Pole & Haefely, 1976).
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Benzodiazepines could enhance GABA-mediated inhibition in 
three ways: by increasing the release of GABA from inhibitory
nerve terminals, by enhancing the postsynaptic action of GABA 
and by interfering with the inactivation of GABA (presumably by 
interfering with cellular uptake). The last possibility was 
discounted by neurochemical studies which failed to demonstrate 
any significant effect of benzodiazepines on GABA uptake in 
vitro (Iversen & Johnston, 1971). In order to distinguish 
between the first two possibilities it was necessary to examine 
the effect of benzodiazepines on the inhibitory action of GABA 
(and other neurotransmitters) administered microelectro- 
phoretically near single cells. Yet attempts to establish that 
systemically or electrophoretically administered 
benzodiazepines potentiate, in a selective fashion, the action 
of electrophoretic GABA on single central neurones in vivo have 
yielded conflicting results (see Haefely et al., 1981). 
Benzodiazepines have been reported to antagonise (Steiner & 
Felix, 1976; Gähwiler, 1976), enhance (Kozhechkin &
Ostrovskaya, 1977; Gallaher, 1978; Geller et al., 1978;
Nestoros & Nistri, 1979; Nistri et al., 1980; Jiang, 1981), 
mimic (Dray & Straughan, 1976) or have no effect on (Curtis et 
al., 1976a; Curtis et al., 1976b; Assumpeao et al., 1979) the 
postsynaptic action of electrophoretic GABA. Variable effects 
on the spontaneous and excitant induced firing of cells have 
also been reported.
Intracellular studies carried out in vitro using cultured 
spinal neurones have demonstrated convincingly that low 
concentrations of benzodiazepines selectively facilitate the
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postsynaptic action of GABA, while failing to influence the 
postsynaptic action of glycine and L-glutamate (Choi et al., 
1977; MacDonald & Barker, 1982; Skerrit & MacDonald, 1984). 
However, benzodiazepine effects were found to be peculiarly 
dose dependent: whereas low concentrations of benzodiazepines
(similar to those achieved in the mammalian central nervous 
system after systemic administration of conventional doses) 
augmented GABA responses, higher concentrations antagonised the 
action of GABA (MacDonald & Barker, 1978; MacDonald & Barker, 
1982). This dual effect of benzodiazepines on GABA responses 
provides a possible explanation for the multiplicity of results 
reported in microelectrophoretic studies in vivo, as a variety 
of benzodiazepines had been administered from solutions of 
differing (and often high) concentrations using arbitrary (and 
probably insufficient) retaining currents. Furthermore, 
benzodiazepine concentrations attained near GABA receptors on 
the soma were likely to be considerably higher than at 
dendritic receptors further away from the micropipette.
Additional difficulties in previous in vivo microelectro- 
phoretic experiments were attributable to the technical 
problems associated with electrophoretic administration of 
substances only weakly soluble in water, although very potent 
when administered systemically. The recent availability of the 
water soluble benzodiazepine midazolam (Ro21-3981: 8-chloro-6 
(2-fluorophenyl)-l-methyl-4H-imidazo[1, 5-a][1,4] 
benzodiazepine; Pieri et al., 1981), together with the 
discovery of a selective benzodiazepine antagonist
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(Rol5-1788: ethyl-8- fluoro-5, 6-dihydro-5-methyl-6-oxo-4H- 
imidazo [1,5a][1,4]benzodiazepine-3-carboxylate; Hunkier et 
al., 1981; Pole et al., 1981) prompted a re-evaluation of the 
effects of intravenous and electrophoretic benzodiazepine 
agonists and antagonists on the postsynaptic action of GABA, 
glycine and noradrenaline on neurones of the cat spinal cord.
In addition, midazolam and Rol5-1788 were administered 
electrophoretically and intravenously while measuring the 
excitability of la terminations and determining their 
sensitivity to gabamimetics, to study the interaction between 
benzodiazepines and GABA at receptors on primary afferent 
terminals.
Midazolam enhances primary afferent depolarization in the 
spinal cord of unanaesthetised cats at dose levels (0.3 mg 
kg Pole et al., 1981) similar to those which induce 
anaesthesia in humans (Fragen et al., 1978; Brown et al., 1979; 
Forster et al., 1980; Jensen et al., 1982). It was thus also
of interest to determine the effects of midazolam on conscious 
cats. In humans, anaesthesia is produced by blood levels 
exceeding 1.25^M (Lauven et al., 1982), but taking into 
consideration the binding by plasma proteins (Vinik et al., 
1982) brain levels are probably of the order of 10-50nM.
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RESULTS
(i) Conscious cats
When administered intravenously over a period of 5 seconds, 
midazolam maleate (1 mg kg \  5 mg kg 20 mg kg  ^
diluted in 5 ml 165mM NaCl) produced similar effects at each 
dose level. Within 20-40 sec there was a decrease in muscle 
tone. When released the animals stood and walked but 
frequently fell over. Weakness and ataxia were most prominent 
in the hind limbs. These effects were maximum within 1-3 
minutes of the injection; subsequently there was a rapid 
improvement over 4-5 minutes, but the animals were still 
somewhat ataxic an hour later.
There was no indication of a reduction in consciousness in 
any animal, such as that produced by intravenous pentobarbitone 
sodium (20-30 mg kg )^. The cats appeared disorientated and 
agitated, becoming difficult to handle and trying to escape 
although previously friendly and tractable.
(ii) Inhibition of spinal reflexes
This study was carried out primarily as a consequence of 
the finding (see below) that midazolam enhanced the effects of 
glycine on some spinal neurones, glycine having been 
established as the transmitter of strychnine-sensitive,
"direct" inhibition (Curtis and Johnston, 1974). When 
administered intravenously in increasing doses from 0.1 mg 
kg 1 to a maximum of 10 mg kg \  midazolam reduced the
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amplitudes of flexor and extensor monosynaptic reflexes, and 
increased and lengthened both the DRP and the prolonged, 
"presynaptic" inhibition of G reflexes produced by tetanic 
stimulation of PBST afferents. Significant enhancement of both 
these phenomena was observed after midazolam 0.1 mg kg ^. In 
contrast, midazolam in doses as high as 10 mg kg  ^had no 
significant effect on the short latency, glycinergic inhibition 
of PBST reflexes by low threshold Q volleys in three cats, 
inhibition which was subsequently considerably reduced by 
intravenous strychnine hydrochloride, 0.05 mg kg ^.
(iii) Interneurones
The effects of microelectrophoretic midazolam was studied 
on 41 dorsal horn interneurones. With 38 of these cells, 
midazolam reduced the firing produced by DLH, and the initial 
rate could be restored by increasing the current being used to 
eject the excitant. This reduction of the effectiveness of DLH 
by midazolam appeared not to be antagonised by Rol5-1788.
With 31 of the 41 neurones the depression by GABA of 
DLH-produced firing was potentiated by midazolam (67.8 + 28.3 
(S.D.)%) ejected with currents of 5-10nA from 20mM in 150mM 
NaCl solutions or 20-40nA from the 5mM in 150mM NaCl solutions 
(see Fig. 8B, E and H). Midazolam was without effect on the 
action of GABA on the other 10 cells, neither enhancement nor 
antagonism being observed. On several cells where currents of 
10-20nA (20mM in 150mM solutions) of midazolam potentiated the 
action of GABA, currents of 80nA appeared to reverse this 
potentiation. On some cells the maximum potentiation of GABA
Fig. 8. A-F: Effects of microelectrophoretic midazolam
(MIDAZ; 5mM in 150mM NaCl) on the inhibition of two spinal 
dorsal horn interneurones excited by DLH (A-C, -lOnA; D-F,
-15nA) by glycine (GL), GABA (GA) and noradrenaline (NA) using 
currents and times of ejection indicated by the figures, 
horizontal bars and symbols. The negative values indicate 
reduction of the anionic retaining currents. A, before; B, 
during midazolam 20nA for 4.5 minutes, terminating at the 
vertical broken line, the effect of NA during midazolam being 
identical to that just after it; C, 5 min after B. D, before;
E, during midazolam 23nA for 3 min; F, 5 min after E. Full 
recovery of the GABA effect had not occurred when recording 
ceased suddenly 5 min later.
G-K: antagonism by Rol5-1788 of the enhanced
effectiveness of GABA on a spinal interneurone by midazolam 
(2mM in lOOmM NaCl). Firing was maintained by DLH 12-18nA and 
GABA was ejected for 15 sec with 20 sec intervals throughout.
G, before; H, during midazolam 30nA which commenced 2 min 
earlier and continued for 8 min 45 sec; I, during the 
simultaneous administration of midazolam and Rol5-1788, the 
latter for a total time of 1 min 40 sec which terminated at the 
top vertical broken line; J, 3 min after I, the midazolam 
current ceased at the lower vertical broken line; K, 5.5 min 
after J. (Ordinates: firing rate, spikes sec Abscissae:
time, min).
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(or glycine, see below) by midazolam did not occur until after 
termination of the benzodiazepine ejection. Recovery from the 
actions of midazolam usually required longer than 2 minutes, 
and with many cells complete recovery was not observed within 
6-8 minutes (see Fig. 8F). Additionally, with many cells upon 
which midazolam reversibly enhanced the effect of GABA, 
repeated administration of the benzodiazepine appeared to be 
much less effective.
Of the 21 cells where both GABA and glycine were used to 
inhibit firing and midazolam potentiated the effect of GABA, 
the effect of glycine on 15 cells was also enhanced, although 
to a smaller extent (20.1+ 16.6%) and usually with currents 
higher than those required to produce maximal potentiation 
(67.2+ 31.3%) of GABA effects (Fig. 8D-F). Noradrenaline and 
GABA were tested together on 9 cells. The effects of GABA were 
enhanced on all (70.5 + 21.5%), and midazolam increased the 
noradrenaline depressions of 6 of these by 19.5 + 9.6%. The 
much smaller influence of midazolam on the inhibitory action of 
noradrenaline compared to GABA is illustrated in Fig. 8B and 
E. With the 7 neurones upon which GABA, glycine and 
noradrenaline were all tested, the ratios of the percent 
increase by midazolam were 1.0:0.33:0.18 respectively.
The interaction between Rol5-1788 and midazolam was studied 
on 7 neurones. As illustrated for one neurone in Fig. 8G-K, 
the enhancement of the effect of GABA on 5 neurones by 
midazolam was totally blocked by Rol5-1788 (15-30nA), the 
antagonist alone having no effect on the inhibitory effect of 
GABA. With the other two cells the action of midazolam was 
reduced by 50% and 30%.
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The effects of intravenously administered benzodiazopines
were also determined on the actions of amino acids and
noradrenaline on four neurones. In the case of the results
illustrated in Fig. 9, where electrophoretically administered
midazolam enhanced the inhibitory effect of GABA, but not those
of glycine or noradrenaline (Fig. 9A-C), intravenous midazolam
(0.3 mg kg increased the amplitude of the DRP recorded
from the L dorsal root in response to L dorsal root 6 /
stimulation by 30%, and prolonged its duration, and also 
increased the inhibitory effect of GABA in a specific fashion. 
This latter result is illustrated in Fig. 9E after a further 
dose of midazolam (0.3 mg kg ^). The enhanced effectiveness 
of GABA was rapidly reversed by intravenous Rol5-1788, 1 mg
kg  ^ (Fig. 9F) which also reduced the amplitude and duration 
of the DRP to near control levels.
Experiments of this type were not readily performed because 
the reduction in blood pressure by midazolam led to changes in 
both extracellular spike amplitude and the sensitivity of 
neurones to depressants. Primarily as a consequence of these 
technical difficulties convincing evidence of a selective 
enhancement of the inhibitory effect of microelectrophoretic 
GABA was not observed with 3 other neurones.
(iv) la afferent terminations
In confirmation of the increase of DRPs, intravenous 
midazolam increased the PAD of single extensor muscle group la 
terminations in the ventral horn. Three terminations were
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Fig. 9. Effects of electrophoretic (A-C) and intravenous
(D-F) midazolam on the inhibition of the firing of a spinal 
interneurone (DLH, 5nA) by GL, NA and GA. A, before: B,
during midazolam (5mM in 150mM NaCl) 20nA for 2 min 20 sec 
terminating at the vertical broken line; C, 3 min after B; D, 2 
min after C; E, 12 min after C and 4 min after intravenous 
midazolam maleate 0.6 mg kg ^ ; F , 7 min after E and 3 min 
after intravenous Rol5-1788, 1.0 mg kg ^ . (Ordinates: 
firing rate, spikes sec ^ . Abscissae: time, min).
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tested in this fashion, one in each of 3 cats, and in the two 
to which Rol5-1788 (1 mg kg was subsequently administered 
the effect of midazolam was reversed.
Results from two experiments are illustrated in Fig. 10. 
Synaptically generated PAD of a gastrocnemius la termination 
was increased from a 19% (Fig. 10A) to a 27% (Fig. 10B) 
reduction in threshold by midazolam (0.5 mg kg ^), the PAD 
after Rol5-1788 (1.0 mg kg being 22%. Midazolam, however, 
produced no concomitant increase in the depolarizing action of 
GABA (Fig. 10A and 10B). This probably resulted from movement 
of the stimulating (and GABA-administering) micropipette away 
from the termination, reflected as an increase in its threshold 
from 0.50 to 0.56pA, as a consequence of a 20mm Hg reduction in 
arterial blood pressure by midazolam. Blood pressure changes 
affect the depolarizing action of electrophoretic GABA to a 
much greater extent than the depolarizing action of 
synaptically released GABA, as small changes in the 
micropipette terminal distance greatly alter the concentration 
of GABA near the termination under study.
The enhancement of PAD (from 18 to 24%) of another extensor 
la termination by midazolam (0.5 mg kg 1 i.v.) is illustrated 
in Fig. 10G and H, and in this instance the depolarizing action 
of microelectrophoretic P4S was also increased, from a 13% to a 
20% reduction in threshold. Although the threshold of the 
termination increased from 1.53 to 1.69pA, movement of the 
pipette away from the termination presumably had less effect on 
the concentration of P4S around the terminal, compared with
Fig. 10. Effects of midazolam on PAD of group la extensor
afferent terminations and the depolarizing actions of GABA (GA, 
14nA) and piperidine-4-sulphonic acid (P4S, lOnA). PAD was 
produced by tetanic stimulation (4 volleys, 320Hz) of PBST 
afferents (2T) 70 ms before the pulse used to determine 
termination threshold. A-C: gastrocnemius termination,
initial threshold 0.50pA; A, before, B, 4 min after intravenous 
midazolam maleate, 0.5 mg kg ^; C, 3.5 min after B and 1 min 
after Rol5-1788, 1 mg kg ^. D-H: gastrocnemius termination,
initial threshold 1.33p A ; D, before, E, during electrophoretic 
midazolam (5mM in 150mM NaCl) 40nA for 6 min, terminating at 
vertical broken line; F, 5 min after E; G, 14 min after F; H, 3 
min after intravenous midazolam maleate, 0.5 mg kg 
(Ordinates: changes in threshold ( AT) expressed as a
percentage. The actual threshold (pA) is given beneath each 
record. Abscissae: time, min).
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GABA and the termination of Fig. 10A-C, since P4S is a poor 
substrate for amino acid uptake processes (see Curtis and 
Lodge, 1982; Curtis et al., 1982).
Midazolam was ejected microelectrophoretically near 22 
individual ventral horn la terminations of threshold less than 
1.5pA and blocking factor less than 4 . Although the 
thresholds of virtually all were reduced by either GABA (40nA) 
or P4S (10-20nA), and the effects of these amino acids and PAD 
were reduced by BMC (20-40nA), considerable difficulty was 
experienced in demonstrating reversible enhancement of PAD and 
the depolarizing action of gabamimetics by the benzodiazepine. 
Since relatively small intravenous doses of midazolam (0.5 mg 
kg "*■) significantly enhanced PAD of single la terminations, 
most microelectrophoretic tests were carried out using a 5mM 
solution of midazolam maleate in 150mM NaCl, in order to 
obviate problems due to leakage from solutions of higher 
concentration.
Using such solutions, midazolam ejected with currents of 
20-40nA reversibly enhanced the depolarizing action of GABA on 
9 of 15 terminals, that of P4S on 3 of 3 and increased the PAD 
of 13 of 22. With these 13 terminals midazolam increased the 
effect of GABA on 6 and of P4S on 2. Such an effect of 
midazolam is illustrated in Fig. 10D-F for a gastrocnemius la 
termination of threshold 1.33pA. P4S (lOnA) reduced the 
threshold by 12%, and during tetanic stimulation of the PBST 
nerve (70ms interval) the PAD was approximately 20% (Fig.
10D). During the ejection of midazolam, P4S reduced the
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threshold by 17% and PAD was 23% (Fig. 10E). Five minutes after 
the ejection of midazolam ceased (Fig. 10F), the change in 
threshold during P4S was 13%, PAD remaining at 22%.
It was not unusual for the potentiation of GABA by 
midazolam to be irreversible. This is illustrated for a 
plantaris la termination of threshold 0.64pA in Fig. 11. GABA 
(40nA) initially reduced the threshold of this termination by 
8%. During electrophoretic midazolam (20nA) the depolarizing 
action of GABA was enhanced, 40nA producing a 13% reduction in 
threshold. The enhancement of GABA did not reverse after 
terminating the ejection of midazolam. In fact the maximum 
potentiation of GABA was observed after the ejection of the 
benzodiazepine, 40nA producing a 15% reduction in threshold.
The enhancement of the effects of GABA, P4S and of PAD by 
microelectrophoretic midazolam were generally very small, that 
for P4S in Fig. 10E being exceptional. Electrophoretic 
midazolam never decreased the threshold of any la termination. 
Sometimes electrophoretic midazolam increased the threshold of 
la terminals, particularly when ejected with currents of 
80-120nA. This effect, in contrast to the very slow recovery 
(5-10 minutes) of enhanced PAD or GABA, recovered within 1-2 
minutes of terminating the ejection of midazolam. The 
elevation of action potential threshold by benzodiazepines has 
been previously reported (MacDonald & Barker, 1982) and is 
consistent with the "local anaesthetic" action of midazolam on 
peripheral nerve fibres (Pieri et al., 1981).
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Fig. 11. Effect of midazolam on the depolarizing action of
GABA. (40nA) on a plantaris group la afferent termination of 
threshold 0.64pA and blocking factor 3.6. The depolarizing 
action of GABA was enhanced during and after electrophoretic 
application of midazolam (5mM in 150mM NaCl) 20nA. (Ordinate: 
changes in threshold expressed as a percentage ( AT%). 
Abscissae: time, min).
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Because of the relatively small changes in PAD and the 
action of GABA produced by midazolam, convincing evidence of 
antagonism by Rol5-1788 was not obtained. Currents greater 
than 30-40nA could not be passed through pipettes containing 
Rol5-1788, and within this limitation this substance alone had 
no effect on termination thresholds, the action of GABA or PAD.
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DISCUSSION
When administered systemically to pentobarbitone 
anaesthetised cats in relatively low doses, midazolam maleate 
(0.1 - 0.6 mg kg 1) augmented the (hyperpolarizing) 
inhibition of interneurones by microelectrophoretic GABA, and 
the depolarization of la primary afferent terminations by this 
amino acid (and P4S). This enhancement of the postsynaptic 
effectiveness of GABA, which could be shown to be selective for 
GABA in the case of interneurones, was also observed with 
microelectrophoretic midazolam. This action, antagonised by 
Rol5-1788 which alone had no influence on either the effect of 
GABA or the firing of neurones, is consistent with many 
previous reports of the action in vivo and in vitro of these 
and other benzodiazepines in the mammalian central nervous 
system (Geller et al., 1980; Haefely et al., 1981; Pieri et 
al., 1981; Pole et al., 1981; Mohler and Richards, 1981; Bold 
et al., 1982).
Enhancement of the postsynaptic inhibitory action of 
electrophoretic GABA was not observed in a previous 
investigation using a similar preparation and methods to eject 
midazolam (20mM in 150mM NaCl) with currents of 60-80nA (Davies 
& Pole, 1978). This result is compatible with the results of 
the present study, where small doses (5-20nA) of midazolam 
potentiated GABA while larger doses (60-80nA) reversed this 
potentiation. Similar findings have been reported in studies 
carried out on mammalian spinal neurones in cell culture:
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chlordiazepoxide (l-5nA) potentiated GABA effects on membrane 
potential and conductance/ however further chlordiazepoxide 
ejection (1-lOnA) failed to potentiate or even reduced GABA 
effects (MacDonald & Barker, 1978).
Most benzodiazepines appear to have a "bell-shaped" dose- 
response relationship for GABA potentiation, however the range 
of concentrations involved is different for individual drugs 
(MacDonald Sc Barker, 1982; Skerrit & MacDonald, 1984). In a 
recent investigation of the effects of midazolam and the water 
soluble des-fluoro analogue of Rol5-1788 on the frog spinal 
cord in vitro, it was possible to quantify the potentiation of 
GABA effects by midazolam (Nistri & Berti, 1983). The dorsal 
root depolarization induced by GABA was enhanced maximally by 
25nM midazolam; InM was about 50% as effective. However 
increasing the midazolam concentration to lOOnM resulted in no 
GABA augmentation, while higher concentrations reduced the GABA 
response. Thus a failure to demonstrate potentiation of the 
inhibitory action of GABA using large electrophoretic currents 
to eject midazolam is not unexpected, as the ratio between the 
GABA potentiating midazolam concentrations and non-potentiating 
midazolam concentrations could be as low as 4. The failure of 
several investigators (Dray & Straughan, 1976; Curtis et al., 
1976a; Davies & Pole, 1978) to demonstrate GABA potentiation 
using electrophoretically administered benzodiazepines was 
possibly attributable to the use of excessive benzodiazepine 
ejecting currents. Furthermore, the concentrations of 
benzodiazepines achieved in some studies may have been high 
enough to antagonise GABA effects (Steiner & Felix, 1976).
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Potentiation of GABA has been demonstrated in experiments where 
benzodiazepines were ejected with small currents from dilute 
solutions (eg. Nestoros & Nistri# 1979).
It is likely that many unexpected results of the present 
investigation are attributable to the concentration dependency 
of benzodiazepine action. There were probably several cells 
where the initial midazolam ejection current selected produced 
midazolam concentrations higher than optimal for GABA 
enhancement# and only after cessation of the ejection current 
were optimal benzodiazepine concentrations achieved in the 
extraneuronal space. Thus maximum potentiation of GABA's 
inhibitory action occurred after midazolam ejection. A similar 
explanation probably accounts for the results of Nistri & 
Constanti (1978)# where further potentiation of GABA responses 
occurred during recovery from high bath concentrations of 
flunitrazepam.
The long and often incomplete recovery of initial GABA 
responses following midazolam ejection deserves some 
discussion. Midazolam maleate manifests a pH-dependent ring 
phenomenon (Brown et al., 1979). In the micropipette at a pH 
of 3# the benzodiazepine ring of midazolam is open and the drug 
remains highly water soluble# however# after micro- 
electrophoretic administration into the extraneuronal space, 
the benzodiazepine ring closes so that midazolam adopts an 
unionised# lipid soluble structure at physiological pH. The 
lipophilic nature of midazolam at physiological pH probably 
hinders diffusion away from the site of administration and so
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accounts for the prolonged and often incomplete recoveries 
observed after microelectrophoretic ejection (especially- 
considering that a residual midazolam concentration of lOOpM 
would probably produce some GABA enhancement).
Further problems of interpretation could have arisen from 
inadequately controlled diffusional efflux of midazolam from 
the micropipette. Even though dilute solutions were employed 
and conventional retaining current applied (so that 0.5V 
existed across the midazolam barrel orifice) it is likely that 
some diffusional efflux of midazolam still occurred. This is 
probably true for all substances administered from glass 
micropipettes, but fails to be important as the concentrations 
achieved are usually insufficient to elicit a pharmacological 
response, especially if the compound is inactivated in vivo (by 
uptake or enzymic destruction). The situation is different for 
midazolam, however, as it is not inactivated in vivo and 
diffuses away from its site of administration poorly, yet is 
active at extremely low concentrations (ED,-q for GABA 
potentiation = InM, Nistri & Berti, 1983). The amount of 
uncontrolled diffusional efflux probably varies from 
micropipette to micropipette, and also from cell to cell 
according to the amount of tissue debris "capping" the 
micropipette orifice. Uncontrolled efflux is important, as the 
resulting potentiation of GABA during "control" periods would 
tend to obscure any potentiation of GABA occurring during 
ejection of midazolam. Such occurrences may have accounted for 
the relatively small potentiation of GABA effects on cells and
70
terminations during microelectrophoretic ejection of midazolam, 
and also for some of the apparent failures to demonstrate 
potentiation of the effects of this amino acid.
The present investigation has demonstrated that 
benzodiazepine receptors are present on primary afferent 
terminals. Midazolam never decreased the electrical threshold 
of la terminations, even when ejected with large currents, and 
thus failed to mimic the action of GABA. However, when 
administered intravenously or electrophoretically it enhanced 
the depolarizing action of electrophoretic GABA and P4S, and 
also the depolarization produced by GABA released at axo-axonic 
synapses following tetanic stimulation of flexor afferents.
This suggests that benzodiazepine receptors are present in 
association with (postsynaptic) GABA receptors on primary 
afferent terminals. These benzodiazepine receptors on group I 
primary afferent terminals have been demonstrated using 
autoradiographic techniques by Fry & Magee (1982).
In this and many previous studies electrophoretic midazolam 
and other benzodiazepines have decreased the spontaneous and 
excitant-induced firing of neurones. Intracellular studies 
using cultured spinal neurones have suggested that this 
depressant effect of benzodiazepines is not attributable to a 
decrease in the depolarizing action of glutamate (this 
occurring only at high benzodiazepine concentrations) but 
rather to an elevation in the threshold for action potential 
generation (MacDonald & Barker, 1982). The increased threshold 
was frequently associated with an increased membrane
71
conductance at depolarized membrane potentials (near 
threshold). The failure of Rol5-1788 to antagonise the 
midazolam induced decrease in cell-firing suggests that the 
effects of benzodiazepines on active membrane properties may 
not be mediated by the same receptors which facilitate the 
postsynaptic action of GABA (but see MacDonald & Barker,
1982). If such benzodiazepine receptors were present on 
primary afferent terminals, the elevation of threshold produced 
by large midazolam ejecting currents should be expected. 
Furthermore, if the elevation of termination threshold by 
midazolam was associated with an increased terminal conductance 
(as is the case for cultured spinal neurones), the conductance 
increase may have shunted and so diminished any increase in the 
depolarizing action of GABA and PAD.
Benzodiazepines have proved to be very useful neuro- 
pharmacological probes for investigating the neurochemistry of 
the GABA receptor complex. Elegant in vitro ligand binding 
studies have shown that benzodiazepines bind with high affinity 
to saturable membrane recognition sites (Squires & Braestrup, 
1977), in such a way that the affinity of the GABA receptor for 
GABA is increased (Skerrit et al., 1982). It has been proposed 
that the benzodiazepine receptor forms part of a supramolecular 
complex together with the GABA receptor and its associated 
chloride ion channel (Pole et al., 1982). In this scheme 
occupation of the benzodiazepine receptor leads to allosteric 
modulation of the adjacent GABA receptor; the resulting 
increased affinity of the GABA recognition site for its ligand 
underlies the increased postsynaptic effectiveness of GABA that
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is seen in the presence of benzodiazepines. Biophysical 
studies using fluctuation analysis have suggested that 
benzodiazepines increase the postsynaptic action of GABA by 
increasing the frequency of chloride channel opening for a 
given concentration of GABA (without altering chloride channel 
lifetime or conductance) and such an explanation is compatible 
with the binding data (Study & Barker, 1981).
In contrast to many in vitro studies using cultured 
neurones and brain slices (Wolf & Hass, 1977; Jahnsen &
Laursen, 1981; Riley & Scholfield, 1983) which have shown a 
consistent potentiation of GABA-mediated events by 
benzodiazepines, microelectrophoretic studies on single central 
neurones in vivo have produced a confusing array of results 
(see Haefely et al., 1981). Although the effect of GABA on a 
variety of central neurones has been reported to be increased 
by microelectrophoretically applied benzodiazepines, in some 
cases selectively (cat spinal cord, flurazepam (concentration 
not stated), Nistri et al., 1980; rabbit cortex, 
chlordiazepoxide 200mM, Kozhechkin & Ostrovskaya, 1977; cat 
cortex, flurazepam 20mM in 160mM NaCl, Nestoros & Nistri, 1979; 
rat dorsal raphe, flurazepam lOOmM, Gallagher, 1978; rat 
cerebellum, flurazepam 20mM in 150mM NaCl, Jiang 1981; 
flurazepam lOOmM Bold et al., 1982), such enhancement has not 
been demonstrated in other investigations of the effects of 
flurazepam, chlordiazepoxide and midazolam (Curtis et al., 
1976a; Curtis et al., 1976b; Dray & Straughan, 1976; Davies & 
Pole, 1978; Assumpeao et al.,1979). These contrary findings 
and the present difficulty in demonstrating a large reversible
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enhancement of PAD and the action of GABA on la terminals are 
not unexpected given the complex concentration dependent 
effects of benzodiazepines on the postsynaptic action of GABA, 
neuronal excitability (MacDonald & Barker, 1982) and 
transmitter release (Mitchell & Martin, 1978; Mitchell, 1980). 
Thus, microelectrophoretic administration, in which 
concentrations of benzodiazepines around the neurones (or 
terminations) under investigation would not be predictable, 
uniform or consistent from cell to cell can give variable and 
sometimes erroneous results. For example, it is highly likely 
that the small potentiation of the postsynaptic inhibitory 
action of glycine and noradrenaline observed in the present 
study is artifactual rather than real, and in some way is 
attributable to the complicated interactions that occur in 
electrophoretic experiments in vivo. In contrast, 
benzodiazepines have interpretable and consistent effects in 
vitro (cultured neurones, ganglia, brain slices, hemisected 
frog cord) as a result of the predictable and relatively 
uniform concentrations that are attained.
Although rather unsuitable for electrophoretic 
administration in vivo, benzodiazepines when administered 
systemically can provide useful information about GABA-mediated 
events in the mammalian nervous system. As benzodiazepines 
selectively augment the action of GABA when administered in 
small intravenous doses, they can be used to help identify 
synaptic inhibitions mediated by this neurotransmitter. For 
example, a recent investigation has shown that diazepam and 
midazolam given intravenously (0.1 mg kg )^ augmented the
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late bicuculline-sensitive component of the recurrent 
inhibition of motoneurones in a Rol5-1788-sensitive fashion 
(Pole & Haefely, 1982). This finding adds support to the 
proposal that some Renshaw cells release GABA (Cullheim & 
Kellerth, 1981). In the present study midazolam (0.1-10 mg 
kg )^ increased and prolonged "presynaptic" inhibition, which 
is mediated by GABA, while having no effect on "direct" 
postsynaptic inhibition, which is mediated by glycine. This 
suggests the small enhancement of glycine's inhibitory action 
observed during electrophoretic midazolam is likely to be a 
microelectrophoretic artifact, whereas the larger potentiation 
of GABA is meaningful.
Although useful for studying the operation of systems of 
neurones, the systemic administration of benzodiazepines is 
somewhat unsatisfactory for studying effects on single cells 
and terminals because of the cardiovascular changes which 
accompany intravenous injection. Severe difficulty in 
"holding" cells was experienced in the present investigation 
during intravenous administration of small doses of midazolam. 
In most cats large transient falls in blood pressure and pulse 
rate followed very slow intravenous injections of midazolam 
(0.1-0.6 mg kg 1) and the resulting movement of the cord in 
relation to the seven barrel micropipette affected the size of 
the recorded action potential and the sensitivity of the cells 
to electrophoretically administered compounds. In one 
successful experiment the intravenous injection of midazolam 
(0.3-0.6 mg kg )^ produced a similar augmentation of the 
inhibitory action of GABA to that achieved by electrophoretic
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midazolam. This suggested that the selective facilitation of 
GABA produced by electrophoretic midazolam occurred at similar 
local concentrations to those achieved with systemic 
administration.
Severe difficulty was also encountered in "holding" 
terminals during intravenous administration of midazolam. The 
large falls in blood pressure following midazolam injection 
were inevitably associated with an increase in the termination 
threshold, presumably related to an increase in the 
micropipette-termination distance. Although this has little 
effect on PAD, which measures the depolarizing action of GABA 
released synaptically at axo-axonic synapses, any change in the 
micropipette-terminal distance critically affects the 
concentration of electrophoresed GABA at the terminal (see 
Curtis & Lodge, 1982). This problem was circumvented to some 
extent by the use of P4S, which probably has a wider "sphere of 
influence" than GABA, as it is not as efficiently taken up by 
spinal neurones and glia (Krogsgaard-Larsen et al., 1980). In 
one successful experiment the intravenous administration of 
midazolam (0.5 mg kg produced enhancement of PAD and the 
depolarizing action of P4S which was similar to that achieved 
during electrophoretic midazolam. This suggests that the 
potentiation of synaptically evoked primary afferent 
depolarization following intravenous and electrophoretic 
midazolam resulted predominantly from an increased 
effectiveness of GABA at depolarizing axo-axonic synapses 
(rather than from other factors, such as an increased release 
of GABA from synaptic terminals).
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In the present investigation microelectrophoretic Rol5-1788 
was a selective antagonist of the potentiation of GABA by 
midazolam. Although currents greater than 40nA could not be 
passed through barrels containing a saturated solution of 
Rol5-1788, such doses were sufficient to partially or 
completely block the enhancement of GABA by midazolam.
Effective currents of Rol5-1788, ejected in the absence of 
midazolam, had no effect on DLH induced firing, or the 
inhibitory action of GABA or glycine. Thus, at the 
concentrations achieved in the present study, Rol5-1788 
appeared to be a competitive benzodiazepine antagonist devoid 
of demonstrable intrinsic activity. Recent in vitro studies 
using cultured neurones (Skerrit & MacDonald, 1983; Krespan et 
al., 1984) and several behavioural studies (Nutt et al., 1982; 
Vellucci & Webster, 1983) have suggested that at high 
concentrations (doses) Rol5-1788 is a partial agonist and 
weakly enhances the postsynaptic action of GABA; presumably 
these high concentrations were not achieved in the present 
investigation. The des-fluoro analogue of Rol5-1788, Rol4-7437 
is water soluble and therefore likely to be a more useful 
benzodiazepine antagonist in microelectrophoretic studies; 
unfortunately it was not available at the time this study was 
carried out. Rol5-1788 was also an effective benzodiazepine 
antagonist when administered intravenously (1 mg kg )^ after 
intravenous midazolam; it reversed both the GABA potentiating 
and cardiovascular effects of midazolam. The failure of 
Rol5-1788 to influence the action of endogenously released or 
exogenously administered GABA suggests that benzodiazepine 
receptors are of pharmacological rather than physiological 
importance.
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It is clear from this and other studies (Pole et al. , 1981; 
Nistri & Berti, 1983; Scholfield, 1983) that Rol5-1788 and its 
des-fluoro analogue are selective benzodiazepine antagonists if 
given in appropriate doses. These antagonists should prove 
useful in determining which of the range of benzodiazepine 
effects observed in vitro and in vivo are attributable to 
activation of benzodiazepine receptors coupled to GABA 
receptors, and which are attributable to interaction with other 
benzodiazepine acceptor sites, or due to physicochemical 
interaction with lipid membranes. For example, it would be of 
interest to examine whether the effects of benzodiazepines on 
action potential threshold are blocked by Rol5-1788, especially 
as the results of the present study suggest that the depression 
of cell firing by midazolam was not blocked by Rol5-1788. It 
would also be worthwhile to determine whether the antagonism of 
GABA responses produced by high concentrations of some 
benzodiazepines (flurazepam and to a lesser extent midazolam) 
in vitro is reduced by Rol5-1788, or a completely different 
mechanism is involved. Preliminary experiments on the 
hemisected frog cord have suggested that the antagonism of GABA 
effects by 200nM midazolam is not affected by Rol4-7437 (Nistri 
& Berti, 1983). Recent work has suggested that the reduced 
effectiveness of GABA seen at high benzodiazepine 
concentrations may be attributable to the activation of a 
Rol5-1788-insensitive, low affinity benzodiazepine receptor 
that is activated by Ro5-4864 (Skerrit et al., 1984). In this 
context it is noteworthy that large doses of flurazepam (60-100 
mg kg  ^ intraperitoneally; 40 mg kg  ^ intravenously), when
administered to cats, cause increased muscle tone and
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convulsions (Rosenberg, 1980). Brain flurazepam concentrations 
achieved by such doses would be expected to antagonise the 
action of GABA in vitro (see MacDonald & Barker, 1982), and 
this could well be the basis of the observed behavioural 
changes.
In the present study GABA mediated inhibition of spinal 
reflexes was enhanced by doses of midazolam ranging from 0.1-10 
mg kg Prolonged GABA mediated inhibition was clearly
enhanced after 0.1 mg kg ^, while maximum enhancement 
occurred after 1-5 mg kg ^. Yet cats were not anaesthetised 
or even sedated by intravenous midazolam given in doses ranging 
from 1-20 mg kg ^. Midazolam also failed to anaesthetise 
rats, mice, dogs and squirrel monkeys when given in comparable 
doses (Pieri et al., 1981). Thus doses of midazolam which 
potentiate the postsynaptic action of GABA produce muscle 
relaxation and prevent convulsions (Pieri et al., 1981), but do 
not induce anaesthesia in rodents, dogs, cats or squirrel 
monkeys. It would seem that the potentiation of GABA-mediated 
inhibition within the nervous system is insufficient to produce 
anaesthesia in mammals.
Similar conclusions have been drawn from a comparison of 
the in vitro and in vivo effects of the anticonvulsant 
barbiturate phenobarbitone (Heyer & MacDonald, 1982). Central 
nervous system concentrations of phenobarbitone, whose primary 
effect is to increase the postsynaptic action of GABA, prevent 
convulsions in rats in the absence of significant sedation 
(Raines et al., 1979). Concentrations of phenobarbitone which
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produce anaesthesia probably reduce presynaptic calcium entry 
and thus neurotransmitter release, in addition to augmenting 
the postsynaptic action of GABA; thus phenobarbitone 
anaesthesia results from a combination of reduced excitatory 
transmission and facilitated GABA-mediated inhibition (Heyer & 
MacDonald, 1982).
Although many anaesthetics potentiate the postsynaptic 
action of GABA (see Scholfield, 1978), enhancement of the 
action of GABA per se appears to be an inadequate explanation 
for general anaesthesia. Therefore it is somewhat surprising 
that the higher primates, including humans, are sedated and 
anaesthetised by very low doses of benzodiazepines. It seems 
possible that benzodiazepines have central effects in humans, 
in addition to their effects on inhibition mediated by GABA, 
which contribute to the reduction in consciousness seen in man 
after administration of midazolam and other benzodiazepines.
Most investigators consider that the potentiation of 
GABA-mediated inhibition produced by benzodiazepines is the 
basis of their "anxiolytic" effects (Haefley et al., 1981). In 
relation to this, cats given intravenous midazolam did not 
appear "tranquillised"; their agitated demeanor may be directly 
attributable to the drugs central effects or alternatively to 
the cat's reaction to the rapid onset of ataxia and muscle 
relaxation, and the experimental situation. The results of
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Nistri & Constanti (1978) seriously question the notion that 
anxiolysis is causally related to augmented GABAergic 
inhibition; they found that 7-des-chlorodiazepam, a drug devoid 
of anxiolytic properties in behavioural screening tests, 
potentiated the action of GABA.
In summary, benzodiazepines potently and selectively 
potentiate the postsynaptic action of GABA when given in 
therapeutic doses, and there is no doubt that augmented 
GABA-mediated inhibition is at least partly responsible for the 
muscle relaxant and anticonvulsant effects of this family of 
drugs. However, two important effects of benzodiazepines in 
humans, namely sedation/anaesthesia and "anxiolysis" may not be 
completely attributable to facilitated GABAergic inhibition.
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V. THE EFFECT OF NALOXONE, MORPHINE AND METHIONINE-
ENKEPHALINAMIDE ON la AFFERENT TERMINATIONS IN THE CAT 
SPINAL CORD
INTRODUCTION
There is increasing evidence that opioid peptides may be 
neurotransmitters within the mammalian nervous system (Duggan & 
North, 1984). Opioid peptides have been found in the terminals 
of a variety of central and peripheral neurones, frequently in 
areas that contain opiate receptors (Atweh & Kuhar, 1983), and 
they are released from brain slices and synaptosomes in a 
calcium-sensitive fashion by solutions containing high levels 
of potassium ions (Iversen et al., 1978; Henderson et al.,
1978). Furthermore, stimulation of certain excitatory pathways 
leads to demonstrable increases in the efflux of opioid 
peptides from certain other regions of the nervous system 
(Yaksh & Eide, 1981; Cesselin et al., 1982). Many 
investigations have demonstrated that opiates and opioid 
peptides influence the behaviour of neural systems by affecting 
synaptic transmission and the excitability of neurones 
(reviewed by Duggan & North, 1984). In these studies the 
determination of genuine opioid effects has been facilitated by 
the availability of naloxone, a specific opioid antagonist when 
used in appropriate doses (Duggan & Johnson, 1983). The 
considerable evidence which has accumulated suggests that 
opioid peptides can influence the output of neural systems by 
either a direct postsynaptic inhibitory action on neurones 
and/or a presynaptic inhibitory effect on neurotransmitter 
release from nerve terminals (Duggan & North, 1984).
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Studies on myenteric plexus neurones (North et al., 1979), 
locus coeruleus neurones (Williams et al., 1982), substantia 
gelatinosa neurones (Yoshimura & North, 1983) and some 
autonomic ganglia cells (Katayama & Nishi, 1984; Wouters & van 
der Berken, 1980) have suggested that the postsynaptic 
inhibitory action of enkephalin is attributable to the 
activation of a potassium conductance, possibly a 
calcium-sensitive potassium conductance (North et al., 1979; 
Morita & North, 1982; Cherubini et al., 1984). Less convincing 
studies on spinal neurones in vivo (Zieglgansberger & Tulloch, 
1979), and cultured spinal neurones in vitro (Barker et al., 
1978), have suggested that the inhibitory action of opioids is 
produced by a decrease in the postsynaptic effectiveness of the 
putative excitatory transmitter glutamate. The presence of 
enkephalin-containing axo-somatic and axo-dendritic synapses in 
areas where microelectrophoretically administered opioids 
depress spontaneous, evoked and excitant induced firing in a 
naloxone-reversible manner suggest that enkephalins are likely 
to be postsynaptic inhibitory neurotransmitters in certain 
regions of the nervous system, for example in the locus 
coeruleus and the substantia gelatinosa. However, a 
naloxone-sensitive postsynaptic inhibition, mimicked by 
electrophoretic enkephalin, has yet to be convincingly 
demonstrated in the brain or spinal cord.
Electrophysiological studies have demonstrated that opioid 
receptors are also present on the terminals of several types of 
central and peripheral neurones and that their occupation 
results in a diminution of transmitter release (presynaptic
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inhibition). Enkephalin analogues presynaptically inhibited 
acetylcholine release from motoneurone terminals at the frog 
neuromuscular junction (Bixby & Spitzer, 1983), and from 
preganglionic terminals in autonomic ganglia (Konishi et al., 
1979; Katayama & Nishi, 1984). There is some evidence for a 
physiological role for opioid peptides in autonomic ganglionic 
transmission, as they are synthetised in some preganglionic 
neurones and transported peripherally to autonomic ganglia 
(Glazer & Basbaum, 1980), where enkephalin-containing terminals 
can be visualised (Hokfelt et al., 1978). Furthermore, high 
frequency stimulation of preganglionic nerves produced a long 
lasting naloxone-sensitive presynaptic inhibition of 
cholinergic (Konishi et al., 1981) and substance P-mediated 
(Jiang et al., 1982) transmission. Opioids also reduced 
transmitter release from postganglionic autonomic nerve 
terminals (Henderson &. North, 1976; Waterfield et al., 1977; 
Ueda et al., 1983). Biochemical studies on the
calcium-dependent potassium-evoked release of transmitters from 
brain slices have also suggested that enkephalins decrease the 
release of certain neurotransmitters, presumably by an action 
on presynaptic receptors on nerve terminals. For example, it 
has been proposed that enkephalins presynaptically inhibit the 
release of substance P from primary afferent terminals in the 
rat trigeminal nucleus (Jessel & Iversen, 1977) and the release 
of noradrenaline from terminals in cerebral cortex slices 
(Arbilla & Langer, 1978).
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Ligand binding studies have suggested that at least some
primary afferent fibres or terminals possess opioid receptors,
3as the number of H-naloxone binding sites in the spinal cord 
dorsal horn decreased after dorsal rhizotomy (Lamotte et al., 
1976). Intracellular studies on cultured embryonic mammalian 
spinal neurones have clearly demonstrated that opiates 
(MacDonald & Nelson, 1978) and methionine enkephalin (Jia and 
Nelson, 1983) reduce transmitter release from the terminals of 
some immature dorsal root ganglion cells; _if the receptors on 
dorsal root ganglion cells are similar to those on the axon 
terminals they give rise to, then a study of enkephalin effects 
on dorsal root ganglion cells may provide information relevant 
to the mechanism underlying the presynaptic inhibitory action 
of enkephalin. Such studies have suggested that opioids 
decrease voltage-dependent calcium entry into dorsal root 
ganglion cells in a naloxone-sensitive manner, either directly 
by decreasing the voltage-dependent calcium conductance (Mudge 
et al., 1979) or indirectly by increasing a voltage-dependent 
or calcium-sensitive potassium conductance (Werz & Macdonald, 
1983). A similar reduction of calcium entry into presynaptic 
terminals would account for the reduced transmitter release 
that occurs in the presence of opioids. Direct verification of 
this proposal is at present impossible, since intracellular 
recordings cannot be made from mammalian nerve terminals.
An additional mechanism for the presynaptic inhibitory 
action of opioid peptides has been suggested from studies 
carried out on neurones of the myenteric plexus. AH cells 
appear to possess opiate receptors on their processes, but not
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on their somata, and activation of these receptors resulted in 
opening of potassium channels and neuronal hyperpolarization 
(North & Tonini/ 1977). The hyperpolarization of neuronal 
processes, together with the underlying conductance increase, 
prevented action potential propagation into some presynaptic 
varicosities and thereby decreased transmitter release (Morita 
& North, 1981). The increased potassium conductance would also 
be expected to reduce presynaptic calcium entry into invaded 
varicosities and presumably both these mechanisms contribute to 
the presynaptic inhibitory action of opioids on transmitter 
release from myenteric neurones. A similar proposal has been 
made to account for the presynaptic inhibitory effect of 
enkephalin on transmitter release from noradrenergic terminals 
in the cortex (Taube et al., 1976), since locus coeruleus 
neurones (Pepper and Henderson, 1980) and the axon terminals 
they give rise to (Nakamura et al., 1982) are apparently 
hyperpolarized by opioids in a naloxone-sensitive manner. 
Enkephalin could reduce noradrenaline release by blocking 
action potential propagation into some terminals in addition to 
indirectly decreasing calcium entry into invaded terminals. 
Despite convincing evidence for a presynaptic inhibitory effect 
of exogenous opioids on transmitter release from certain nerve 
terminals and ultrastructural evidence of enkephalinergic 
axo-axonic synapses (LaMotte & de Lanerolle, 1983), a 
naloxone-sensitive presynaptic inhibitory event mimicked by 
electrophoretic enkephalin has yet to be demonstrated within 
the central nervous system.
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It has been suggested that opioid peptides may regulate the
processing of afferent information in different regions of the
central nervous system by controlling the effectiveness of
local GABA-releasing inhibitory interneurones (Nicoll et al.,
2 51980). In the hippocampal slice preparation D-Ala -Met - 
enkephalinamide (DALA) had no direct effect on the membrane 
potential or resistance of pyramidal cells, but reduced the 
size of orthodromically and antidromically evoked GABA-mediated 
IPSPs in a naloxone-reversible fashion. Although the amplitude 
and time course of EPSPs was unaffected by DALA, they were more 
effective in firing pyramidal cells because of the reduced 
GABAergic inhibition. Since DALA had no effect on the action 
of exogenous GABA, Nicoll & coworkers proposed that opioids 
reduced the firing of inhibitory interneurones and/or reduced 
the release of GABA from their terminals. Thus in the 
hippocampus opioid peptides increase the response of pyramidal 
cells to excitatory inputs by disinhibition. In the olfactory 
bulb slice DALA reduced the dendrodendritic inhibition of 
mitral cells by GABA-releasing granule cells in a 
naloxone-reversible manner, but had no effect on the passive 
membrane properties of mitral cells. Because IPSPs generated 
solely by dendritic reciprocal synapses were reduced by DALA, 
it is likely that opioids have a direct presynaptic effect on 
GABA release at reciprocal synapses (Nicoll et al., 1980).
Thus in the olfactory bulb enkephalins increased the response 
of output neurones by disinhibition. In the hemisected frog 
spinal cord DALA almost completely abolished the dorsal root 
potential and the accompanying inhibition of primary afferent 
excitatory transmission produced by ventral root stimulation.
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This opioid effect was naloxone-sensitive and occurred in the 
absence of any change in the response to exogenous GABA (and 
/3-alanine). Therefore it is likely that opioid peptides 
reduced the firing of the GABA-releasing interneurones 
mediating presynaptic inhibition and/or reduced the release of 
GABA from their terminals (Nicoll et al., 1980).
Since enkephalins attenuated a variety of GABAergic 
inhibitory pathways in the central nervous system, Nicoll & 
collaborators proposed that inhibitory GABA-releasing 
interneurones may be primary targets for opioid peptide 
containing pathways. Results from experiments on the retina of 
goldfish (Djamgoz et al., 1981), which demonstrated that 
opioids reduce the action of GABA-releasing amacrine cells, are 
in accordance with this proposal. Furthermore, the anatomy of 
this region favours a presynaptic effect of enkephalin on GABA 
release from the terminals of amacrine cells.
The superfusion technique used to administer opioid 
peptides in all of these experiments was insufficiently precise 
to determine whether the disinhibition of projection neurones 
was attributable to postsynaptic depression of inhibitory 
neurone excitability and/or block of GABA release from nerve 
terminals. Further experiments are required to determine 
whether enkephalin receptors are present on the bodies and/or 
terminals of these GABA-releasing interneurones, and which, if 
any, of these receptors are innervated by opioid 
peptide-releasing pathways. The presence of enkephalin 
receptors on GABA-releasing terminals is suggested by the
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finding that DALA presynaptically reduces GABA release at 
dendritic reciprocal synapses in the olfactory bulb (Nicoll et 
al., 1980). It is also likely that enkephalin receptors are 
present on the cell bodies of GABA-releasing interneurones, 
given that the firing of such cells in the hippocampus is 
reduced by enkephalins (Zieglgansberger et al., 1979; Lee et 
al., 1980).
Although many studies have shown that exogenously 
administered opioids affect the firing of neurones 
presynaptically and/or postsynaptically, very few 
naloxone-sensitive events thought to be mediated by opioid 
peptides have been studied within the central nervous system. 
Several investigators have demonstrated that low doses of 
systemic naloxone increase spinal reflexes in cats (Goldfarb & 
Hu, 1976), dogs (Martin et al., 1976), rabbits (Catley et al., 
1983) and humans (Boureau et al., 1978). When given 
intravenously in small doses (0.025-2.0 mg kg ^) to 
decerebrate (Goldfarb & Hu, 1976; Goldfarb et al., 1978) or 
pentobarbitone anaesthetised (Duggan et al., 1984) spinal cats, 
naloxone markedly increased monosynaptic reflexes in both 
flexor and extensor muscles. Polysynaptic reflexes to impulses 
in myelinated and unmyelinated cutaneous and muscle afferents 
were also increased to a similar extent by these doses of 
naloxone (Duggan et al., 1984). Doses of naloxone which 
increased spinal reflexes had no effect on "direct" glycinergic 
inhibition or prolonged "presynaptic" GABAergic inhibition of 
extensor monosynaptic reflexes (Goldfarb & Hu, 1976). The 
effect of naloxone was presumably stereospecific, since
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administration of the active (-)-isomer of the opiate
antagonist furylmethylnormetazocine increased spinal reflexes
while the inactive (+)-isomer did not (Duggan et al., 1984).
Furthermore, (-)-naloxone increased cutaneomuscular reflexes in
spinal rabbits, while (+)-naloxone was without effect (Catley
et al., 1983). Intravenous naloxone (approx. 0.01 mg kg )^
increased the monosynaptic H reflex in normal conscious man
(Boureau et al., 1978), but had no effect when administered to
paraplegics (Wilier & Bussei, 1980). Monosynaptic reflexes
recorded from the isolated frog spinal cord in vitro were also
“ V _0markedly increased by naloxone (10 -10 M) (Wouters et
al., 1979).
The stereospecificity of opiate antagonist action and the 
extremely low doses required suggests that the observed 
increase in spinal reflexes resulted from antagonism of an 
inhibitory process controlled or mediated by opioid peptides. 
Enhancement of a monosynaptic reflex could result from an 
increased release of transmitter from primary afferent 
terminals or an increased excitability of motoneurones. Opioid 
peptides, whose action naloxone is presumably antagonising, 
might affect primary afferent terminals or motoneurones 
directly, or control the firing of interneurones acting on 
these structures.
Since naloxone increased reflexes in acute and chronic 
spinal preparations (Goldfarb & Hu, 1976), naloxone induced 
changes in the descending inhibition of motoneurones cannot 
account for the observed increase in motoneuronal firing.
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Circulating endorphins from the pituitary are unlikely to be 
responsible for an inhibition of spinal reflexes, as 
cutaneomuscular reflexes in spinal rabbits were unaltered by 
hypophysectomy, but increased by (-)-naloxone (Catley et al., 
1983). It is therefore likely that naloxone increases spinal 
reflexes by antagonising a segmental inhibition, directed at 
primary afferent terminals and/or motoneurones. In the case of 
a monosynaptic reflex, the inhibition must be tonically 
present. This is because reflex transmission is completed 
before any inhibitory interneurones also activated by the 
peripheral nerve stimulus can exert their effects on either 
primary afferent terminals or motoneurone excitability.
Morton et al. (1983) have reported that intravenous doses 
of naloxone which increased spinal reflexes augmented the 
amplitude on monosynaptic EPSPs recorded intracellularly from 
motoneurones. EPSPs from several types of primary afferents, 
both muscular and cutaneous, were all increased in a single 
motoneurone. In most cases increases in EPSPs occurred in the 
absence of changes in membrane potential, although small 
depolarizations following naloxone were recorded in a third of 
motoneurones. Somatic membrane conductance was not altered by 
naloxone. As EPSPs could be enhanced by intravenous naloxone 
in the absence of detectable changes in somatic membrane 
potential and conductance, it seems reasonable to conclude that 
naloxone did not enhance EPSPs by blocking a hyperpolarizing 
postsynaptic inhibition directed at the somata of motoneurones.
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What type of tonic inhibition could account for the 
enhancing effect of systemic naloxone on monosynaptic EPSP 
amplitude? A tonic presynaptic inhibition of group la 
excitatory transmission could account for a reduction in EPSP 
amplitude in the absence of changes in somatic membrane 
potential or conductance. This might involve a direct effect 
of opioid peptides on la terminals, possibly at peptidergic 
axo-axonic synapses, which reduces the amount of excitatory 
transmitter released. Alternatively, opioid peptides may 
somehow enhance the firing of the GABA-releasing interneurones 
that form axo-axonic synapses on la terminals and so mediate 
the presynaptic component of prolonged spinal inhibition. 
Morphological data is not helpful in deciding between these 
hypothetical possibilities: although enkephalin is found in
axons and terminals of the ventral horn (Aronin et al., 1981), 
there are no detailed accounts of the fine structure of the 
enkephalin-containing neural elements in this region. If 
enkephalins have a direct presynaptic inhibitory effect on 
transmitter release from la terminals, electrophoretic 
enkephalin should have a similar action and, in addition, might 
produce a naloxone-sensitive alteration in la terminal 
excitability or conductance. If, however, tonic opioid 
inhibition was mediated through the increased activity of GABA 
releasing interneurones mediating presynaptic inhibition, 
intravenous naloxone would be expected to reduce a tonic 
depolarization of la terminals and thereby decrease terminal 
excitability and conductance.
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The existence of a tonic postsynaptic dendritic inhibition 
mediated or controlled by opioid peptides could also account 
for naloxone's effect on monosynaptic EPSPs and reflexes. The 
conductance increase generating such a "remote" inhibition 
might not be detected by a microelectrode located in the soma. 
Such an inhibition might be mediated by enkephalinergic 
axo-dendritic synapses on motoneurones, or alternatively by an 
action of endogenous opioids which enhances the firing of 
inhibitory interneurones which synapse primarily on motoneurone 
dendrites. The post-naloxone depolarization of some 
motoneurones observed in the study of Morton et al. (1983) may 
have arisen from the removal of such a tonic dendritic 
hyperpolarization.
The present investigation was carried out primarily to 
determine if microelectrophoretic enkephalin has a direct 
naloxone-sensitive action on la terminals, compatible with a 
presynaptic enkephalinergic inhibition of la excitatory 
transmission. The effect of electrophoretic enkephalin on GABA 
release at axo-axonic synapses was also examined, to determine 
whether enkephalin receptors are located on GABA-releasing 
terminals in the spinal cord, as they appear to be in the 
retina and the olfactory bulb. In addition, the effect of 
systemic naloxone on la terminal excitability was examined to 
assess whether the tonic segmental inhibition antagonised by 
naloxone is mediated indirectly through the increased activity 
of the GABA-releasing interneurones that mediate presynaptic
inhibition.
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The present study has examined the effects of
5microelectrophoretically administered morphine, methionine - 
enkephalinamide (MENKA) and naloxone on terminal and 
non-terminal portions of extensor muscle group la afferents in 
the cat spinal cord. As electrophoretically administered 
morphine, MENKA and naloxone all reversibly increased the 
electrical threshold of la terminations and fibres, a study was 
also made of procaine, a local anaesthetic previously shown to 
have a similar effect on afferent fibres within the spinal cord 
(Curtis & Ryall, 1966).
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RESULTS
(i) Local anaesthetic actions on la afferent fibres
Procaine/ naloxone, morphine and MENKA were ejected 
microelectrophoretically near myelinated la afferent fibres in 
the dorsal columns and superficial laminae of the dorsal horn, 
in order to determine their effect on the electrical threshold 
of la fibres at sites remote from the terminals they give rise 
to, which are located in the intermediate nucleus and ventral 
horn. Fibre thresholds of less than 1 pA, and a reduction in 
threshold by as much as 5% by electrophoretic potassium (80nA), 
suggested that the electrodes were close to nodes of Ranvier. 
Under these conditions procaine (80nA, 20mM in 150mM NaCl) 
increased the threshold of all 8 fibres examined by as much as 
10% within one minute of commencing its ejection. Recovery 
occurred within 30 sec.
The effects of naloxone (20mM in 150mM NaCl), morphine 
(50mM in 150mM NaCl) and MENKA (20mM in lOOmM NaCl) were also 
determined on these fibres, and on others where a comparison 
with procaine was not possible. When ejected with currents of 
80nA, all three substances reversibly elevated fibre thresholds 
to a similar extent to procaine, and with a similar time 
course. On one fibre tested in the dorsal horn, the effects of 
naloxone and MENKA were additive, no antagonism being 
demonstrated. Increases in threshold by as much as 40% 
occurred when MENKA and morphine were ejected with currents of 
200nA, naloxone being less effective.
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These results suggest that when naloxone, MENKA and 
morphine were ejected with currents of 80nA from the solutions 
used in this investigation, concentrations were achieved which 
had a significant local anaesthetic-like effect on excitable 
membranes located within approximately 80 pm of the 
micropipettes. Such effects were not unexpected for either 
naloxone or morphine since the potencies of these as local 
anaesthetics on peripheral nerve fibres in vitro are within an 
order of magnitude of that of procaine (Seeman, 1975).
(ii) Effects of procaine on la terminations
As an aid to the assessment of specific opiate effects on 
la terminals by morphine, MENKA and naloxone, the effects of 
procaine were studied on termination thresholds, PAD and 
depolarization by either GABA or P4S. In most studies P4S was 
used for preference since, not being inactivated as efficiently 
as GABA, reductions in threshold by P4S are less affected by 
small changes in the micropipette-terminal distance and are 
less complicated by the consequences of amino acid uptake than 
those produced by GABA (see Curtis et al., 1982).
When ejected with currents of 40-80nA, procaine rapidly 
(within 1 min) and reversibly increased the threshold of all 7 
la terminations studied. In addition the depolarizing action 
of P4S and synaptic PAD were reduced. For 5 of these 
terminations the action of P4S was reduced to a greater extent 
than that of PAD, the reductions being similar for the other 
two. The recovery from these effects of procaine was rapid, 
generally within 1 min of terminating the ejection. The
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reduction by procaine of the sensitivity of la terminations to 
P4S suggests antagonism of the postsynaptic action of GABA as a 
more likely explanation of reduced PAD than a local anaesthetic 
effect on GABAergic terminals which reduces GABA release at 
axo-axonic synapses.
Fig. 12 A-C, illustrates the effect of procaine (40nA for 3 
min 10 sec) on a lateral gastrocnemius la termination, of 
initial threshold 0.75 pA, which was alternately depolarized by 
P4S and by synaptic PAD produced by tetanic stimulation of low 
threshold PBST afferents (Fig. 12A). Within one minute of 
starting to eject procaine the threshold increased to 0.87 pA, 
and over the following minute the lowering of threshold by P4S 
was reduced from 11% to 6%, and PAD was reduced from 30% to 24% 
(Fig. 12B). During the final minute of procaine the threshold 
was increased to 0.95 pA (not illustrated), and within one 
minute of terminating the ejection the threshold fell to 0.84 
pA. At that time (Fig. 12C) P4S produced an 11% decrease in 
threshold, and PAD was 28%.
In view of the possible antagonism between procaine and 
gabamimetics, a number of attempts were made to determine if 
procaine reduced inhibition of the firing of spinal 
interneurones by GABA. Cell firing rates were maintained by 
the continuous electrophoretic ejection of DL-homocysteic acid, 
and the effect of procaine (20-60nA) was studied on submaximal 
inhibition by GABA and glycine. As reported previously (Curtis 
& Phillis, 1960), procaine reduced both the sensitivity of 
spinal interneurones to the excitant amino acid and the
Fig. 12. Changes in the threshold (10Hz stimulation, 50%
response) of electrically stimulated la terminations produced
by microelectrophoretically administered procaine (A-C), 
methionine-enkephalinamide (MENKA, D-G), morphine (H,I), 
piperidine-4-sulphonic acid (P4S), and GABA (GA) for the times 
indicated by horizontal bars above the records (currents,nA). 
Primary afferent depolarization (PAD) was produced by tetanic 
stimulation of posterior biceps-semitendinosus afferents (four 
volleys, 2T, 320Hz) 30 ms prior to the testing pulse.
Ordinates: percentage change ( ATI) in control threshold value
indicated in pA for each set of records. The maximum 
percentage change for P4S, GA and PAD is given below the 
records. The vertical arrows in E, H signal adjustment of the 
multiplying factor in the feedback system to a value of 1.00 
(see text). Abscissae: time, min. A-C: Lateral gastrocnemius
termination, blocking factor 3.6. A: before; B: during the
ejection of procaine which commenced 1 min earlier and 
continued for 3 min 20 sec; C: 1 min 20 sec after procaine.
D-G: flexor digitorum longus termination, blocking factor 2.
D: before; E: at the start of the ejection of MENKA for 2 min
34 sec; F: 2 min after MENKA; G: 8 min after MENKA. H, I:
same termination as D-G. H: during the ejection of morphine
for 2 min 50 sec; I: 2 min after morphine.
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amplitude of extracellularly recorded action potentials. 
Antagonism of the effects of either inhibitory amino acid were 
thus difficult to assess, but there was no obvious reduction of 
the inhibitory effect of GABA on any of the four cells studied, 
whereas with three the effect of glycine was slightly reduced.
(iii) Effects of naloxone on la terminations
Naloxone was administered (40-80nA) near 13 ventral horn la 
terminations and had no effect on the threshold of 5. The 
thresholds of the other 8 fibres were reversibly increased with 
time courses of onset and offset similar to those produced by 
procaine. The effects of MENKA were tested on 6 of these 8 
fibres, and the threshold of all were also increased.
Electrophoretic naloxone had no effect on the PAD of all 19 
terminations investigated (see Fig. 13 E,F). With 8 terminals 
there was a reduction in the depolarizing action of GABA or P4S 
(Fig. 13 E,F). This effect was not observed with 6 other 
terminals and could not be fully assessed with an additional 3.
(iv) Effect of MENKA on la terminations
The effects of microelectrophoretic MENKA (20-80nA) were 
determined on 30 la terminations excited near extensor 
motoneurones. The thresholds of 17 were increased (Fig. 12 
D-G), those of 13 were unaltered (Fig. 13 A-D). The peptide 
decreased the depolarization of 9 terminals by either GABA or 
P4S, having no effect on the action of these gabamimetics on 13 
and an effect on 3 which could not be assessed. Increases in 
threshold and reduced effectiveness of GABA or P4S were more
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common when currents exceeding 40nA were used to eject MENKA, 
and these effects were of similar time course to those of 
procaine.
In contrast to these somewhat variable results, MENKA 
reduced the PAD of 36 of 37 terminations by as much as 60%, the 
effect on one termination being impossible to evaluate. This 
reduction in PAD became evident within 1-2 minutes of starting 
the ejection of MENKA, and was frequently observed in the 
absence of a concomitant reduction in the depolarizing action 
of GABA or P4S. Recovery took as long as 8 minutes after 
terminating the MENKA current. The consistently observed 
prolonged reduction of PAD by MENKA was different in duration 
from the procaine-like effects of MENKA on threshold and 
gabamimetic depolarizations, which, when present, reversed 
rapidly.
The effect of MENKA (40nA for 2 min 34 sec) on a flexor 
digitorum longus (FDL) la termination is illustrated in Fig. 12 
D-G. Within 30 sec MENKA elevated the threshold by 20%, by 
which time the PAD was reduced from 18% to 16% (Fig. 12E). In 
the second minute (Fig. 12E) there was no further change in 
threshold but PAD was further reduced to 11%, GABA producing a 
similar percentage reduction in threshold as observed prior to 
MENKA. Although the threshold recovered to 0.58 pA within 50 
sec of terminating the MENKA current, PAD was not restored to 
the pre-MENKA level for almost 8 minutes (Fig. 12 F-G) .
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Results from another FDL terminal are illustrated in Fig.
13 A-D on which MENKA (20nA for 3 min 10 sec) had no effect on 
threshold, the change from 0.9 to 0.97 pA occurring before the 
period of MENKA ejection. There was also no change in the 13% 
reduction of threshold by GABA. PAD, however, was decreased 
from a 13% to a 6% reduction in threshold (Fig. 13B), recovery 
taking 5-6 min (Fig. 13 C,D).
The possible antagonism by naloxone of the effects of MENKA 
were studied on 17 terminals. With two terminals naloxone did 
not have any influence on the reduction of PAD by MENKA, 
possibly because of inadequate naloxone ejection currents.
With 15, however, naloxone clearly reduced the effect of MENKA 
on PAD, either when ejected simultaneously with MENKA (Fig. 13 
E-H) or just after MENKA, in which case the recovery of PAD was 
more rapid than in the absence of naloxone.
The interaction between naloxone and MENKA ejected near a 
FDL la termination is illustrated in Fig. 13 E-H. Naloxone 
(20nA) had no effect on threshold or PAD, although it reduced 
the GABA depolarization from a 14% to an 11% decrease in 
threshold. During the continued administration of naloxone, 
MENKA (20nA) which had previously decreased PAD by 
approximately 50% (Fig. 13 A,B), only reduced it from 14% to 
13% (Fig. 13 F,G). Ten minutes after terminating the ejection 
of naloxone, MENKA again produced a large (39%) reduction in 
PAD (not illustrated).
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Fig. 13. Changes in threshold, as in Fig. 12 of a flexor
digitorum longus la termination, blocking factor 1.7. A: 
before; B: during MENKA, the ejection of which commenced 1 min
40 sec earlier and continued for a total of 3 min 10 sec; C: 4
min after MENKA; D, E: 6 min after MENKA; F: 2 min 10 sec
after commencing the ejection of naloxone which continued for 8 
min 40 sec, terminating in H; G: 2 min 10 sec after commencing
the ejection of MENKA for a total time of 3 min 10 sec; H: 1
min 10 sec after MENKA, the ejection of naloxone ceasing at the 
vertical broken line; I: 2 min 20 sec after H. (Ordinates:
percent change ( AT%) in control threshold. Abscissa: time,
min) .
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Similar effects of MENKA (maximum current 80nA) were 
observed when extensor muscle la terminations were stimulated 
in the intermediate nucleus. Thus, of 5 terminations upon 
which BMC reduced the depolarizing action of P4S and PAD 
generated by tetanic stimulation of the PBST nerve, the 
thresholds of 3 were elevated by MENKA and the PAD of 4 
reduced. With two of these 4, the reduction of PAD was 
reversed by naloxone. With 3 other la terminations, upon which 
BMC was not tested, MENKA reduced PAD, an effect partially 
reversed on one by naloxone, conditions not being sufficiently 
stable to assess the effect of naloxone on the other two.
(v) Effect of MENKA on synaptic excitation of group I 
interneurones
In order to investigate the possibility that opioid 
peptides exert a presynaptic inhibitory effect on transmitter 
release from la afferent terminals, the effects of MENKA were 
determined on the monosynaptic excitation of interneurones in 
the intermediate nucleus by impulses in group I extensor 
afferents. With all 6 neurones investigated, MENKA (20-200nA) 
depressed spontaneous and DLH-maintained firing. Under these 
conditions, and when the firing rate was restored to the 
control level by increasing the DLH current, MENKA had no 
effect on either the firing index or latency of monosynaptic 
excitation. (-)-Baclofen (40nA) was also tested on one of 
these neurones; in contrast to MENKA it reversibly depressed 
monosynaptic firing (see Curtis et al., 1981 and Chapter VI).
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Histograms illustrating the effects of MENKA and baclofen 
on the monosynaptic excitation of an intermediate nucleus 
interneurone are shown in Fig. 14. During the administration 
of (-)-baclofen (lOmM in 150mM NaCl, 40nA) the latency for 
excitation was prolonged and the monosynaptic firing index was 
reduced from 100% to 59% (Fig. 14, A and B). This effect was 
reversible, full recovery occurring after 2 minutes (Fig.
14C). The administration of MENKA (20mM in lOOmM NaCl, 120nA) 
failed to alter the monosynaptic firing index or even the 
latency for excitation of the same cell (Fig. 14, D-F).
(vi) Effect of morphine on la terminations
Morphine (40-80nA) increased the threshold of 4 of 5 la 
terminations, having no effect on one. On all five 
terminations the depolarizing effect of GABA or P4S was reduced 
by morphine, and the time course of this and the change in 
threshold was relatively rapid in onset and recovery, as with 
procaine. The PAD of only one termination was slightly (6%) 
reduced by morphine, that of the other four being unaffected. 
The simultaneous administration of naloxone with morphine 
tended to raise termination thresholds further and reduce the 
effects of gabamimetics even more than during the ejection of 
morphine alone. Thus no antagonism between these compounds was 
demonstrated.
These effects of morphine (40nA) are illustrated in Fig. 12 
H, I for a FDL la termination. The threshold was increased 
from 0.67 to 0.79 uA over a period of 40-50 sec, the 
depolarizing effect of GABA (60nA) was reduced from 11% to 4%, 
while PAD (16%) was apparently unchanged (Fig. 12H). When the
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Fig. 14. Histograms of the monosynaptic excitation of a
group I intermediate nucleus interneurone fired by stimulation 
of the gastrocnemius nerve (2T) at the time of the vertical 
arrow, the background firing rate (25-40Hz) being maintained by 
the continuous ejection of DLH (see text). Ordinates; number 
of action potentials in consecutive 0.1 msec bins, 32 sweeps at 
0.5Hz. Abscissae: time, msec. The numbers indicate the
firing index, as a percentage of 32. A: before; B: 4.5 min
during the ejection of (-)-baclofen (lOmM in 150mM NaCI; 20nA 
for 5 min); C: 2 min after baclofen. D: before; E: 3 min
during the ejection of methionine-enkephalinamide (MENKA: 120nA 
for 4 min); F: 1 minute after MENKA.
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morphine current was terminated, the threshold fell to 0.66 pA 
within two minutes and there was partial recovery of the effect 
of GABA (Fig. 121). Complete recovery was not observed because 
of subsequent instability of the threshold measurements.
(vii) Effect of intravenous naloxone on la terminals
The effects were examined of intravenous doses of naloxone 
hydrochloride (50-100 pg kg on four la terminations, each 
in a different cat. In contrast to the reversible effects of 
relatively rapid onset and recovery produced by micro­
elect rophoret ically administered agents, slow changes in 
threshold following the systemic administration of a drug are 
difficult to interpret in terms of direct or indirect effects 
on the termination being excited. The measured threshold 
depends critically on the distance between a termination and 
the stimulating microelectrode. Alterations in this distance 
can be produced by factors such as inadequate fixation of the 
vertebral column, by progressive oedema of the spinal cord, and 
by random and drug related changes in blood pressure and 
respiration.
Naloxone, however, had no consistent effects on the 
threshold of these four terminations. Furthermore, there was 
no effect on synaptically evoked PAD, or the depolarizing 
action of GABA (or P4S). The effect of intravenous naloxone 
(50 pg kg on a gastrocnemius la termination in the ventral 
horn is illustrated in Fig. 15. The threshold of the 
termination was increasing gradually at a constant rate
GASTROC 0.5 juA
NALOXONE 
5 Ojug/kg
GA
50 \
PAD
Fig. 15. Changes in threshold of a gastrocnemius la
termination, blocking factor unknown, before, during and after 
intravenous naloxone, 50pg kg ^. (Ordinate: percent change
( AT%) in control threshold. Abscissae: time, min).
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throughout the period of observation/ before, during, and after 
injection of naloxone. Naloxone had no effect on termination 
threshold, synaptically evoked PAD or the depolarizing action 
of GABA.
Removal of a tonic GABAergic PAD by naloxone would be 
expected to result in an increase in termination threshold and 
a reduced termination conductance. Furthermore, the reduced 
terminal conductance would augment (phasic) PAD and the 
depolarizing action of gabamimetics. The failure to detect 
such changes in studies of the excitability of single la 
terminations suggests that opioid peptides are not responsible 
for the maintenance of a tonic GABA-mediated presynaptic 
inhibition of la transmission.
In an additional cat the effect of intravenous naloxone on 
the excitability of a population of la fibres and terminals was 
examined, in order to circumvent some of the interpretative 
problems associated with the determination of single 
termination excitability during drug-induced changes in blood 
pressure and spinal cord blood flow. In this experiment the 
number of la fibres and terminals in the ventral horn activated 
by 12|iA cathodal stimuli was unaffected by intravenous doses of 
naloxone which concurrently increased monosynaptic extensor 
muscle reflexes. Therefore both types of experiment suggest 
that la terminals are not subjected to a tonic naloxone- 
sensitive depolarization (or hyperpolarization). Thus the 
GABA-releasing interneurones which mediate PAD do not appear to 
be under opioid control.
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DISCUSSION
In microelectrophoretic studies, where non-specific effects 
of administered compounds may result from the non-uniform drug 
distribution attained around neurones and terminals (Curtis, 
1976), only those effects of MENKA and morphine which are 
antagonised by relatively low concentrations of naloxone are 
likely to be attributable to an action at opioid receptors. 
Therefore the most significant finding of the present 
investigation is the naloxone-sensitive reduction by micro­
electrophoretic MENKA of the GABA-mediated PAD of extensor la 
terminals in both the ventral horn and intermediate nucleus of 
the cat spinal cord. Since this effect was not necessarily 
accompanied by either an alteration in terminal threshold or a 
diminished effectiveness of GABA (or P4S), it is likely that 
MENKA. reduces the amount of GABA released at axo-axonic 
synapses on la terminals.
It is unlikely that the small amounts of MENKA ejected 
electrophoretically near la terminals in the ventral horn would 
affect the firing of the GABA-releasing interneurones whose 
axon terminals synapse with la terminals. Results from 
previous investigations have suggested that the firing of these 
cells, which are apparently located in the intermediate nucleus 
(Jankowska et al., 1981b; Solodkin et al., 1984), is not 
affected by compounds administered electrophoretically in the 
ventral horn: ejection of large currents (60-80nA) of the
inhibitory amino acid glycine (0.2M) failed to reduce 
synaptically evoked PAD, while ejection of large doses of
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excitatory amino acids failed to either produce a bicuculline-
sensitive reduction in termination threshold or to reduce PAD
as a consequence of inactivation of the spike mechanism of the
GABA-releasing interneurones (Curtis et al., 1982; Curtis et
al., 1984). It is therefore likely that electrophoretic MENKA
decreases GABA release at axo-axonic synapses by a direct
action on the GABAergic nerve terminals (rather than through an
effect on the firing of the neurones that give rise to them).
The opioid receptors on these GABA-releasing terminals appear
to be of an enkephalin- rather than a morphine-preferring type
since morphine had no detectable naloxone-sensitive effect on
PAD. Biochemical evidence suggests that enkephalin receptors
are present on other GABA-releasing terminals in the central
3nervous system, as the potassium-evoked release of H-GABA 
from rat brain synaptosomes is inhibited by low concentrations 
(10 -10 M) of methionine-enkephalin in a naloxone-
reversible manner (Brennan et al., 1980).
The finding that GABA-releasing interneurones mediating 
presynaptic inhibition in the cat spinal cord possess 
enkephalin receptors on their axon terminals suggests that the 
reduction of PAD and presynaptic inhibition by opioids in the 
isolated rat (Suzue & Jessel, 1980) and frog (Nicoll et al., 
1980) spinal cord, and in the cat spinal cord (Pomeranz & 
Gurevich, 1979) is attributable, at least in part, to a direct 
effect on GABA release at axo-axonic synapses. A direct effect 
of enkephalin analogues on GABA release from reciprocal 
synapses on mitral cells in the olfactory bulb has previously 
been demonstrated (Nicoll et al., 1980). Further studies are
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required to determine whether enkephalin decreases transmitter 
release from GABAergic terminals in the hippocampus, as well as 
decreasing the firing of the cells that give rise to them (see 
Zieglgänsberger et al., 1979).
The presynaptic inhibitory effect of MENKA on transmitter 
release from GABAergic terminals associated with axo-axonic 
synapses requires further study. The effect of electrophoretic 
MENKA on the excitability of GABA-releasing terminals could be 
determined by extracellular stimulation of terminations (10Hz, 
50% of tests) in the ventral horn while recording the 
antidromic firing of the GABAergic neurones that give rise to 
them with a second micropipette positioned in the intermediate 
nucleus. Such an investigation could determine if the 
presynaptic inhibitory effect of MENKA on transmitter release 
is associated with naloxone-sensitive terminal hyper­
polarization, as appears to be the case for noradrenergic 
terminals in the cerebral cortex (Nakamura et al., 1982) and 
sympathetic preganglionic terminals (Wouters & Van Der Berken, 
1980), or occurs without alteration of the terminal membrane 
potential, as might be expected if MENKA had a direct effect on 
voltage-dependent calcium channels (Mudge et al., 1979). 
Furthermore, the effect of MENKA on the firing of the GABA 
releasing interneurones would be of interest, to determine 
whether enkephalin receptors were present on the cell bodies as 
well as on the terminals of these neurones. It would be of 
interest to determine whether MENKA also has a presynaptic
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inhibitory effect on transmitter release from GABA-releasing 
and glycine-releasing terminals involved in the postsynaptic 
inhibition of spinal neurones.
The functional importance, if any, of enkephalin receptors 
on GABAergic neurones and their terminals remains to be 
demonstrated. If, under the conditions of the present 
investigation, tonically released opioid peptides diminished 
the effectiveness of GABAergic synapses upon la excitatory 
terminals on motoneurones, antagonism by naloxone would be 
expected to reduce, not enhance, la transmission. Naloxone, 
however, in doses adequate to enhance la transmission, had no 
obvious effect on the excitability or conductance of la 
terminals.
If opioid peptides were responsible for the maintenance of 
a tonic GABA-mediated depolarization of la terminals by an 
effect on interneurones of the presynaptic inhibitory pathway, 
then systemic naloxone would have been expected to reduce the 
excitability and conductance of la terminals (and so increase 
termination threshold and the size of the phasic PAD - see 
Curtis & Lodge, 1982). The failure of intravenous naloxone to 
alter the electrical threshold of la terminals suggests that 
opioid peptides do not maintain a tonic depolarization of la 
terminals associated with a tonic presynaptic inhibition of 
monosynaptic reflexes.
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MENKA and morphine had no naloxone-sensitive effect on the 
excitability of la terminals, both in the ventral horn and in 
the intermediate nucleus. The failure of these compounds to 
alter the depolarizing action of GABA (or P4S) on la terminals 
in a naloxone-sensitive fashion suggests that opioids have no 
effect on the conductance of la terminals (see Curtis et al., 
1981). Furthermore, MENKA had no presynaptic inhibitory effect 
on the monosynaptic excitation of intermediate nucleus neurones 
by volleys in group I afferents. These findings, especially 
the failure of MENKA to reduce transmitter release from group I 
terminals in the intermediate nucleus, suggest that la 
terminals do not possess functional enkephalin receptors. In 
this respect they resemble the (mature) dorsal root ganglion 
cells that give rise to them (Williams & Zieglgänsberger,
1981). (Cultured embryonic dorsal root ganglion cells (Werz & 
MacDonald, 1983) and their axon terminals (Jia & Nelson, 1983), 
however, do possess enkephalin receptors).
Several other investigations have suggested that 
exogenously administered enkephalins fail to affect the release 
of transmitter from la terminals. Electrophoretic MENKA had no 
effect on the amplitude or time course of multifibre la EPSPs 
recorded intracellularly from motoneurones in the ventral horn 
of the cat spinal cord (Duggan & Zhao, 1984). In addition, 
enkephalin analogues had no significant effect on monosynaptic 
reflexes when administered intravenously to conscious humans 
(Roby et al., 1983), or added to the solution perfusing 
isolated immature rat spinal cords (Suzue & Jessel, 1980).
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(The effect of opioids on monosynaptic reflexes recorded from 
hemisected frog spinal cords is controversial: Wouters et al.
(1979) found that DALA potently suppressed spinal reflex 
activity, whereas Nicoll et al. (1980) observed that similar 
concentrations of the same enkephalin analogue had no effect or 
increased monosynaptic reflexes, increases presumably being 
attributable to a diminution in tonic presynaptic inhibition). 
The failure of microelectrophoretic MENKA to depress la 
transmission suggests that the naloxone-sensitive segmental 
inhibition which inhibits monosynaptic reflexes is not mediated 
by a direct presynaptic inhibitory effect of opioid peptides on 
la terminals.
To summarise, the results of the present investigation 
indicate that the naloxone-reversible tonic inhibition of 
monosynaptic and polysynaptic spinal reflexes cannot be 
explained by antagonism of either a direct opioid effect on la 
terminals, or an indirect effect of opioids mediated through 
the increased activity of the GABA-releasing interneurones that 
mediate presynaptic inhibition. A direct postsynaptic 
inhibitory action of enkephalin on motoneurones seems unlikely, 
as large doses of electrophoretic MENKA and naloxone both 
failed to alter the size of la EPSPs recorded intracellularly 
from motoneurones (Duggan & Zhao, 1984). Furthermore, the 
failure of electrophoretic naloxone to increase EPSPs suggests 
that the tonic inhibition seen in anaesthetised cats is not 
attributable to the release of opioid peptides near 
motoneurones. The naloxone-reversible tonic inhibition of
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motoneurones is likely to arise from an action of opioid 
peptides in the dorsal horn which ultimately increases the 
firing of inhibitory interneurones which synapse primarily on 
motoneurone dendrites. Another possibility that cannot be 
excluded on the basis of the available evidence is that opioid 
peptides facilitate the operation of a presynaptic inhibitory 
pathway, utilising a transmitter other than GABA, which has no 
effect on the excitability or conductance of la terminals.
Further intracellular studies on motoneurones are required 
to elucidate the basis of this naloxone-sensitive inhibition. 
The existence of a tonic dendritic postsynaptic inhibition 
(presumably generated by a conductance increase to chloride 
and/or potassium) might be detected by an analysis of the 
falling phase of multifibre la EPSPs (which represent EPSP 
components from distal dendrites), the repetitive firing rate 
of motoneurones to injected steady current and the voltage 
decay of brief intracellular current pulses, before, and after, 
intravenous naloxone; these tests are more sensitive indicators 
of "remote" inhibition than the measurement of somatic membrane 
potential and conductance (Burke & Rudomin, 1977; Carlen et 
al., 1980). The presence of a tonic hyperpolarizing dendritic 
inhibition would be compatible with the finding that 
intravenous naloxone leads to a depolarization of some 
motoneurones in the absence of detectable change in somatic 
membrane conductance (Morton et al., 1983).
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The failure to detect any evidence of a naloxone-sensitive 
remote postsynaptic inhibition would suggest the operation of a 
tonic presynaptic inhibitory process. The presence of such a 
presynaptic inhibition could be established by intracellular 
recording of single fibre somatic la EPSPs before and after 
naloxone; an increase in the size of single fibre somatic la 
EPSPs could only be accounted for by the removal of a tonic 
presynaptic inhibition controlled by endogenous opioids.
Whatever the precise mechanism involved, it is clear that 
inhibitory interneurones in the spinal cord are primary targets 
for opioid peptide releasing pathways, enkephalins having no 
direct effect on motoneurones. This is in accordance with 
Nicoll's proposal that opioid effects are often directed at 
local inhibitory interneurones (Nicoll et al., 1980). Future
studies may establish which types of interneurones are affected 
by endogenous opioids, and whether the activity of 
interneurones that inhibit motoneurones is increased by 
disinhibition.
It has been suggested that the naloxone-reversible 
inhibition of spinal reflexes is attributable to the release of 
opioid peptides in response to the surgical trauma necessary to 
prepare cats for investigation (Duggan et al., 1984). As the 
inhibition was shown to be nonselective, reducing the response 
of both flexor and extensor motoneurones to a variety of 
inputs, Duggan and coworkers proposed that its role was to 
reduce movement of an injured part and so facilitate its
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repair. However, low systemic doses of naloxone increase 
monosynaptic spinal reflexes in conscious humans (Boureau et 
al., 1978) and augment bladder reflexes in chronically 
paraplegic cats (Thor et al., 1983). The potentiation by 
naloxone of spinal reflexes in preparations unexposed to acute 
injury suggests that endogenous opioids may be released in the 
absence of noxious afferent input. This notion is supported by 
the finding that naloxone increases reflexes in the isolated 
frog spinal cord (Wouters et al., 1979). Further experiments 
are required to determine to what extent opioid mediated spinal 
inhibition is attributable to activation of nociceptive 
afferents. The average potentiation by naloxone of 
monosynaptic spinal reflexes recorded non-invasively (H reflex) 
from anaesthetised cats would provide information on basal 
opioid inhibition, and could be compared with the average 
potentiation of H reflexes by naloxone in anaesthetised cats 
exposed to extensive surgical trauma.
The naloxone-sensitive reduction by MENKA of GABAergic PAD 
reported in the present study of la terminals may be of general 
importance, since methionine-enkephalin has been shown to 
reduce the bicuculline-sensitive PAD of A <5 tooth pulp afferents 
in the trigeminal nucleus of the cat (Lovick, 1983). The PAD 
of tooth pulp afferents was generated by stimulation of the 
nucleus raphe magnus, while methionine-enkephalin was 
administered electrophoretically near the terminal regions of 
A<5 afferents. As in the present investigation the reduction of 
PAD by enkephalin was reduced by naloxone, which alone did not 
influence PAD. Methionine-enkephalin had no effect on A5
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terminal excitability, and presumably reduced PAD by depression 
of GABAergic interneurone firing and/or block of GABA release 
from invaded nerve terminals. A naloxone-reversible 
enhancement by electrophoretic opioids of the PAD of A6 and C 
afferent "terminals" in the dorsal horn of the cat lumbar cord 
has been reported (Sastry, 1979). However, in this 
investigation no measures were taken to identify the terminal 
portions of afferent fibres, apart from location near 
appropriate neurones.
The non-specific, naloxone-insensitive effects of 
electrophoretic morphine and MENKA on the excitability and 
GABA-sensitivity of la terminals were a complicating feature of 
the present investigation. Electrophoretic administration of 
morphine, MENKA and naloxone frequently increased the threshold 
of la fibres and terminals, especially when large ejection 
currents were used. This was clearly not an opiate action, as 
the effect of naloxone and MENKA (or morphine) on termination 
threshold was additive, rather than antagonistic. Presumably 
the microelectrophoretic ejection of these compounds produces 
concentrations that have a local anaesthetic-like effect on 
terminals located close to the micropipette. Electrophoretic 
morphine (Duggan & Curtis, 1972) and naloxone (Nicoll et al., 
1977) have previously been reported to have a local anaesthetic 
effect on central neurones when administered with large 
currents, and this is not unexpected considering their effects 
on the excitability of Pacinian corpuscle terminals (Chelyshev 
& Gataullin, 1983) and their potency in blocking conduction of 
peripheral nerve fibres (Seeman, 1975).
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As well as increasing termination threshold, naloxone, 
morphine and MENKA all were capable of reducing the 
postsynaptic action of GABA on la terminals, especially when 
large ejection currents were utilised. Previous investigations 
have demonstrated that concentrations of naloxone achieved in 
microelectrophoretic studies can competitively antagonise the 
postsynaptic action of GABA (Dingledine et al., 1978; Groul et 
al., 1980). While both stereoisomers of naloxone weakly block 
GABA effects, only the (-)-isomer antagonises the action of 
opioids (Groul et al., 1980). The failure of intravenous 
naloxone to affect prolonged spinal inhibition (Goldfarb & Hu, 
1976) or PAD suggests that extraneuronal concentrations of 
naloxone produced by systemic doses that increase spinal 
reflexes have no effect on the postsynaptic action of GABA.
Electrophoretic morphine has been shown to decrease the 
postsynaptic action of GABA (Williams & Zieglgänsberger, 1981) 
and glycine (Curtis & Duggan, 1969) in a naloxone-insensitive 
fashion. Leucine-enkephalin has also been demonstrated to 
reduce the postsynaptic action of GABA when administered 
electrophoretically (Barker et al., 1978). The postsynaptic 
antagonism of GABA produced by the high local concentrations of 
morphine and MENKA achieved during microelectrophoresis could 
result from competitive interactions at the level of the GABA 
recognition site, or from a blocking effect on chloride 
channels opened by GABA. The reduced sensitivity of la 
terminals to gabamimetics, and spinal neurones to glycine, 
during electrophoretic procaine suggests that the latter 
possibility may be more likely.
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The non-specific effects of naloxone, morphine, MENKA (and 
procaine) on the excitability and GABA-sensitivity of la 
terminals tended to be rapid in onset and offset, and could 
frequently be avoided by the use of small ejection currents, as 
in Fig. 13. The presynaptic effect of MENKA on GABA release at 
axo-axonic synapses was easily distinguished from any 
non-specific effects by its long duration of action and 
sensitivity to naloxone. Furthermore, by judicious selection 
of ejecting currents the reduction of PAD by MENKA could be 
observed in the absence of increases in termination threshold 
or a diminished effectiveness of GABA (or P4S).
In conclusion, the major finding of the present 
investigation is that electrophoretic MENKA brings about a 
naloxone-sensitive reduction in the release of GABA from 
axo-axonic synapses, but fails to alter the release of 
excitatory transmitter from la terminals. Thus GABA-releasing 
terminals at axo-axonic synapses appear to possess enkephalin 
receptors, while la terminals do not. Any physiological 
significance of MENKA's presynaptic inhibitory effect on GABA 
release is difficult to assess in the absence of detailed 
information about the relationship between opioid 
peptide-containing terminals and GABA-releasing neurones and 
terminals in the intermediate region and ventral horn of the 
spinal cord. If future immunohistochemical studies suggest 
that enkephalin containing terminals contact glutamic acid 
decarboxylase-positive (GABA releasing) terminals, then MENKA's 
inhibitory effect on GABA release is likely to be of functional
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importance. The demonstration of a naloxone-reversible 
reduction of PAD by activation of some opioid-releasing pathway 
would be of similar significance. However, the failure of 
intravenous naloxone to alter phasic or tonic PAD of la 
terminals suggests that under the conditions of the present 
study, endogenous peptides do not tonically influence GABAergic 
axo-axonic transmission.
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VI. THE DIFFERENTIAL EFFECTS OF BACLOFEN ON SEGMENTAL AND 
DESCENDING EXCITATION OF SPINAL NEURONES
INTRODUCTION
Baclofen (ß-p-chlorphenyl GABA) was synthesised by 
introducing a lipophilic substituent into the GABA molecule in 
an attempt to produce a drug better able to penetrate the 
blood-brain barrier than the parent compound (Faigle & Keberle, 
1972). When administered intravenously to cats (+)-baclofen 
reduced monosynaptic and polysynaptic reflexes (monosynaptic 
reflexes were reduced to a greater extent), and diminished 
decerebrate rigidity (Bein, 1972; Kato et al., 1978). Baclofen 
has proved to be of therapeutic benefit in the alleviation of 
spasticity resulting from a variety of neurological disorders 
(Lance, 1980).
Early microelectrophoretic studies reported that 
extraneuronal concentrations of (+)-baclofen, which are now 
appreciated as being relatively high, produced a weak 
bicuculline-insensitive depression of neuronal firing (Curtis 
et al., 1974; Davies & Watkins, 1974). Subsequent studies in 
the cat spinal cord demonstrated that the low extraneuronal 
concentrations of baclofen achieved after systemic 
administration have no direct effect on postsynaptic 
excitability or conductance (Pierau & Zimmerman, 1973; Fox et 
al., 1978), or on the depolarizing action of L-glutamate 
(Davies, 1981). The major effect of baclofen appeared to be
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presynaptic: it reduced transmitter release from primary
afferent terminals and thereby depressed the monosynaptic 
excitation of spinal neurones (Fox et al., 1978; Curtis et al. , 
1981; Davies, 1981). For example, low doses of intravenous 
(+)-baclofen (0.1 - 5 mg kg greatly depressed monosynaptic 
la EPSPs recorded from spinal motoneurones in the absence of 
any detectable change in postsynaptic membrane potential or 
resistance (Pierau & Zimmerman, 1973). The effect of baclofen 
on transmitter release from primary afferents has been shown to 
be stereospecific, with activity residing in the (-)-isomer 
(Olpe et al., 1978; Ault & Evans, 1981; Curtis et al., 1981; 
Davies, 1981). The presynaptic inhibitory action of baclofen 
was unaffected by concentrations of bicuculline which 
antagonised the postsynaptic inhibitory action of GABA (Davies, 
1981).
Microelectrophoretic adminstration of baclofen near spinal 
neurones allowed a comparison to be made of its effects on 
different types of synaptic excitation and inhibition. When 
administered electrophoretically (-), but not (+), -baclofen 
selectively reduced the monosynaptic excitation of 
interneurones in the cat spinal cord by impulses in low 
threshold muscle and cutaneous primary afferents, but had 
little or no effect on the polysynaptic excitation of the same 
cells (Curtis et al., 1981; Davies, 1981). The monosynaptic 
cholinergic excitation of Renshaw cells, and the glycinergic 
and GABAergic inhibition of spinal neurones were also 
relatively insensitive to electrophoretic baclofen (Curtis et
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al., 1981). Accordingly, relatively low concentrations of
baclofen have been proposed to selectively reduce the release 
of excitatory transmitter from the terminals of primary 
afferent fibres, while having minimal effect on transmitter 
release from motoneurones axon collaterals and the axon 
terminals of excitatory and inhibitory interneurones (apart 
from some GABA-releasing interneurones) (Curtis et al., 1981). 
Excitatory transmitter release from descending corticospinal 
and reticulospinal fibres also appeared to be unaffected by 
baclofen (Kato et al., 1978).
The selective, stereospecific action of baclofen on 
transmitter release from primary afferents indicates that 
bicuculline-insensitive receptors for (-)-baclofen are present 
on primary afferent excitatory terminals within the cat spinal 
cord, but not on the majority of other intraspinal terminals, 
either excitatory or inhibitory in nature.
(-)-Baclofen has been shown to decrease the duration and 
magnitude of the calcium component of action potentials 
recorded from cultured embryonic avian (Dunlap, 1981) and 
mature mammalian A5 and C type (Desarmenien et al., 1984) 
dorsal root ganglion cells in a bicuculline-insensitive 
manner. This effect of baclofen has been attributed to a 
reduction in the voltage-dependent calcium ion conductance of 
these neurones (Dunlap & Fischbach, 1981). A similar action on 
the central terminals of these neurones would account for the 
reduction of transmitter release from primary afferents by
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baclofen, as transmitter release appears to depend on the 
influx of calcium ions into the presynaptic nerve terminal 
(Katz, 1969; Krnjevic et al., 1979). Furthermore, an effect of 
baclofen on presynaptic calcium channels is compatible with the 
finding that concentrations of baclofen which decrease 
transmitter release from primary afferents have no detectable 
effect on the excitability or conductance of la terminations 
(Curtis et al., 1981).
Intracellular studies on dorsal root ganglion cells have 
demonstrated that GABA also has a baclofen-like 
bicuculline-insensitive effect on voltage-dependent calcium 
channels (Dunlap & Fischbach, 1978; Dunlap, 1981; Desarmenien 
et al., 1984). Although GABA also depolarized dorsal root 
ganglion cells in a bicuculline-sensitive manner by increasing 
the chloride ion conductance (Gallagher et al., 1978), the 
bicuculline-insensitive effect of GABA on calcium entry was 
evident at GABA concentrations which were insufficient to open 
chloride channels (Desarmenien et al., 1984; Dunlap 1981). 
Gabamimetics such as muscimol (Dunlap, 1981; but see also 
Desarmenien et al., 1984) and isoguvacine (Desarmenien et al., 
1984) had little or no effect on voltage-dependent calcium 
channels, even at concentrations which depolarized ganglion 
cells in a bicuculline-reversible manner. These results 
suggest that dorsal root ganglion cells possess 2 types of GABA 
receptor, a bicuculline-sensitive GABA receptor (activated by 
"conventional" gabamimetics but not by baclofen) and a 
bicuculline-insensitive GABA receptor (activated by baclofen 
but not by conventional gabamimetics).
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The existence of a "novel" bicuculline-insensitive GABA 
receptor that is activated by (-)-baclofen has also been 
suggested by Bowery and collaborators to explain the effects of 
a range of GABA analogues on the potassium-evoked release of 
preloaded transmitter from autonomic nerve terminals and brain 
slices (Bowery et al., 1980; Bowery et al., 1981). Supporting 
evidence for the existence of such a receptor has been provided 
by recent ligand binding studies (Hill & Bowery, 1981). This 
receptor, the GABAD receptor, differs from the "classical"
GABA receptor site (the GABA^ receptor) in that it is 
unaffected by recognised GABA antagonists (such as bicuculline) 
and the majority of accepted gabamimetics (such as P4S, 
muscimol and isoguvacine) (Bowery et al., 1983). Activation of 
GABA0 receptors by baclofen or GABA causes a bicuculline- 
insensitive decrease in transmitter release from presynaptic 
terminals in central and peripheral preparations (Bowery et 
al., 1980; Bowery et al., 1981; Ault & Nadler, 1982; Collins et 
al., 1982). Pure GABA^ agonists, such as isoguvacine and 
P4S, have no effect on transmitter release from these 
preparations.
The presence of two types of GABA receptor on dorsal root 
ganglion cells has led to the suggestion that GABA^ and 
GABAd receptors may coexist on the primary afferent terminals 
they give rise to (Desarmenien et al., 1984). The 
bicuculline-sensitive depolarization of la terminals by 
electrophoretic GABA and gabamimetics such as P4S provides 
direct evidence that GABA receptors are present on primary
122
afferent terminals (Curtis & Lodge# 1982; Curtis et al.,
1982). Furthermore, the reduction of synaptically evoked 
primary afferent depolarization by electrophoretic bicuculline 
suggests that GABA released at axo-axonic synapses acts on this 
type of GABA receptor in a functionally important manner 
(Curtis & Lodge, 1982). The depression of excitatory 
transmitter release from the terminals of primary afferent 
fibres by electrophoretic (-)-baclofen indicates that baclofen 
receptors are also present on primary afferent terminals (in 
addition to GABA^ receptors). These baclofen receptors may 
indeed be of the GABAß type and thus activated by GABA 
released at axo-axonic synapses. However, there is no direct 
evidence that electrophoretically administered or synaptically 
released GABA has a baclofen-like bicuculline-insensitive 
effect on transmitter release from la terminals, and it is 
possible that baclofen receptors on primary afferent terminals 
are not activated by GABA released at axo-axonic synapses.
The prolonged "presynaptic" inhibition of the firing of 
extensor motoneurones which follows tetanic stimulation of low 
threshold flexor afferents has presynaptic and postsynaptic 
components (Eccles, 1964; Granit et al., 1964; Cook & Cangiano, 
1972; Curtis, 1978; Carlen et al., 1980). Rudomin and 
collaborators have produced evidence that the same population 
of GABA-releasing interneurones in the spinal intermediate 
nucleus may be responsible for generating both components of 
this prolonged spinal inhibition (Solodkin et al., 1984). The 
postsynaptic hyperpolarizing component of prolonged inhibition
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is sensitive to picrotoxinin and bicuculline, and thus appears 
to result from the activation of GABA receptors located 
primarily on motoneurone dendrites (Kellerth, 1968; see also 
Cook & Cangiano, 1972). The presynaptic component of prolonged 
spinal inhibition probably results from the action of GABA 
released from axo-axonic synapses on primary afferent terminals 
(Nicoll Sc Alger, 1979). Presynaptic inhibition of la 
excitatory transmission is accompanied by a bicuculline- 
sensitive depolarization of la terminals; this depolarization 
is produced by the activation of GABA^ receptors, presumably 
coupled to chloride channels, on primary afferent terminals 
(Curtis Sc Lodge, 1982). The increased chloride conductance of 
the presynaptic membrane might be expected to shunt the 
depolarization of la terminals by afferent impulses and thereby 
diminish any voltage-dependent transmitter releasing mechanism, 
such as the influx of calcium ions (Eccles, 1964; Katz, 1969;
Nicoll Sc Alger, 1979). Although the increased chloride 
conductance of la terminals and the presynaptic inhibition of 
la transmission both result from the action of GABA released at 
axo-axonic synapses, there is no direct evidence that the 
increased chloride conductance, or the associated 
depolarization, actually reduces transmitter release from la 
terminals. Furthermore, there is no convincing direct evidence 
that GABA actually does reduce transmitter release from primary 
afferent terminals in the spinal cord. Although the reduction 
of the "presynaptic" inhibition of extensor monosynaptic 
reflexes by bicuculline suggests the involvement of GABA 
receptors, the available information is insufficient to assess
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the relative contribution of GABA and GABA mechanismsA  o
towards the GABA-mediated presynaptic component of the 
prolonged inhibition of la excitatory transmission.
The selective effect of baclofen on transmitter release 
from primary afferent terminals appears to be associated with 
the presence on them of axo-axonic synapses. In order to 
evaluate this hypothesis the first part of the present 
investigation has examined whether baclofen influences 
transmitter release from descending pathways located in the 
ipsilateral dorsolateral funiculus (DLF). The terminals of 
these fibres# which end in the intermediate region of the 
lumbar spinal cord# do not appear to receive GABA-releasing 
axo-axonic synapses (R.E.W. Fyffe# personal communication) 
although detailed morphological data is lacking. In the second 
part of the study (-)-baclofen# GABA# P4S and muscimol were 
administered electrophoretically near intermediate nucleus 
interneurones in an attempt to demonstrate a bicuculline- 
insensitive baclofen-like effect of GABA on transmitter release 
from primary afferent terminals.
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RESULTS
Stimulation of the red nucleus (RN) or the ipsilateral 
dorsolateral funiculus (DLF) with single electrical pulses 
rarely fired intermediate nucleus neurones that were excited 
monosynaptically by group I afferent impulses. It was 
therefore impossible to compare the effect of micro- 
electrophoretically administered (-)-baclofen on the excitation 
of individual neurones by impulses in descending and primary 
afferent fibres. Previous investigations of this kind have 
demonstrated that electrophoretic and intravenous baclofen 
reduced the monosynaptic firing of single intermediate nucleus 
interneurones by primary afferent impulses (Curtis et al.,
1981; Davies, 1981). Thus in order to compare the effect of 
baclofen on monosynaptic excitation by primary afferent and 
descending volleys, field potentials generated by the 
excitation of many intermediate neurones were recorded, and 
baclofen was administered intravenously. Such negative field 
potentials represent the synaptic excitation and firing of many 
neurones (Eccles et al., 1954). Provided that the field 
potentials were generated by monosynaptic excitation, 
reductions in the rate of rise and amplitude would reflect a 
reduction in transmitter release from excitatory nerve 
terminals or a reduced postsynaptic effect of the transmitter.
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(i) The effect of baclofen on group I excitation in the
intermediate nucleus
The monosynaptic excitation and firing of interneurones in 
response to group I afferent impulses generated negative field 
potentials in the intermediate nucleus region of the lumbar 
spinal cord. These potentials were maximal 0.8 - 1.2 ms after 
the arrival at the cord dorsum of the primary afferent volley. 
Intravenously administered baclofen reduced the amplitude and 
slowed the rate of rise of field potentials recorded in the 
intermediate nucleus in response to group I muscle afferent 
volleys# suggesting that monosynaptic excitation was reduced. 
Similar findings have previously been reported by Ono et al. 
(1979).
Results from two experiments are illustrated in Fig. 16.
The amplitude and rate of rise of the potential recorded at a 
depth of 2.1 mm in the segment in response to stimulation 
of the gastrocnemius nerve (G# 2T) was substantially reduced
(by 60%) after the administration of (t)-baclofen 
hydrochloride/ 5 mg kg 1 (compare Fig. 16, A and B). In 
another experiment (Fig. 16/ C and D)/ the field potential 
generated by stimulating the flexor digitorum longus nerve 
(FDL/ 2T) was reduced by 60% of the control value by 
(+)-baclofen (5mg kg ^). Effects similar to these were 
observed in all 8 animals to which either (+)-baclofen (three)/ 
(+)-baclofen hydrochloride (four) or (-)-baclofen hydrochloride 
(one) were administered progressively to doses ranging from
Fig. 16. Averaged field potentials recorded
extracellularly in the region of the seventh lumbar 
intermediate nucleus in two animals, (A, B and C-F) in response 
to electrical stimulation of the ipsilateral dorsolateral 
funiculus (DLF), gastrocnemius nerve (G), flexor digitorum 
longus nerve (FDL) and contralateral red nucleus (RN) - see 
text. A: surface stimulation of DLF fibres (3T), G(2T), 32 
sweeps at 4Hz, before and B: 4 min after intravenous
( + )-baclofen hydrochloride 7 5 mg kg 1 injected progressively 
over 15 min. C, E: FDL (2T), RN (3T, 2mA), 32 sweeps at 4Hz,
before and D, F: 9 and 4.5 min after (+)-baclofen
hydrochloride, 5mg kg  ^ injected progressively over 30 min. 
Calibrations: 0.1 and 0.2mV for A, B and C-F respectively;
time, ms.
CONTROL BACLOFEN
20
MSEC
80 -  
Q
?  60H
100 -
BACLOFEN 
1 mg /kg
o o
• •
1 m g / k g  1 m g / k g  2 m g / k g  1 m g / k gI I I !
• •
o o o o
o
z  40
Ou
O DL F 
•  GASTROC
25 MIN
Fig. 17. Effect of sequential intravenous doses of
(+)-baclofen hydrochloride on the amplitude of averaged field 
potentials. Averaged field potential amplitude is expressed as 
a percentage of its pre-baclofen value (Ordinate: % control
field). Data is from the same animal as illustrated in Fig. 16 
A and B. Filled circles: averaged fields recorded in response
to stimulation of the gastrocnemius nerve (GASTROC, 2T, 32 
sweeps at 4Hz); open circles: averaged fields recorded in
response to surface stimulation of the ipsilateral dorsolateral 
funiculus (DLF, 3T, 32 sweeps at 4Hz). Intravenous doses of 
(t)-baclofen hydrochloride are indicated by vertical arrows. 
(Abscissa: time, min).
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1-6.25 mg kg . The fields were generated by stimulation of 
low threshold G, PI and FDL afferent fibres, and there was no 
concomitant reduction in the amplitude of the primary afferent 
volleys recorded from the dorsal surface of the cord.
The effect of baclofen was dose dependent, sequential doses 
of intravenous baclofen (1-6 mg kg ^) causing a progressive 
reduction in the amplitude and rate of rise of group I field 
potentials (see Fig. 17).
A phenomenon not investigated in detail was the apparent 
greater sensitivity to baclofen of the latter phases of field 
potentials generated by FDL nerve stimulation (1.4-2T), these 
potentials in three cats being clearly biphasic, with a second 
peak 0.6-0.8 ms after the first. A similar reduction was also 
observed in the late phase of potentials evoked by stimulation 
of the G nerve. The preferential effect of baclofen on the 
late component of group I evoked field potentials is 
illustrated in Fig. 18. In this experiment (t)-baclofen 
hydrochloride (1 mg kg abolished the second peak of the 
field potential generated by FDL (2T) stimulation, while only 
reducing the amplitude of the first peak by 17% (compare Fig. 
18, A and B). Further doses of baclofen progressively reduced 
the first peak of the FDL field potential.
Since la and lb afferents converge onto a common population 
of intermediate nucleus interneurones (Jankowska et al.,
1981a), it is possible that the early part of FDL and G field
Fig. 18. Averaged field potentials recorded
extracellularly in the region of the seventh lumbar 
intermediate nucleus in response to electrical stimulation of 
the ipsilateral dorsolateral funiculus (DLF) and flexor 
digitorum longus (FDL). A: stimulation of the DLF mounted on
bipolar platinum electrode (4T) and FDL (2T), 32 sweeps at 4Hz, 
before and B: 1 min after intravenous (+)-baclofen 3.3 mg
kg  ^ (injected progressively over 14 minutes). The arrow in 
A indicates the late component of the FDL field potential which 
was especially sensitive to intravenous (+)-baclofen. 
Calibration: 0.5mV; time, ms.
DLF FDL
CONTROL
BACLOFEN 1 mg kg“ 1
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potentials reflects that excitation of intermediate neurones by- 
group la volleys, while the latter part is produced by impulses 
in group lb afferents (see also Fig. 1 in Eccles et al.,
1954). If this is so, transmitter release from lb afferent 
terminals may be more sensitive to baclofen than transmitter 
release from la terminals.
(ii) The effect of baclofen on DLF fields
Although the lumbar dorsolateral funiculus contains many 
types of descending fibres, only rubrospinal, propriospinal and 
corticospinal fibres terminate on neurones in the vicinity of 
the intermediate nucleus (Nyberg-Hansen, 1966). Thus field 
potentials recorded in the region of the intermediate nucleus 
in response to stimulating the DLF at the L^-L^ level were 
likely to be generated by cells excited by volleys in 
rubrospinal (Hongo et al., 1972), long propriospinal (Jankowska 
et al., 1983) and corticospinal (Lundberg et al., 1962) 
fibres. Time courses were somewhat slower than those generated 
by stimulating muscle afferents, the times to peak after the 
fastest descending volley being 1.4, 1.5, 1.8 and 2.3 ms in 
four experiments. In the one animal in which a group I excited 
interneurone was also fired by a DLF volley, the lumbar central 
latency (minimum value of 2.8ms) was considerably longer than 
the group I central latency (0.8ms).
The extent to which DLF fields reflect monosynaptic 
excitation is thus difficult to assess, but baclofen had much 
less effect on the rising phases and amplitudes of these
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potentials than on those generated by group I afferent volleys, 
suggesting that monosynaptic excitation by impulses in 
descending fibres was little influenced. For example, as 
illustrated in Fig. 16, A and B, (+)-baclofen hydrochloride, 5 
mg kg 1 reduced the amplitude of the field produced by 
surface stimulation (3T) of the DLF by less than 5%, with no 
significant alteration in the rate of rise, whereas the 
amplitude and rate of rise of the potential generated by a G 
volley (2T) were reduced by approximately 60%. In the other 3 
experiments, in which the DLF was placed on stimulating 
electrodes, the fields were either not affected or reduced by 
10 and 20% by doses of (+)-baclofen (5.3, 3.3, 6.25 mg kg 
which reduced fields generated by stimulating the FDL nerve 
peripherally by 30, 80 and 50% respectively. Small intravenous 
doses of baclofen (1-2 mg kg ^) frequently resulted in 
transient hypotension, and bradycardia. Larger cumulative 
doses generally produced marked hypotension and slow, irregular 
oscillations in blood pressure; the associated deterioration in 
spinal cord blood flow may have been responsible for these 
reduced DLF fields.
In the one experiment in which DLF stimulation (3.6T) fired 
a neurone, monosynaptic excitation by G or FDL stimulation (2T) 
was suppressed after the administration of 3 mg (+)-baclofen 
hydrochloride kg yet a further dose of 2.3 mg kg  ^
failed to either modify the shape and amplitude of the DLF 
field potential or the discharge of the single neurone (compare 
Fig. 19, A and B).
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Fig. 19. Averaged field and action potentials recorded
extracellularly in the region of the seventh lumbar 
intermediate nucleus in response to electrical stimulation of 
the ipsilateral dorsolateral funiculus (DLF), gastrocnemius 
nerve (G), and flexor digitorum longus nerve (FDL). A: 
surface stimulation of DLF fibres (3T), G (2T), FDL (2T), 16 
sweeps at 4Hz, before and B: 2 min after intravenous
(j-)-baclofen hydrochloride/ 5.3 mg kg  ^ injected
progressively over 23 minutes. Arrows indicate averaged action 
potentials of a single neurone, superimposed on averaged field 
potentials, this potential not being as apparent in the DLF 
record as in G and FDL because of the fluctuation of latency in 
relation to the bin width (50ps) of the averager. Every single 
record used to compile the average of B contained a DLF-evoked 
action potential. Calibrations: 0.5mV; time, ms.
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(iii) The effect of baclofen on RN fields
More specific information about the effect of baclofen on 
monosynaptic rubrospinal excitatory transmission was obtained 
in two animals in which the red nucleus was stimulated. Within 
the spinal cord the peak of the field potentials (3T stimuli) 
occured 3 ms after the arrival at of the fastest 
descending volley (see Fig. 16 E# F). In both experiments, 
doses of baclofen which substantially reduced the amplitude and 
rate of rise of group I afferent volley field potentials (Fig. 
16, C and D), had no effect on the rising phase, amplitude or 
time course of RN evoked field potentials, as illustrated in 
Fig. 16 E, F for 5 mg (t)-baclofen hydrochloride kg 1. The 
field potential generated by FDL volleys was, however, reduced 
by 60% of the control value. In the other animal 2 mg kg 1 
resulted in a 50% reduction of PI (1.5T) and FDL (1.5T) fields 
without any modification of the RN field.
(iv) Synaptic inhibition of group I excitatory transmission
Tetanic stimulation of low threshold flexor afferents 
produces a prolonged inhibition of the monosynaptic firing of 
extensor motoneurones (Eccles, 1964). This inhibition 
comprises a presynaptic component and a postsynaptic component, 
both being mediated by GABA (Eccles, 1964; Granit, 1964;
Curtis, 1978; Carlen et al., 1980; Solodkin et al., 1984). The 
monosynaptic firing of intermediate nucleus interneurones by 
impulses in extensor group I afferent fibres is also inhibited
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by conditioning volleys in low threshold flexor afferents. The 
demonstration that such volleys generate a bicuculline- 
sensitive depolarization of group la terminals in the 
intermediate nucleus (Curtis, Lodge & Headley, unpublished 
observations; see also Rudomin et al., 1981 and chapter III) 
suggests that this inhibition may also have a presynaptic 
component mediated by GABA, in accordance with the finding of 
axo-axonic synapses on la terminals in this region (Fyffe & 
Light, 1984). A postsynaptic GABA-mediated component is also 
likely.
The monosynaptic firing index of 6 intermediate nucleus 
neurones excited by impulses in group I extensor afferent 
fibres was reduced by prior (30 ms) tetanic stimulation of low 
threshold PBST afferents, and in every instance the inhibition 
was almost completely blocked by electrophoretic BMC.
Histograms illustrating the sensitivity of this inhibition to 
bicuculline are shown in Fig. 21. Initially the monosynaptic 
firing index of this cell was reduced 38% by prior (30 ms) 
electrical stimulation (4 volleys, 320Hz, 2T) of low threshold 
PBST afferents (Fig. 21 B, i-iii). During the administration 
of BMC (50nA) the inhibition was reversibly reduced to 2% (Fig. 
21 C and D, i-iii). Fig. 20 illustrates similar findings for a 
different cell. The inhibition of monosynaptic firing produced 
by tetanic flexor afferent volleys was reduced from 37% to 4% 
during electrophoretic BMC (40nA) (compare Fig. 20 B, i-iii and 
C, i-iii).
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(v) The effect of GABA analogues of group I excitation of
intermediate nucleus interneurones.
GABA, P4S, muscimol and (-)-baclofen were administered 
microelectrophoretically near single intermediate nucleus 
interneurones to compare their respective effects on group I 
excitatory transmission. All of these substances reduced the 
NMDA-maintained firing of spinal neurones. As a means for 
circumventing reductions in postsynaptic excitability as the 
major cause of reduced efficiency of synaptic excitation (as 
measured by the firing index in response to afferent volleys), 
the background firing rate was restored to the initial control 
level by increasing the current used to eject NMDA (see Curtis 
et al., 1981). The "presynaptic" effect of compounds on
excitatory transmission was assesed after the background firing 
rate had been restored. Such a technique, however, makes no 
compensation for increases in neuronal conductance induced by 
depressant amino acids (and by NMDA), and no allowance for 
possible effects of increasing concentrations of NMDA (elevated 
extracellular potassium concentration, reduced extracellular 
calcium concentration - see Curtis et al., 1984) on transmitter 
release.
(-)-Baclofen, ejected from a 5mM in 150mM NaCl solution, 
readily and reversibly reduced the monosynaptic firing index of 
all 8 interneurones tested, under conditions where postsynaptic 
excitability was maintained artificially at a constant level. 
Histograms illustrating the effect of baclofen on the
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monosynaptic excitation of an intermediate nucleus interneurone 
are shown in Fig. 20 A. During the administration of 
(-)-baclofen (20nA) the monosynaptic firing index was reduced 
from 81% to 17% (Fig. 20 A i and ii). The effect of 
(-)-baclofen was reversible, full recovery occurring after 2.5 
minutes (Fig. 20 A iii). This action of baclofen was 
unaffected by concentrations of BMC which blocked the prolonged 
synaptic inhibition of neuronal firing produced by conditioning 
volleys in low threshold flexor afferents (Fig. 20 A i-iii and 
D i-iii; see earlier). This suggests that (-)- baclofen 
reduced excitatory transmitter release from group I afferent 
terminals in a bicuculline-insensitive fashion, confirming the 
earlier observation of Davies (1981).
GABA was administered electrophoretically near 5 intermediate 
neurones fired monosynaptically by impulses in group I 
afferents. Doses of GABA (40-60nA) which substantially reduced 
the NMDA-maintained firing had no effect on the latency or 
monosynaptic firing index of 4 cells, even though postsynaptic 
excitability was depressed. In contrast, (-)-baclofen (40nA) 
reduced the firing index of the two cells on which it was 
tested. The synaptic excitation of the remaining cell was 
abolished by doses of GABA (50nA) which completely inhibited 
background firing; however, partial restoration of postsynaptic 
excitability by increased NMDA ejection fully restored 
monosynaptic excitation. The failure of electrophoretic GABA 
(60nA) to influence the monosynaptic firing of an intermediate 
neurone is illustrated in Fig. 21 A i-iii. The monosynaptic
Fig. 20. Histograms of the monosynaptic excitation of an
intermediate nucleus group I interneurone fired by stimulation 
of the FDL nerve (1.3T) at the time of the vertical arrow, the 
background firing rate (40-50Hz) being maintained by the 
continuous ejection of N-methyl-D-aspartate (see text). 
Ordinates: number of action potentials in consecutive 0.2 ms
bins, 64 sweeps at 4Hz. Abscissae: time, ms. The numbers
indicate the firing index, as a percentage of 64, in the 
interval 2-4.6ms after the stimulus, the peripheral FDL volley 
having a latency of 1.85ms to the cord dorsum. As i, before; 
ii, 2 min during the ejection of (-)-baclofen (20nA for 2.5 
min); iii, 2.5 min after baclofen. B: i, as for A iii; ii,
the FDL stimulus was preceded (30ms) by tetanic stimulation (4 
volleys, 320Hz, 2T) of PBST afferents; iii, FDL stimulus 
alone. C,D: as for B and A respectively but 10 and 7 min
during the electrophoretic ejection of bicuculline 
methochloride (BMC, 40nA for 10.5 min). E: 3 min after BMC.
The apparent enhancement of the inhibitory effect of PBST nerve 
stimulation was not observed with other interneurones.
0 6 MSEC
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firing index of this neurone in response to group I plantaris 
afferent volleys (1.4T) was initially 100% (Fig. 21 A i). The 
electrophoretic administration of GABA (60nA) reduced the 
NMDA-maintained firing from 40 spikes sec  ^to nil.
Monosynaptic excitation was unaffected by this dose of GABA, 
both during the period of depressed background firing (not 
illustrated) and after postsynaptic excitability had been 
restored with additional NMDA (Fig. 21 A ii). It is noteworthy 
that low threshold flexor volleys reduced the monosynaptic 
firing index of this neurone by 40% in a bicuculline-sensitive 
manner (Fig. 21 B, i-iii and C, i-iii; see earlier). Thus when 
GABA was administered electrophoretically, an effect on 
excitatory transmitter release from group I terminals could not 
be demonstrated, even though the firing of this neurone was 
readily depressed by afferent volleys which were assumed, at 
least in part, to have a presynaptic inhibitory effect at 
bicuculline-sensitive GABA receptors.
Microelectrophoretically administered GABA is efficiently 
removed from the extracellular space by uptake into neurones 
and glia (Curtis & Johnston, 1974), and consequently may 
influence only a small part of the neurone under investigation 
(Curtis, 1976). In an attempt to circumvent this problem P4S 
was ejected near 9 intermediate nucleus neurones; this 
gabamimetic might be expected to influence a greater proportion 
of excitatory synaptic terminals upon a neurone as it is poorly 
inactivated by spinal tissue (Krogsgaard-Larsen et al., 1980). 
When ejected with currents of 40-80nA, P4S had no effect on the
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Fig. 21. Histograms of the monosynaptic excitation of an
intermediate nucleus group I interneurone fired by stimulation 
of the plantaris nerve (1.4T) at the time of the vertical 
arrow, the background firing rate (40-50Hz) being maintained by 
the continuous ejection of N-methyl-D-aspartate (see text). 
Ordinates: number of action potentials in consecutive 0.2 ms
bins, 64 sweeps at 4Hz. Abscissae: time, ms. The numbers
indicate the firing index, as a percentage of 64, in the 
interval 2.2-3ms after the stimulus, the peripheral plantaris 
volley having a latency of 1.65ms to the cord dorsum. A: i,
before; ii, 2 min during the ejection of GABA (60nA for 3 min); 
iii, 3.5 min after GABA. B: i, plantaris stimulus alone; ii,
the plantaris stimulus was preceded (30ms) by tetanic 
stimulation (4 volleys, 320Hz, 2T) of PBST afferents; iii, 
plantaris stimulus alone. C: as for B but 0.5, 1.0 and 1.5
min after the electrophoretic ejection of bicuculline 
methochloride (BMC, 50nA for 6 min). D: as for B but 20 min
after BMC.
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monosynaptic firing index of 5 cells, even when NMDA- 
maintained firing was depressed. The latency of cell firing 
was often prolonged by doses of P4S which depressed background 
firing, but not when postsynaptic excitability was restored.
The monosynaptic firing index of 4 intermediate neurones was 
reduced 13-100% by currents of P4S (14-50nA) which 
substantially diminished postsynaptic excitability. However, 
in every instance, partial restoration of background firing 
with additional NMDA fully restored the firing index to its 
initial value. The effects of (-)-baclofen and P4S could be 
compared on 6 neurones; baclofen (15-40nA) reduced the firing 
index of all neurones on which it was tested, in contrast to 
P4S, which failed to affect monosynaptic firing when 
postsynaptic excitability was maintained artificially. Thus a 
presynaptic inhibitory action of P4S could not be demonstrated.
Muscimol, another gabamimetic poorly taken up by spinal 
tissue (Johnston et al., 1978), was ejected (80nA) near one
intermediate nucleus interneurone and also had no effect on its 
monosynaptic excitation despite reduction of NMDA-maintained 
firing.
GABA and/or P4S were administered electrophoretically near 
the 6 intermediate extensor neurones which were inhibited by 
conditioning volleys in flexor afferents. A presynaptic 
inhibitory effect of electrophoretic GABA or P4S on transmitter 
release from group I afferent terminals could not be 
demonstrated for any of these neurones.
DISCUSSION
The major finding of the present investigation is that 
systemic doses of (-)-baclofen, which substantially reduced the 
monosynaptic excitation of intermediate nucleus neurones by 
impulses in extensor muscle group I afferent fibres, had little 
or no effect on excitation by impulses in descending fibres of 
the ipsilateral dorsolateral funiculus. Relatively low 
concentrations of (-)-baclofen (probably less than luM; see 
Faigle et al., 1980) thus appear not to influence the release 
of excitatory transmitters from the terminals of rubrospinal, 
corticospinal and propriospinal fibres, in contrast to the 
reduction of the release of primary afferent transmitters. 
Furthermore, the failure of systemic baclofen to influence the 
excitation of intermediate nucleus neurones by impulses in 
descending fibres is in accordance with the proposal that 
relatively low concentrations of baclofen have no direct 
postsynaptic inhibitory action on spinal neurones (Fox et al., 
1978).
The present findings are consistent with those of an 
earlier investigation in which intravenous doses of baclofen 
sufficient to abolish monosynaptic spinal reflexes did not 
alter motoneuronal firing in response to stimulation of the 
reticular formation, pyramidal tract and the cuneiform nucleus 
(Kato et al., 1978). A more recent study of sympathetic 
preganglionic neurones in the isolated rat spinal cord in vitro
has also suggested that (-)-baclofen has a greater effect on
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primary afferent excitation than on the excitation produced by 
descending volleys (McKenna & Schramm, 1984). These and other 
studies emphasise that the effect of (-)-baclofen on 
transmitter release from primary afferent terminals is very 
selective, there being no effect on transmitter release from 
the spinal terminals of motoneurones (axon collaterals), 
excitatory and inhibitory interneurones, and a variety of 
descending fibres (see Curtis et al., 1981).
The reduction by (-)-baclofen of monosynaptic excitatory 
transmission has been attributed to the occupation of GABAg 
receptors on primary afferent terminals (Bowery, 1982). The 
failure of systemic baclofen to affect rubrospinal excitatory 
transmission suggests that the terminals of rubrospinal fibres 
do not possess such receptors. Furthermore, a previous 
investigation has demonstrated that rubrospinal terminals also 
fail to possess bicuculline-sensitive GABA receptors 
(Chapter III). Thus the spinal terminals of rubrospinal 
neurones are apparently devoid of GABA^ and baclofen 
(GABA ) receptors. In this respect they resemble the
13
peripheral terminals of spinal motoneurones (Glavinovic, 1979; 
Smart, 1980).
In contrast, the central terminals of peripherally located 
dorsal root ganglion cells possess both GABA^ and baclofen 
(GABA-.) receptors. It seems likely that the existence of
13
receptors for GABA and baclofen on primary afferent terminals 
is related to the presence on them of GABA-releasing axo-axonic
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synapses. The failure to detect either type of receptor on the 
spinal terminals of central neurones is in accordance with this 
proposal, as there is no suggestion that such terminals receive 
GABA-releasing axo-axonic synapses.
The results of several studies have led to the suggestion 
that GABA may activate the GABAß receptors on primary 
afferent terminals with which (-)-baclofen interacts, and so 
reduce transmitter release from primary afferent terminals in a 
bicuculline-insensitive manner (Dunlap & Fischbach, 1978;
Dunlap 1981). In order to examine this proposal GABA and 
(-)-baclofen were ejected microelectrophoretically near single 
intermediate nucleus interneurones excited by impulses in group 
I afferents. Substances which inhibit transmitter release from 
group I afferent terminals would be expected to reduce the 
monosynaptic firing index under conditions where postsynaptic 
excitability (assessed by firing rate) was maintained at a 
constant level. Under such conditions electrophoretic 
(-)-baclofen readily and reversibly reduced the monosynaptic 
firing index of intermediate cells in a bicuculline-insensitive 
manner. However, when GABA was administered in this fashion a 
baclofen-like effect on monosynaptic firing could not be 
demonstrated, even under conditions where postsynaptic 
excitability was substantially reduced. Thus electrophoretic 
GABA failed to have a demonstrable presynaptic inhibitory 
effect on group I excitatory transmission.
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The failure of electrophoretically administered GABA to 
affect transmitter release from group I terminals may be 
related to the non-uniform distribution of GABA around the 
neurones under investigation (see Curtis, 1976). The efficient 
inactivation of exogenously administered GABA makes it very 
difficult to produce appropriate concentrations near group I 
terminals distributed over the entire neuronal surface, many 
terminals being a considerable distance away from the 
micropipette orifice. Furthermore, the high GABA concentration 
in the vicinity of the micropipette increases the somatic 
conductance and hyperpolarizes the neurone to such an extent 
that monosynaptic firing is likely to fail before adequate GABA 
concentrations can be attained near a sufficient proportion of 
excitatory terminals. Thus when administered micro­
elect rophoret ically GABA's postsynaptic inhibitory action may 
predominate over any additional presynaptic effects. Similar 
considerations apply to electrophoretically administered P4S 
and muscimol.
The limitations of the microelectrophoretic method of drug 
administration apparently affect (-)-baclofen to a lesser 
extent. Unlike GABA, (-)-baclofen is not taken up by spinal 
tissue (Bowery et al., 1983), and consequently it diffuses 
further (see Curtis et al., 1981), producing a more uniform 
concentration distribution around the neurone being studied.
In addition, it has less postsynaptic inhibitory activity to 
complicate the interpretation of its effects. Thus when 
(-)-baclofen is ejected electrophoretically, enough primary
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afferent terminals are exposed to sufficiently high 
concentrations for group I excitatory transmission to be 
reduced presynaptically.
As the electrophoretic administration of GABA had failed to 
provide useful evidence for or against a bicuculline- 
insensitive presynaptic inhibitory action of GABA, this issue 
was also addressed by examining the effect of electrophoretic 
BMC on a GABA-mediated inhibition likely to have presynaptic 
and postsynaptic components. Electrophoretic BMC consistently 
and completely blocked the long lasting inhibition of 
intermediate nucleus interneurone firing produced by 
conditioning volleys in low threshold flexor afferents. This 
result suggests that the inhibition of monosynaptic firing 
present 30ms after the conditioning stimulus is largely 
attributable to the action of GABA on bicuculline-sensitive 
receptors, however, there is no evidence to what extent these 
receptors are located presynaptically or postsynaptically. 
Furthermore, the present type of investigation would fail to 
detect a bicuculline-insensitive presynaptic component of 
prolonged spinal inhibition, if it was insufficiently powerful 
to inhibit cell firing in its own right. Therefore although 
the data provides no evidence for a bicuculline-insensitive 
presynaptic action of GABA, neither does it entirely rule out 
such a phenomenon. In summary, the present investigation fails 
to provide direct evidence that GABA reduces transmitter 
release from primary afferent terminals by activating 
bicuculline-sensitive or bicuculline-insensitive presynaptic
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receptors. It is therefore impossible to evaluate the proposal 
that (-)-baclofen reduces transmitter release from primary 
afferent terminals by activating a bicuculline-insensitive GABA 
receptor located at GABA-releasing axo-axonic synapses.
Should GABA and GABA receptors both be concerned with
SD
the regulation of excitatory transmitter release two 
potentially additive mechanisms would be involved. A reduction 
of the calcium conductance of the presynaptic membrane 
subsequent to GABA receptor activation would directly reduce 
the entry of calcium into the terminal, while an increase in 
the presynaptic membrane chloride conductance and the 
associated depolarization produced by GABA^ receptor 
activation would decrease the size and duration of the invading 
action potential and so indirectly reduce voltage-dependent 
calcium influx. When presynaptic calcium entry becomes 
sufficiently reduced transmitter release from boutons would 
fail. At present, however, the relative contribution of 
GABA^ and GABAß mechanisms to presynaptic inhibition in the 
spinal cord remains uncertain.
Further experiments are required to substantiate the 
hypothesis that GABA reduces transmitter release in a 
bicuculline-insensitive manner. It would be worthwhile to 
re-examine the effect of electrophoretic GABA (and P4S) on the 
monosynaptic firing of neurones in the presence of 
extraneuronal concentrations of BMC sufficent to antagonise the 
postsynaptic inhibitory action of GABA. This might circumvent
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some of the limitations of the present study, and allow the
disclosure of a baclofen-like effect of GABA on group I
excitatory transmission. The contribution of GABADa
mechanisms towards presynaptic inhibition could be inferred by 
determining to what extent the presynaptic inhibition of group 
I excitatory transmission is insensitive to bicuculline. This 
would involve examining the effect of intravenous bicuculline 
on the depression of multifibre la EPSPs that occurs in the 
absence of any change in postsynaptic membrane potential or 
conductance (somatic and dendritic). The effect of bicuculline 
on the presynaptic inhibition of single fibre somatic la EPSPs 
would also be informative, as postsynpatic conductance changes 
are likely to have little effect on the amplitude of these 
potentials. Such investigations should also provide direct 
information about the contribution of GABA^ mechanisms to 
presynaptic inhibition.
In the spinal cord low concentrations of (-)-baclofen
selectively reduce transmitter release from primary afferent
terminals, having little or no effect on transmitter release
from local excitatory interneurones and descending excitatory
fibres. Since axo-axonic synapses are present on primary
afferent terminals, but probably not on other types of
intraspinal terminals, it is possible that in the spinal cord
baclofen reduces transmitter release only from terminals which
are postsynaptic to GABA releasing axo-axonic synapses,
presumably because GABA_, receptors are locateda
postsynaptically at these sites. Although in the spinal cord
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the effect of (-)-baclofen on transmitter release appears
linked to the presence of GABA-releasing axo-axonic synapses,
this appears not to be the case for the supraspinal regions
which have been studied in vitro. For example, (-)-baclofen
reduced transmitter release from the terminals of CA3
hippocampal pyramidal cells in a bicuculline-insensitive
manner, while having little or no effect on transmitter release
from other excitatory fibres in the hippocampal slice
preparation (Ault & Nadler, 1982). The stereospecific effect
of (-)-baclofen was mimicked by GABA (but not by selective
GABA^ agonists) in the presence of bicuculline. Thus the
terminals of CA3 pyramidal cells appear to possess GABA^
receptors, athough there is no evidence that they receive
axo-axonic synapses. It is difficult, however to envisage how
these non-synaptic receptors are activated by GABA under
physiological conditions. Nonsynaptic GABAQ receptors also
appear to be present on the terminals of superficial neurones
in the olfactory cortex, but not on terminals of the lateral
olfactory tract (Collins et al., 1982; Scholfield, 1983). The
reduction by (-)-baclofen of transmitter release from the
terminals of the intraspinal GABA-releasing interneurones which
mediate presynaptic inhibition suggests that extrasynaptic
GABA receptors may also be present in the spinal cord (see a
Curtis et al., 1981).
Although low concentrations of (-)-baclofen appear to have 
no direct postsynaptic inhibitory effect on spinal neurones 
(Fox et al., 1978; Ault & Evans, 1981), this appears not to be 
the case for supraspinal neurones. (-)-Baclofen consistently
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hyperpolarized CA1 hippocampal pyramidal cells, probably by 
increasing their potassium conductance (Newberry & Nicoll,
1984a; see also Gähwiler et al.# 1984). This effect of 
(-)-baclofen, which was mimicked by GABA in the presence of 
bicuculline, appeared to result from activation of dendritic 
GABA receptors (Nicoll & Newberry, 1984). Furthermore these
O
GABAg receptors appeared to be innervated, and their 
activation seemed to be responsible for the bicuculline- 
insensitive slow dendritic IPSP which followed orthodromic 
activation of CA1 pyramidal cells (Newberry & Nicoll, 1984b; 
see also Kehl & McLennan, 1983). (-)-Baclofen also 
hyperpolarized neurones of the dorsolateral septal nucleus 
(Gallagher et al., 1984), but had no direct effect on the 
membrane potential of neurones in the olfactory cortex 
(Scholfield, 1983).
Thus in supraspinal regions the neurophysiological data
suggests that (-)-baclofen may have presynaptic and/or
postsynaptic effects, although only the latter are likely to be
of functional importance. Recent autoradiographic and ligand
binding studies have also suggested that GABAß receptors may
be located presynaptically on excitatory nerve terminals and/or
postsynaptically on supraspinal neurones, according to which
particular region of the brain was being examined (Bowery et
al., 1983; Kilpatrick et al., 1983; Karbon et al., 1983; Price
et al., 1984). The suggestion by Bowery and co-workers that
GABA receptors in the cerebellum are located primarily on a
Purkinje cell dendrites is particularly interesting, in the
145
light of the physiological data which suggests that GABAB
receptors in the hippocampus are present on pyramidal cell 
dendrites postsynaptic to GABA-releasing synapses (Bowery et 
al.# 1983; Newberry & Nicoll, 1984b).
Although GABA receptors appear to be involved in 
bicuculline-insensitive postsynaptic inhibition in the 
hippocampus, there is no evidence for a bicuculline-insensitive 
postsynaptic inhibitory process in the spinal cord mediated by 
GABA. Furthermore, intracellular studies of spinal neurones in 
vivo and in vitro have not demonstrated a hyperpolarizing 
action of (-)-baclofen or GABA in the presence of bicuculline 
(Curtis et al., 1971b; Barker & Ransom, 1978; Pun & Westbrook, 
1983). Thus in the spinal cord GABA_ receptors may be 
involved only in the presynaptic modulation of primary afferent 
excitatory transmission. The extent of their contribution to 
the presynaptic component of prolonged GABA-mediated inhibition 
in the spinal cord will probably be fully characterised only 
after the discovery of a potent and selective baclofen 
(GABAg) antagonist.
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